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ABSTRACT
This thesis is the result of a multidisciplinary approach which combines behavioral, 
biochemical and neurochemical assays to identify and delineate the molecular mechanisms 
involved in the control of attention. Blockade of prefrontocortical glutamate NMDAR is 
associated with attentional performance deficits as assessed in a task capable of measuring 
selective attention and response control such as the five choice serial reaction time (5- 
CSRT) task.
I investigated whether phosphorylation of proteins linked to the PKA/CREB pathway in 
the prefrontal cortex (PFC) and in subcortical regions may be affected by NMDAR 
blockade. Pharmacological experiments using western blot and immunohistochemical 
techniques clearly demonstrated that increased CREB phosphorylation (p-CREB) in the 
PFC but not in subcortical regions may be associated to deficits in attention performance 
caused by the blockade of prefrontocortical NMDAR with the selective antagonist CPP.
Attempts has been made to identify the intracellular pathways responsible for CPP-induced 
p-CREB changes by examining different protein kinases upstream to CREB such as 
protein kinase A (PKA), extracellular regulated protein kinases 1/2 (ERK1/2) and 
calcium/calmodulin kinase II (CaMKII). However, the precise role of these kinases in 
NMDAR antagonist induced changes in p-CREB is unclear and deserves further studies.
The hypothesis that attention deficits induced by NMDAR blockade in the PFC might 
reflect excessive glutamate (GLU) release in the PFC was investigated by assessing the 
effects of intracortical CPP on attention, GLU release and p-CREB under basal conditions 
and in rats pre-treated with the mGlu2/3 receptor agonist LY379268. The results provide 
evidence that enhanced GLU release in the PFC and CREB phosphorylation are associated 
to attention deficit.
As there are evidences that drug responses may be modulated by the behavioural state of 
animals, I evaluated the effect of blockade of NMDAR in the PFC on p-CREB in rats 
performing the 5-CSRT task. Intriguingly, I found that in these rats CPP-induced p-CREB 
in the PFC was decreased as opposed to the increase found in behaviourally naive rats at 
the same time point, suggesting that the direction of CPP-induced p-CREB changes 
critically depends on the behavioural state of animals.
Moreover CPP-induced cognitive impairments were prevented by the intracortical 
administration of Sp-cAMP suggesting that the activation of the PKA/CREB cascade in the 
PFC is required for the correct performance of the task.
In conclusion the present thesis support the role of CREB and provide new information on 
the mechanisms involved in the control of attention and executive functions associated 
with some neuropsychiatric disorders.
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CHAPTER 1 
INTRODUCTION
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1. COGNITIVE FUNCTIONS
Defining cognitive deficits is not easy, because of the complexity of the phenomenon and 
its poor comprehension. Cognition literally means “the act or process of perceiving or 
knowing”. Consequently, this description tends to apply to processes such as memory, 
attention, perception, action, problem solving and mental imagery, abstract concepts such 
as reasoning, intelligence, learning, and many others that are related to numerous 
capabilities of the human brain.
Clinical diagnoses of cognitive disabilities have been described in schizophrenia, autism, 
attention deficit and hyperactivity disorder (ADHD), Down’s syndrome, traumatic brain 
injury and Alzheimer’s disease. Cognitive deficits in schizophrenia have been 
documented in numerous studies. The following paragraphs contain a brief description of 
cognitive symptoms in schizophrenia, with particular emphasis on deficits in executive 
functions including attention.
Symptoms of schizophrenia can be separated into positive (acquired through the illness 
process), negative (symptoms that reflect functions and behaviours that have been lost 
due to the illness), and cognitive symptoms (deficits in thinking, present from the onset of 
the disorder; Weickert et al. 2000).
The diagnosis of schizophrenia according to DSM-IV (Diagnostic and Statistical Manual 
of Mental Disorders; Cooper 1995) criteria is based on the concomitant appearance of at 
least two of the following symptoms each present for a significant portion of time during 
a 6-month period: delusions, hallucinations, disorganized speech (e.g., frequent 
derailment or incoherence), grossly disorganized or catatonic behavior and negative
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symptoms. Although psychosis is usually the most striking clinical aspect of the illness, 
disturbances in specific cognitive processes, such as attention, certain types of memory, 
and executive functions, are considered to be the core features of the illness (Elvevag and 
Goldberg 2000; Birkett et al. 2007; Harvey et al. 2001), and are associated with impaired 
quality of life and poor outcome (Green et al. 2000; Luck and Gold 2008). Cognitive 
deficits are fundamental aspects of schizophrenia that may account for much of the long­
term social disability associated with the disorder. In particular, cognitive symptoms, 
which cannot be regarded as unitary, include: impaired executive functions and attention 
(inability to focus/sustain attention), impaired memory, reduced ability to learn from 
mistakes or feedback, reduced capacity to form new concepts and poor problem-solving. 
Although cognitive symptoms have several similar features with negative symptoms 
(onset, temporal course, correlations with other aspects of the illness, and prognostic 
importance), negative and cognitive symptoms may be separable (Harvey, 2006).
1.1 Executive Functions and Attention
Executive functions (EF) could perhaps be viewed as the quintessence of higher-order 
cognition. Although there is no agreement upon definitions of EF in the literature, even 
after decades of extensive research, the majority of authors concur that EF are related to 
higher-order control processes involved in the goal-directed thought and actions (Barkley 
1997; Miyake et al. 2000). EF are defined as the ability to initiate and stop actions, to 
monitor and adapt behavior as needed, to anticipate outcomes and to plan future 
behaviors when faced with unpredictable novel tasks and situations. For example, on 
being presented with a potentially rewarding stimulus, the automatic response might be to
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take it. However, where this behavior conflicts with internal/external plans the executive 
functions might be engaged to inhibit this response.
The prefrontal cortex (PFC) plays a key monitoring role in EF, but other brain areas are 
also involved (Elliott 2003). Attempts to localize executive functioning to discrete frontal 
areas have been inconclusive. The emerging view is that executive function is mediated 
by dynamic and flexible networks.
Executive processes have been primarily linked to the prefrontal and cortico striatal 
thalamic circuits (Roberts and Bell 2002; Andres 2003).
The PFC is, however, a multifaceted area of the brain, and in recent years, the evidence 
for regional specialization within the PFC for different EF components has accumulated 
(Bunge et al. 2001; Ridderinkhof et al. 2004a,b; Shallice et al. 1994).
Attention is defined as the cognitive process of selectively concentrating on one aspect of 
the environment while filtering or ignoring extraneous information. It is a very basic 
function that often is a precursor to all other neuropsychological/cognitive functions.
Many forms of attention can be described: (1) Focused Attention, which is the ability to 
respond discretely to specific visual, auditory or tactile stimuli, (2) Sustained Attention 
which is the ability to maintain a consistent behavioral response during continuous and 
repetitive activity, (3) Selective Attention which is the capacity to maintain a behavioral or 
cognitive set in the face of distracting or competing stimuli, (4) Alternating Attention, 
which is the capacity for mental flexibility that allows individuals to shift their focus of 
attention and move between tasks having different cognitive requirements, and (5) 
Divided Attention, which is the ability to respond simultaneously to multiple tasks or 
multiple task demands.
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Attention is closely related to and often intimately involved in executive control and 
working memory (Luck and Gold 2008). Abnormalities in attention are one of the 
frequently studied cognitive deficits in schizophrenic patients (Braff 1993), and were 
described in the early clinical accounts of schizophrenia (Groom et al. 2008). Attention is 
apparently dysfunctional in schizophrenia in several ways, including sustained focused 
attention (Comblatt and Keilp 1994), selective attention (Nestor et al. 2001), and 
cognitive control of attention (Cohen et al. 1996).
Cognitive disturbances in patients can be present for years before the onset of psychosis 
and persist throughout the illness, exist in milder forms in unaffected relatives of 
individuals with schizophrenia, and are the best predictor of long-term functional 
outcome (Gold 2004). Their presence in attenuated form among the first-degree relatives 
of schizophrenic patients suggests their promise as components of genetic susceptibility 
to schizophrenia and related disorders (Gur et al. 2007; Snitz et al. 2006). In adults with 
schizophrenia, the stability of neurocognitive deficits across different phases of illness has 
been described (Heaton et al. 2001; Hoff et al. 1999).
1.2 Neuroanatomy of Cognitive Functions
Schizophrenia involves an imbalance in circuits distributed throughout the brain,
including multiple cortical and subcortical regions, that leads to impairment in the ability
to set priorities, to process and produce information, and to turn them into meaningful
thoughts and behaviour. Many studies of cognitive deficits in schizophrenic patients have
focused on the prefrontal cortex (PFC) because of its demonstrated importance in
executive functions (Fuster 1991). However, the role of the striatum, which belongs to the
cortico-striatal circuitry has also recently received some consideration. In the following
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paragraphs I will briefly outline the pathological findings related to excitatory 
(glutamatergic) and inhibitory (GABA) neurotransmission in patients. Afterwards the 
anatomical circuitry involved in the control of executive functions with particular 
emphasis on attention will be briefly reviewed. Evidence from human, monkeys and 
rodents will be presented.
1.3 Cortical and Striatal Abnormalities in Schizophrenic 
Subjects
The Wisconsin Card Sorting Test (WCST) is a neuropsychological test of "set-shifting", 
i.e. the ability to display flexibility in the face of changing schedule demands. Imaging 
studies have shown that this task involves significant activation of the dorsolateral PFC 
(Berman et al. 1995; Cabeza et al. 2000). However, more recent fMRI studies have shown 
that the ventrolateral PFC (Konishi et al. 1998) together with the caudate nucleus 
(Monchi et al. 2001), may be the regions importantly involved in the set-shifting 
processes required during the WCST.
It was found that 75% of schizophrenic patients performing the WCST exhibit deficits 
thus implicating dysfunctions of the cortico-striatal circuit in schizophrenia. In addition, 
schizophrenic patients show an abnormally low glucose utilization rate in the PFC and 
right temporal cortex during a test of attention and vigilance such as the Continuous 
Performance Test (CTP) (Buchsbaum et al. 1990).
It has been reported that the failure of intracortical connectivity and abnormalities of 
presynaptic terminals of the PFC accounts for both cognitive and psychotic
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manifestations of the illness (Dorph-Petersen et al. 2009; Sweet et al. 2009; Weinberger 
et al. 1994).
The question of whether there are histo-pathological changes in the brains of 
schizophrenic patients generated reports of volume loss (Bogerts et al.l 985), increased 
GABAa receptor binding in superficial layers of cingulate cortex (Benes et al. 1992a), 
increased density of glutamate-immunoreactive in cingulate cortex (Benes et al. 1987a,b; 
Benes et al. 1992b) and other subtle cytoarchitectural variations (Kovelman and Scheibel 
1984) in corticolimbic brain regions of individuals with schizophrenia. A reduced number 
of neurons expressing the enzyme nicotinamide-adenine dinucleotide phosphate- 
diaphorase (NADPH-d: the enzyme that catalyzes the reaction of nitric oxide) (Akbarian 
et al. 1993a,b) in the dorsolateral prefrontal area of subjects with schizophrenia was also 
reported.
The presynaptic terminals in the striatum of schizophrenic patients examined post­
mortem also showed a lower level of excitatory amino acid transporters 3 (EAAT 3) and 
significant deficits in the vesicular glutamate transporter 1 (VGluTl) compared to healthy 
controls (McCullumsmith and Meador-Woodruff 2002; Nudmamud-Thanoi et al. 2007). 
These latter data provide additional evidence for a glutamatergic synaptic pathology in 
the caudate nucleus in schizophrenia, likely reflecting a loss of glutamatergic cortico - 
striatal neurons.
Current pathophysiological models of functional disturbances in schizophrenia emphasize 
disinhibitory processes, acting through GABA, glutamate (GLU), and dopamine (DA) 
neurotransmission to affect the firing patterns of local networks of cortical neurons 
(Lisman et al. 2008; Lewis and Sweet 2009).
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A possible role for the striatum in the pathogenesis of the cognitive symptoms of 
schizophrenia has recently emerged (Simpson et al. 2010). Using functional magnetic 
resonance (fMRI) Manoach and coworkers found an aberrant activation of the PFC and 
basal ganglia (including the head of the caudate and the lentiform nucleus) during the 
performance of tasks involving working memory (Manoach et al. 2000; Tost et al. 2005). 
The role of the striatum in attentional processes and cognitive control is further suggested 
by functional neuroimaging in healthy volunteers showing that selective attention 
condition activate the head of caudate nucleus and globus pallidus (Corbetta et al. 1991). 
In addition, attentional set shifting during the Wisconsin Card Sorting Task activates the 
caudate nucleus in healthy human subjects (Rogers et al. 2000). In monkeys lesions of 
the medial striatum cause behavioral inflexibility (Clarke et al. 2008).
1.4 The Prefrontal Cortex: functional anatomy
The PFC is the anterior part of the frontal lobes of the brain, lying in front of the motor 
and premotor areas. This brain region has been implicated in planning complex cognitive 
behaviors, personality expression, decision making and moderating correct social 
behavior (Fuster 1997; Miller and Cohen 2001).
It is well established that anatomically distinct regions of the PFC play a critical role in 
facilitating different forms of behavioral flexibility: orbital regions of the PFC mediate 
simpler forms of behavioral flexibility such as shifts between different stimulus-reward 
associations, while the medial or dorso-lateral regions of the PFC are involved in the 
control of more complex behaviors (Birrell and Brown 2000; Dias et al. 1996a). The 
ventromedial and dorsolateral prefrontal cortices exhibit reciprocal connectivity with
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different posterior brain regions, with ventromedial prefrontal regions being associated 
with emotional processing areas (for example, amygdala) and dorsolateral prefrontal 
regions with non-emotional sensory and motor areas (for example, basal ganglia and 
parietal cortex).
However, patients with frontal lesions do not always show executive deficits (Andres 
2003; Omstein et al. 2008). Indeed, patients with lesions restricted to frontal regions and 
presenting impaired short-term memory storage, showed normal performance in measures 
of executive processes such as the capacity to undertake two tasks simultaneously and the 
capacity to inhibit no-longer relevant information (Andres and Van der Linden 2002).
Whether there is a homolog of primate PFC in the rodent brain is an issue of continuing 
debate (Povinelli and Preuss 1995; Uylings et al. 2003). The PFC of the rat has been 
divided into medial, ventral and lateral (figure 1.1). The medial PFC is subdivided into a 
dorsal region including pre-central (PrC) and anterior cingulated (ACg) cortices and a 
ventral component that comprises prelimbic (PrL), infralimbic (IL) and medial orbital 
(MO) areas (Berendse and Groenewegen 1991; Hoover and Vertes 2007). Each part of 
the medial PFC communicates with its adjacent areas and, with the possible exception of 
IL, each division interconnects with the others as well as with brain regions projecting to 
the PFC. However, from an anatomical perspective the medial regions of the PFC in 
rodents (i.e. IL, PL and ACg) share similar patterns of efferent and afferent connectivity 
with the dorsolateral PFC in primates and humans (Ongur and Price 2000).
The lateral region of the PFC includes dorsal and ventral agranular insular (AID,AIV) 
and lateral orbital (LO) areas. The ventral region of the PFC encompasses the ventral 
orbital (VO) and ventral lateral orbital areas (VLO) (figure 1.1).
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An alternative approach to the issue is to consider the function, rather than anatomy, of 
prefrontal areas. The evolution of PFC in the primates is, presumably, to support a degree 
of behavioural complexity that might not be found in the rat. However, if the rodent does 
demonstrate behaviour dependent on functions associated with primate PFC, the neural 
substrate of such behaviour could be regarded as at least analogous, if not homologous, to 
primate PFC. Accordingly, the medial PFC of rats posses a degree of functional 
equivalence with the dorsolateral PFC of non human primates as lesions of this region 
causes deficits in similar functions; impairs working memory, and temporal sequencing of 
behavior and causes behavioral inflexibility and inattention (Heidbreder and 
Groenewegen 2003; Dailey et al. 2004). Previous studies have suggested separate roles in 
different aspects of cognitive flexibility for the PL and IL cortex, as well as the 
orbitofrontal cortex (Boulougouris et al. 2007; Dailey et al. 2004; Ragozzino and Rozman
Fig.. 1.1 Illustrative diagrams of the rat prefrontal 
cortex
a. Lateral view, 0.9 mm from the midline.
b.Unilateral coronal section, approximately 3.5 mm forward 
of bregma (depicted by the arrow above). The different 
shadings represent the three major subdivisions of the 
prefrontal cortex (medial, ventral and lateral).
From Dailey et al, 2004
Abbreviations:
ACg, anterior cingulate cortex; AID, dorsal agranular insular cortex; AIV, 
ventral agranular insular cortex; AOM, medial anterior olfactory nucleus; AOV, 
ventral anterior olfactory nucleus; cc, corpus callosum; Cg2, cingulate cortex 
area 2; gcc, genu o f corpus callosum; IL, infralimbic cortex; LO, lateral orbital 
cortex; Ml, primary motor area; MO, medial
orbital cortex; OB, olfactory bulb; PrL, prelimbic cortex; PrC, precentral 
cortex; VLO ventrolateral orbital cortex; VO, ventral orbital cortex.
2007; Sun et al. 2010).
ACg
t>)
' j media)
21
Although the PFC has been linked to cognitive functions for a number of reasons, 
unequivocal evidence linking one specific region of the brain to schizophrenia has yet to 
be established. Recently, using positron emission tomography (PET) it has been shown 
that the frontal and parietal lobes are activated in response to attention effort in both 
visual and somatosensory modalities, thus confirming that these cortical areas are 
anatomical substrates for the processes involved in sustained attention (Pardo et al. 1991; 
Granon et al. 1998). Imaging studies in human subjects have also described the 
involvement of the anterior cingulate cortex (ACg) and dorsolateral PFC in cognitive 
control (Kerns et al. 2004). The PFC is activated during ketamine-induced psychosis in 
healthy individuals (Breier et al. 1997). Moreover, the metabolic rate of glucose 
utilization and the regional cerebral blood flow (rCBF) in the PFC were increased after 
ketamine much more in schizophrenic patients than in healthy controls (Vollenweider et 
al. 1997a,b; Holcomb et al. 2005).
Interestingly, Everitt and Robbins (2005) showed that the change from a voluntary drug 
use to more habitual and compulsive use caused a transition at the neural level from PFC 
to striatal control. In agreement, human imaging studies show the involvement of 
prefrontal regions early in instrumental and motor learning, but not after the tasks had 
been learned (Jenkins et al. 1994; Raichle et al. 1994; Jueptner et al. 1997; Duncan et al. 
2000; Doyon et al. 2002).
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1.5 The corticostriatal cognitive circuit: excitatory striatal 
afferent projections
The PFC sends its excitatory afferents to the striatum, the biggest structure of the basal 
ganglia. The striatum consists of the dorsal (caudate putamen or CPu), ventral (nucleus 
accumbens or NAC) striatum and the striatal elements of the olfactory tubercle (OT). 
Although the terms ’dorsal’ and ‘ventral’ striatum are widely used, an unequivocal 
boundary between these main striatal parts it’s hard to define. The medial territory of the 
CPu, is considered part of a “prefrontal cognitive circuit” and has been implicated in 
cognitive control over actions (Owen 1997), action-outcome learning (Yin et al. 2005) 
and continuous visuospatial task performance as reported by a PET activation study in 
humans (Corbetta et al. 1991). The CPu is unique in its complete lack of intrinsic 
glutamatergic neurons. Instead, 95% of striatal neurons are GABAergic medium-sized 
spiny neurons (Kawaguchi 199; Tepper and Bolam 2004). The striatum has been divided 
into three areas on the basis of their afferents and functions (Voom et al. 2004) (fig. 1.2). 
The dorsolateral striatum (fig. 1.2 green) which receives predominantly sensorimotor- 
related information (Brown et al. 1998) from the sensorimotor area of the frontal cortex, 
posterior and lateral intralaminar thalamic nuclei, nuclei of the intermediate basal 
amygdaloid complex (Wright and Groenewegen 1996), dorsal hippocampus and 
dopaminergic (DA) projections from the substantia nigra compacta (SNc; A9 cell group); 
the ventromedial striatum (fig. 1.2 red and pink) that collects visceral-related afferents 
from ventral prelimbic (PLv) and infralimbic cortex (IL) (Vertes 2004), paraventricular 
nucleus (PV) of midline thalamic nuclei, caudal basal amygdaloid nuclei, subiculum and 
CA1 region of the hippocampal formation and DA projections from ventral tegmental 
area (VTA) (A10 cell group). Finally, the striatal area lying between these extremes
called the dorsocentral striatum (fig. 1.2: blue and purple), which receive higher order 
‘associative’ information (McGeorge and Faull 1989; Reep et al. 2003) from the dorsal 
anterior cingulate cortex (ACd) and dorsal prelimbic cortex (PLd), nuclei of the rostral 
basal amygdaloid complex (Wright and Groenewegen 1996) and DA innervations arising 
from the VTA and SNc.
Recently, the dorsomedial and dorsolateral part of the striatum have been implicated 
specifically in the learning and performance of goal-directed actions (White 1989; 
Packard and McGaugh 1996; Devan et al. 1999a; Devan and White 1999b; Featherstone 
and McDonald 2004) as well as in habit learning respectively (Featherstone and 
McDonald 2005; Winocur 1974; Packard and White 1990; Robbins et al. 1990; Reading 
et al. 1991; McDonald and White 1993).
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Fig. 1.2
Excitatory Striatal Afferent Projections
The topographical arrangement of striatal afferents originating in the frontal cortex (upper 
left), midline and intralaminar thalamic nuclei (upper right), basal amygdaloid complex 
(lower left) and hippocampal formation (lower right) are illustrated. Frontal cortical areas 
and their corresponding striatal projection zones are shown in the same colors. The 
dorsolateral striatum receives somatotopically organized sensorimotor information 
(green), the most ventromedial part of the striatum collects cortical afferents (red and 
pink), and striatal areas between these extremes receive information from higher 
associational cortical areas (blue and purple).
Abbreviations: ac, anterior commissure; ACd, dorsal anterior cingulate cortex; Aid, dorsal agranular 
insular cortex; AIv, ventral agranular insular cortex; CeM, central medial thalamic nucleus; CL, central 
lateral thalamic nucleus; IL, infralimbic cortex; IMD, intermediodorsal thalamic nucleus; MD, 
mediodorsal thalamic nucleus; PC, paracentral thalamic nucleus; PFC, prefrontal cortex; PLd, dorsal 
prelimbic cortex; PLv, ventralprelimbic cortex; PV, paraventricular thalamic nucleus; SMC, sensorimotor 
cortex. (Adaptedfrom Voom P. et al., 2004).
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The ventral striatum, which comprises the nucleus accumbens (NAC) has been described 
as a Timbic-motor interface’ (Mogenson et al. 1980) receiving inputs from the PrL and 
IL areas and from distal limbic structures such as the hippocampus and amygdala. The 
PFC is one of the major sources of excitatory amino acid input to the NAC (Sesack and 
Pickel 1992). Specifically, the core region of NAC (NACc) receive glutamatergic 
afferents from the PrL region of the PFC, while the shell region of NAC (NACs) receive 
afferents from the IL subregions of the PFC (Berendse et al. 1992; Brog et al. 1993; 
Groenewegen et al. 1999; Vertes 2004; Voom et al. 2004). A schematic diagram is shown 
in fig. 1.3.
NAc core NAc shell 
medial
NAc shell 
ventral
Prelimbic Cortex Iufraliinbic Cortex
Fig. 1.3
Cortico-accumbal connections
Schematic illustration of connections between the three portions of the NAC shell and 
core regions with sub-regions of the PFC.
Modifiedfrom Shirayama and Chaki 2006.
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It has been reported that glutamatergic afferents from the PFC modulate the neuronal 
activity in the NAC directly or via dopaminergic neurons in the ventral tegmental area 
(VTA) (Kalivas and Stewart 1991; Kalivas et al. 1993). The activity of the NAC is thus 
the results of the balance between limbic and cortical inputs and therefore both increases 
and decreases in neurotransmission in this region exert a potent effect on information 
processing (Goto and Grace 2005). Interestingly, disruption of this balance may be one of 
the central components in the pathophysiology of schizophrenia (Csemansky and 
Bardgett 1998; Meyer-Lindenberg et al. 2002).
The CPu and the NAC contain a small populations of GABA-containing and cholinergic 
intemeurons, in addition to a large number of efferent GABA-ergic medium spiny 
projecting neurons (Meredith et al. 1993). The activity of projecting medium spiny 
neurons is regulated by glutamatergic afferents arising from the PFC, hippocampus and 
amygdala, by dopaminergic afferents from the substantia nigra (SN) and the VTA 
(Pennartz et al. 1992) and by local GAB A and Ach intemeurons. These afferents 
converge primarily on medium spiny GABA neurons, the main output cells of this region 
(Meredith et al. 1993).
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2. CAN COGNITIVE DEFICITS BE 
MIRRORED IN ANIMAL MODELS?
2.1 Tests of Attention in Rodents
A model is defined as any experimental preparation developed to study a particular 
condition or phenomenon in the same or different species. Typically, in preclinical 
research, models are cellular preparations or living animals that are used to mimic human 
condition. Animal models include both models of the full syndrome and models of 
specific signs or symptoms.
Certainly, the primary difficulty in modeling cognitive deficits in rodents is that they 
cannot self-report the features of the disease. The most common approach for developing 
animal models has been to exploit drug-induced states that produce disease-like 
symptoms in healthy humans (pharmacological models). These models generally have 
face or construct validity (only if the drug reproduce the pathological state) and have lead 
to the formulation of prominent theories of schizophrenia such as the dopaminergic and 
more recently the glutamatergic hypotheses.
2.2 The 5-CSRT Task
As with any unobservable cognitive process, assessment of attention requires 
quantification of an observable phenomenon, such as the behaviour of the animal or the 
activity of its nervous system. Three main tasks have been developed to study attention in 
rodents:
(1) The attentional set-shifting procedure to study the ability to shift attention (Birrell and 
Brown 2000).
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(2) The signal detection task to study the ability to attend selectively to a subset of 
environmental information while filtering out extraneous stimuli (McGaughy and Sarter 
1995).
(3) The jive-choice serial reaction time (5-CSRT) task that can be arranged to assess both 
sustained and selective attention, but also to study the ability to sustain attention over 
time (Carli et al. 1983).
The 5-CSRT task was developed based on Leonard’s choice reaction time task (Carli et 
al. 1983; Leonard 1969; Robbins 2002). It constitutes a rodent analogue of the continuous 
performance task (CPT) that is used to quantify attention in humans. The apparatus and 
the training procedure are described in the general methods. Here, it will be discussed 
how various measures of performance may represent the executive functions in their 
various aspects such as attentional functioning and inhibitory response control.
The 5-CSRT task essentially tests the ability of rats to sustain spatial attention divided 
among a number of locations over a large amount of trials. This capacity is measured by 
accuracy of visual discrimination (number of correct responses over a total number of 
correct plus incorrect responses) expressed as the percentage of correct responses. 
Changes in accuracy could not be explained as a simple motor effect since both correct 
and incorrect responses have equivalent motor requirements.
Omissions. not included in the accuracy measure are expressed as the percentage (number 
of omissions over the total number of trials completed). An increase in omissions may 
reflect gross impairments in attention, motivation or motor ability. Similar interpretation 
may be made for correct response latency (the latency to make a correct response) that 
may reflect decision time but also motor and motivational factors. These different
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interpretations may be disambiguated by observing the overall pattern of effects on 
omission and other measures such as latency to make a correct response and latency to 
collect food. The number of anticipatory (occurring during the inter-trial interval) and 
perseverative responses (repeated responses in the holes after a correct response) are 
measures of different aspects of inhibitory response control.
Anticipatory responses occur inappropriately when the rat is waiting for the target 
stimulus. An increase in these responses might signal that the inhibitory control is lost, 
and, as such, might represent a form of impulsivity (Evenden 1999).
By contrast, perseverative responses represent a different form of deficit in inhibitory 
response control. This deficit has been suggested to be more in accordance to 
“compulsive” rather than “impulsive” behaviour, in which rats continue to respond in the 
holes in spite of signals that food is available in the magazines (Chudasama et al. 2003). 
The great advantage of this task is that it provides largely independent measures of 
accuracy, speed, impulsivity, compulsive perseveration and motivation (Robbins 2002). 
A detailed description of the procedures and the training schedule for the 5-CSRT task is 
reported in the general methods section (Chapter 2).
2.3 The 5-CSRT Task: Behavioural Pharmacology and 
Functional Neurochemistry
The fact that the 5-CSRT task includes various independent performance variables has
revealed dissociations between underlying neuronal substrates of various aspects of
performance. This property of the task permits identification of neuromodulatory
mechanisms that selectively affect these different processes of attention and response
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control. The additional advantage of employing this task is that it has been extensively 
used for measuring the effects of drugs and other manipulations such as selective lesions 
of monoaminergic and cholinergic systems and excitotoxic lesions of various cortical and 
sub-cortical regions among which mPFC and its different sub-regions as well as dorsal 
and ventral striatum (Robbins 2002). This impressive achievement has been 
accomplished over three decade of systematic analysis of the task, using lesion, metabolic 
and pharmacological methods. Traditionally the neural mechanisms underlying 
performance on the 5-CSRT task have been mostly studied in non-human primates. From 
the 1980’ however, the majority of studies have been employing rats. The reasons are 
multiple; a better knowledge of the neural organization and projections of the rats’ PFC as 
well as its cellular and sub-cellular structure and neurochemistry.
The level of functioning of the PFC is highly dependent upon serotonin (5-FIT), dopamine 
(DA), noradrenaline (NE) and acetylcholine (Ach) inputs arising from subcortical areas. 
A most important aspect of the relationship of PFC with these chemically defined systems 
is that these are in turn innervated by fibres from the PFC. In particular the orbital and 
medial PFC in primates and the medial PFC in rats are the regions that have direct 
projections back to cholinergic basal nuclei while monoaminergic neurons receive 
efferents mainly from the dorsolateral PFC in primates and the medial PFC in rats 
(Uylings et al. 2003). This bi-directional connection of PFC with cholinergic and 
monoaminergic systems, indicate that the PFC might influence its own cholinergic and 
monoaminergic neurotransmission (Groenewegen and Uylings 2000). Numerous 
evidence suggest that these neurochemical systems although all implicated in functions 
associated with PFC mediate different forms of neuromodulation, which is known by 
their distinct contribution to various aspects of PFC functions such as working memory,
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vigilance, decision-making, reversal learning, attentional set shifting, sustained and 
selective attention and inhibitory response control (Aston-Jones et al. 1996; Goldman- 
Rakic 1998; Robbins 2000; Sarter et al. 2001). Interestingly distinct contributions to 
attentional functioning and inhibitory response control measured in the 5-CSRT task 
revealed that an impaired noradrenergic transmission induced attention deficits in rats 
(Carli et al. 1983).
Excitotoxic or immunotoxic lesions of Ach-ergic basal forebrain nucleus impaired 
accuracy at baseline task performance (Muir et al. 1994; McGaughy et al. 2002).
By contrast, depletion of forebrain 5-HT affected impulsivity but had no effect on 
accuracy (Harrison et al. 1997; Carli et al. 2001). Manipulation of dopaminergic system 
had distinct effects. DA depletion in the NAC decreased the overall probability of 
responding and speed but had no effect on other measures; mesostriatal DA depletion 
impaired accuracy and enhanced perseverative responding; DA depletion in the mPFC 
had some effect on accuracy but only when stimuli were presented unpredictably in time 
(Robbins et al. 1990).
These studies have been extended and include studies examining the selective 
manipulations of specific receptors in particular brain regions and more conventional 
pharmacological studies (Robbins 2002), and due to amount of data that have been 
gathered they cannot be reviewed here. However, although lesions and pharmacological 
manipulations are useful in delineating the cognitive functions of cortical and striatal 
regions, they do not address the molecular mechanisms that occur in each region or 
whether these mechanisms may interact to influence behaviour.
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Relevant for this project is a study by Muir et al. (1996a) showing that the mPFC but not 
post-genual cingulate, anterior dorsolateral and parietal cortex is crucial for attentional 
functioning in the 5-CSRT task in rats. Bilateral excitotoxic lesions of the mPFC caused 
increased perseverative responding whereas post-genual cingulate cortex lesions 
specifically increased anticipatory responses (Muir et al. 1996a). The findings of this 
study have been on the whole replicated but with mPFC lesions causing some additional 
effects such as increased anticipatory responding (Passetti et al. 2002).
Recent studies by Chudasama et al. (2003) with lesions restricted to sub-regions of the 
mPFC such as ACg and IL and to orbitofrontal (OFC) sectors of PFC showed that in a 5- 
CSRT task attentional selectively is related to ACg, impulsive responding to IL and 
perseveration to the OFC suggesting that impulsiveness and compulsiveness can be 
anatomically distinguished. Lesions of the PrL-IL sector of the mPFC impaired 
attentional selectivity and increased impulsivity and perseverative responding (Passetti et 
al. 2002). Therefore it could be suggested that visual selectivity and the ability to use 
temporal cues to guide performance might reside in the dorsal areas of the mPFC (ACg) 
whereas ventral regions of the mPFC and OFC appear critical for different aspects of 
inhibitory response control such as impulsivity (IL) and compulsive perseveration (PrL 
and OFC).
The dorsal and ventral regions of the mPFC have been shown to be involved in different 
behavioral functions or in different aspects of the same function. Briefly, the dorsal part 
of the mPFC (dorsal ACg and dorsal PrL) appears to be primarily involved in memory for 
the temporal order (Kesner 2000) and temporal patterning of behavioral sequences 
(Delatour and Gisquet-Verrier 2001), timing of extrinsic stimuli (Dietrich and Allen
1998), egocentric memory (Ragozzino and Kesner 2001) and spatial win-shift behavior
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(Seamans et al. 1995). In contrast, the ventral part of the mPFC comprising ventral PrL 
and IL as well as the motor cortex appears critical for the flexible shifting to new 
strategies or rules in spatial and visual discrimination (Ragozzino et al. 1998 and 1999). 
The excitotoxic lesions of the PrL/IL but not ACg altered the motor readiness (delay 
dependent speeding of reaction time) and increased impulsivity (Risterucci et al. 2003). 
Recently, PrL and IL regions of PFC have been shown to co-operate in the coordination 
of goal directed actions and habits; PrL appears crucial for voluntary control of goals, IL 
for automatic responding (habit) (Killcross and Coutureau 2003).
The striatum is as an obvious component of the functional neural system engaged by 5- 
CSRT task performance, considering not only its connectivity with the mPFC, but also 
the effects of excitotoxic striatal lesions on 5-CSRT’s task performance. The dorsal CPu 
for instance is the main striatal projection area of ACg and has been implicated in the 
formation of the response required to perform an attentional task (Brown and Robbins 
1991a). Excitotoxic lesions of medial region of the CPu in rats caused impairment in 
accuracy and deficits in response control in the 5-CSRT task reminiscent of the effects of 
excitotoxic lesions of the mPFC (Muir et al. 1996a,b) or blockade of NMDARin the 
mPFC (Mirjana et al. 2004; Murphy et al. 2005). In addition, in rats damage to the CPu 
impairs acquisition of associations between stimuli and motor responses (Colombo et al. 
1989; Packard and White 1990; Packard and McGaugh 1992; McDonald and White 
1994).
The striatal projection area of the PrL-IL includes also the NAC, which is important for 
the control of behaviour by the reward-associated stimuli (Cardinal et al. 2002). In 
addition, lesions of the core region of the NAC affect some aspects of performance, such
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as an elevation in premature responses, but do not affect response accuracy (Christakou et 
al. 2004) consistent with the hypothesis that several components of 5-CSRT task 
performance are mediated by somewhat distinct cortico-striatal circuits.
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3. NMDAR AND COGNITIVE FUNCTIONS
Glutamate (GLU) serves as the major excitatory neurotransmitter in the central nervous 
system. Given the multiplicity of receptor subtypes that have been described for GLU, a 
particular neuron’s response to this excitatory neurotransmitter will be determined by the 
presence and organization of diverse receptor types. GLU receptors have been classified 
as ionotropic and metabotropic (fig. 1.4). Ionotropic N-methyl-D-aspartate receptor 
(NMDA), a-amino-3-hydroxy-5-methyl-4-propionate (AMPA), and kainate (KA), 
receptors are ligand-gated cation channels, whereas metabotropic GLU receptors 
(mGluRs) are coupled to various signal transduction systems (Hollmann and Heinemann 
1994a; Hollmann et al. 1994b; Monaghan et al. 1989; Nakanishi 1992).
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Fig.1.4
Molecular families of glutamate receptors.
Each of the two main glutamate receptor divisions comprises three functionally defined 
groups (classes) of receptor. These are made up of numerous individual subunits, each 
encoded by a different gene.
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The glutamate NMDAR receptor is a tetramer consisting of different subunits, NR1, NR2 
(A, B, C, D) and NR3 (A and B) which affect the biophysical characteristics of the 
receptor and the sensitivity to drugs (Lynch and Guttmann 2001). All NMDAR types 
appear to function as heteromeric assemblies composed of multiple NR1 subunits in 
combinations with at least one type of NR2 subunit. The NR3 subunits do not form 
functional receptors alone, but can co-assemble with NR1/NR2 complexes (Hirai et al. 
1996; Laube et al. 1997; Perez-Otano et al. 2001). Different properties of the NMDAR 
depend on the subunit composition (Nakanishi 1992). Moreover, NMDAR subunits 
interact with various intracellular scaffolding, anchoring and signaling proteins and 
molecules associated with the post-synaptic densities (Cull-Candy et al. 2001). A 
distinctive feature of this receptor is that it is relatively inactivated under normal 
physiological conditions (Scatton 1993).
Autoradiographic studies have shown that NMDAR are widely distributed in the rat brain 
(Buller et al. 1994). In situ hybridization has revealed overlapping but different 
quantitative expression of the various NR2 subunits. In particular, NR2A mRNA is 
distributed ubiquitously like NR1 with highest densities occurring in hippocampal regions 
while NR2B subunit mRNA is expressed predominantly in the forebrain but not in the 
cerebellum where NR2C subunit predominates. In the cerebral cortex NMDAR are 
particularly enriched in the layers II/III and V/VI where they are preferentially localized 
on dendritic spines of pyramidal neurons but also present on excitatory and inhibitory 
axon terminals (Conti et al. 1997).
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The NMDARs beside participating in excitatory synaptic transmission have been shown 
to play a critical roles in many functions such as learning and memory, neuronal plasticity 
but also in excitotoxicity (Dingledine et al. 1999; Li and Tsien 2009; O'Brien et al. 1998). 
The involvement of NMDARs in these diverse processes, reflect their unique features, i.e. 
(1) they are blocked by extracellular Mg2+ in a voltage dependent manner, (2) they have a 
high permeability to Ca2+, Na+ and K+ and, (3) they have slow activation/deactivation 
kinetics.
Fig. 1.5
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sites; and (4) uncompetitive antagonists, which block the ion channel by binding to a site 
within it (fig. 1.5)
3.1 NMDAR Antagonists and Cortical Functions
Neuroimaging studies have provided some initial insights into the target brain regions of 
NMDAR antagonists in the human brain. Earlier studies reported that low doses of 
ketamine affect selectively the areas that are thought to be dysfunctional in schizophrenia 
such as the limbic cortex and basal ganglia (Morris et al. 2005; Soyka et al. 2005; 
Tamminga et al. 2003). A robust dose-dependent increase in cerebral blood flow (rCBF) 
was reported in the anterior cingulate, thalamus, putamen, and frontal cortex in healthy 
volunteers receiving ketamine (Holcomb et al. 2005; Langsjo et al. 2003).
Neuroimaging studies have also examined the regional effects of NMDAR antagonists in 
the brain of rodents. Ketamine has been shown to increase the blood oxygenation in the 
hippocampus, retrosplenial and orbital cortex, nucleus accumbens and ventral pallidum of 
anesthetized rats (Littlewood et al. 2006a,b). Risterucci et al (2005) examined the effects 
of PCP in two different animal models of schizophrenia (i.e. neonatal ventral 
hippocampal lesion and acute administration of PCP) using perfusion imaging. They 
found a significant increase in blood perfusion in the enthorhinal cortex, NAC, thalamus, 
and ventral pallidum, but a decreased blood perfusion in the PFC, temporal cortices and 
dorsal striatum. In contrast, Gozzi et al. (2008a) showed that PCP increased regional 
cerebral blood flow (rCBV) in the rat PFC and cingulate cortex (fig. 1.6).
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Fig. 1.6
Maps of regional cerebral blood flow (rCBV) response following acute PCP
Orange/yellow indicated increased rCBV.
Abbreviations: PFC, prefrontal cortex and Cg, cingulate cortex.
Several lines of investigation have implicated dysfunction of NMDAR in the
pathophysiology of cognitive functions in schizophrenia (Anand et al. 2000; Goff and
Coyle 2001; Meador-Woodruff and Healy 2000). A role for these receptors was
suggested when NMDAR antagonists, such as phencyclidine (PCP) and ketamine, were
found to induce a syndrome resembling the positive and negative symptoms of
schizophrenia in healthy subjects and exacerbate such symptoms in patients with
schizophrenia (Lahti et al. 1995; Luby et al. 1962; Javitt and Zukin 1991; Krystal et al.
1994; Malhotra et al. 1997). This discovery prompted a number of investigators to
suggest that reduced NMDAR function is a core feature of the disease and subsequent
studies with ketamine and dizocilpine (MK-801) have led to the hypothesis of an
NMDAR dysfunction in schizophrenia (Javitt and Zukin 1991; Olney et al. 1999).
In animals systemic or intracortical NMDAR antagonists have been shown to cause
hyperactivity (ONeill, 1987; Jentsch et al. 1998), impairments in sensory-motor gating
(Jentsch and Roth 1999; Yee et al. 2004) and deficits reminiscent of frontal lobe
dysfunctions such as deficits in working memory in T-maze (Moghaddam and Adams
1998; Moghaddam et al. 1997; Romanides et al. 1999; Verma and Moghaddam 1996;
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Wesierska et al. 1990) and in a Delayed Matching-to-Position task (Aura and Riekkinen
1999) as well as impairments in attentional functioning (Greco et al. 2005; Le Pen et al. 
2003; Mirjana et al. 2004; Pozzi et al. 2010). The selective NMDA-R2B receptor 
antagonist (Ro 63-1908) has been shown to induce deficits in attentional performance in 
the 5-CSRT task (Higgins et al. 2003a). Administration of NMDAR antagonists has 
become a widely used pharmacological model of schizophrenic-like cognitive deficit in 
rodents.
3.2 NMDAR and Glutamate Release
The behavioural effects of NMDAR antagonists in humans and experimental animals 
have been mostly attributed to hypoactivity of glutamatergic neurotransmission due to 
postsynaptic blockade of NMDAR (Javitt and Zukin 1991; Jentsch and Roth 1999). 
However, NMDAR antagonists, induce cortical excitation in humans (Breier et al. 1997; 
Holcomb et al. 2005; Vollenweider et al. 1997b) and in behaving animals (Gozzi et al. 
2008b) and increase GLU release in rats (Moghaddam and Adams 1998). Thus, the 
NMDAR hypofunction may paradoxically cause an increase in GLU release and 
hypermetabolism (Gozzi et al. 2008a; Homayoun and Moghaddam 2007; Jackson et al. 
2004; Takita et al. 2002) in corticolimbic regions.
How can NMDA receptor hypofunction lead to increased glutamatergic transmission?
In the intact brain, although locally applied NMDAR antagonists do not affect 
extracellular glutamate levels (Lopez-Gil et al, 2007; Lorrain et al 2003b), systemic 
administration leads to increased extracellular GLU in the mPFC.
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NMDAR are preferentially expressed by pyramidal neurons (almost 70%) but are also 
present on non-pyramidal cells in the rat cortex such as astrocytes (Aoki et al. 1994; Conti 
et al. 1997; DeBiasi et al. 1996). Thus, NMDAR expressed by both cells populations may 
have contributed to NMDAR antagonists effects on extracellular GLU.
In addition, PCP markedly reduced bursting activity of cortical pyramidal neurons and it 
has been suggested that the response of GABA-ergic intemeurons depends on the firing 
pattern of pyramidal cells (Shi and Zhang 2003). Thus, the enhanced GLU release in 
response to blockade of NMDAR likely reflects the reduced drive of cortical inhibitory 
intemeurons by NMDAR antagonists (Homayoun and Moghaddam 2007; Jackson et al. 
2004), which in turn causes GLU release and cortical excitation by removing the 
inhibitory tone on pyramidal neurons resulting in the dishinibition of cortical circuits. 
Indeed, NMDA blockade was associated with approximately 10-fold greater effects on 
GABAergic cells than on glutamatergic cells (Grunze et al.,1996). It follows that 
excitatory projections to the mPFC that are under GABAergic control could be more 
strongly affected by systemic NMDA antagonism than the pyramidal cells themselves, 
thereby leading to increased glutamate release by mPFC pyramidal cells.
These findings suggest that interactions between excitatory and inhibitoiy neurons play 
an important role in the response to systemically applied NMDAR antagonists in vivo. 
NMDAR antagonists may exert at least in part, their effects by disinhibiting GLU non- 
NMDA neurotransmission (Lewis and Moghaddam 2006; Moghaddam 2003a; 
Moghaddam and Jackson 2003b).
Thus, the effect of CPP on extracellular GLU may be mediated by direct or indirect 
suppression of cortical GABA-ergic transmission, which in turn enhances the release of
42
GLU from afferents to the mPFC. In particular, it can be suggested that NMDAR located 
on cortical GABA-ergic intemeurons, precisely the fast spiking intemeurons, are very 
sensitive to the effect of NMDAR antagonists in the mPFC (Homayoun and Moghaddam 
2007) and this cause a disinhibition of postsynaptic GLU neurons and increase GLU 
release. These findings confirm the previous evidence corroborating the hypothesis of a 
hyper-activation of cortico-striatal transmission after the blockade of NMDAR in the 
PFC.
In addition NMDAR antagonist increase a variety of neurotransmitters in the PFC, dorsal 
and ventral striatum and hippocampus (Del Arco et al. 2008a; Martin et al. 1998; 
Matsumoto et al. 1992). Acute injection of NMDAR antagonists increased DA release 
and utilization in the PFC, as well as NE, Ach and 5-HT (Adams and Moghaddam 1998; 
Deutch et al. 1987; Hondo et al. 1994; Knauber et al. 1999; Krystal et al. 1994; Mathe et 
al. 1996; Rao et al. 1990; Wedzony and Golembiowska 1993; Yonezawa et al. 1998; 
Jentsch et al. 1998; Martin et al. 1998; Moghaddam and Adams 1998).
43
3 Inhibitory neuron Excitatory neuron Output
GABA
*
„ Glutamate
Monitor a .—  ■Enough ^ ........
excitation
W f f l  NMDAR
Balanced
ai
o
Fig. 1.7
The hyper-activation of cortico-striatal transmission after the blockade of NMDAR 
in the PFC.
a) Inhibitory neurons monitor levels of excitatory activity via NMDAR signalling. 
Normally, the inhibitory neuron maintains sufficient GABA release to balance inhibition 
with excitation, (b) In the cortex of individuals with schizophrenia, decreased NMDAR 
signalling disrupts this monitoring function, fooling inhibitory neurons into acting as if 
there is insufficient excitatory activity. The inhibitory neurons downregulate their output, 
disinhibiting the excitatory neurons.
Glutamate
Too little 
excitation GABA
NMDAR
Disinhibited
44
4. CREB AND COGNITIVE FUNCTIONS
An exhaustive cellular and molecular explanation of cognitive processes is far from clear 
however, it is possible to identify synaptic plasticity, the ability of the brain to change the 
strength of synaptic connections in response to different stimuli, local protein synthesis in 
neurones and modifications of relevant genes as a common mechanism that may sustain 
cognitive performances. It appears clear that cognitive processes are complex phenomena 
in which interactions between different neuronal districts and brain areas need to be 
extremely fine regulated and integrated. Hence, the alteration in one of the numerous 
cellular pathways implicated may lead to significant changes in the overall cognitive 
capability.
4.1 The Transcription Factor CREB
Second messengers are molecules that convey signals from receptors on the cell surface 
to target molecules inside the cell, in the cytoplasm or nucleus. They rely on and greatly 
amplify the signals of hormones, growth factors and neurotransmitters, and cause changes 
in the activity of the cell. Second messengers are a component of signal transduction 
cascades.
Cyclic adenosine monophosphate (cAMP) is a second messenger important in many 
biological processes. cAMP is derived from adenosine triphosphate (ATP) and is used for 
intracellular signal transduction in many different organisms (Lalli and Sassone-Corsi 
1994). It is involved in the activation of protein kinases and genes. It also regulates the 
passage of Ca2+ through ion channels. All genes regulated by cAMP contain a cis-acting 
DNA sequence, called cAMP-response element (CRE), which binds the phosphorylated
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form of a transcription factor called CRE-binding (CREB, c-AMP Response Element- 
Binding) protein. A transcription factor is a protein that binds to specific DNA sequences 
thus controlling the transcription of genetic information from DNA to mRNA. It can act 
alone or in conjunction with other proteins in a complex, promoting (as activators) or 
blocking (as repressors) the recruitment of RNA polymerase (the enzyme that performs 
the transcription of the genetic information from DNA to mRNA) to specific genes 
(Latchman 1997; Mayr and Montminy 2001).
CREB is constitutively synthesized so that it exists in neurons under basal conditions. In 
its basal state, non-phosphorylated CREB is localized in the nucleus where it is bound to 
its response element CRE without considerable transcriptional activity. Indeed, CREB is 
unable to promote the transcription when not phosphorylated, whereas phosphorylated 
CREB strongly stimulates transcription. Binding of neurotransmitters and hormones to Gs 
protein-coupled receptors activates adenylyl cyclase, leading to an increase in cAMP and 
subsequent activation of the catalytic subunit of cAMP-dependent protein kinase (cAPK 
or PKA). The catalytic subunit of PKA then translocates into the nucleus where it 
phosphorylates CREB protein on serine 133 (SI33) residue. Only phosphorylated CREB 
can interact with CREB binding protein (CBP). The CREB-CBP complex can recruit 
basal transcription factors and RNA polymerase on the promoter and initiate 
transcription.
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Signaling through the cyclic AMP-protein kinase A signal transduction pathway 
phosphorylates CREB.
Binding of hormone to a specific cell surface receptor promotes the interaction of the 
receptor with a G protein. The activated G protein a subunit dissociates from the receptor 
and stimulates the membrane-bound adenylate cyclase to synthesize cAMP. The latter 
phosphorylates the regulatory subunits of protein kinase A, enabling release of the 
catalytic subunits which migrate to the nucleus and activate the transcription factor CREB 
(CRE- binding protein) by phosphorylation. Activated CREB binds to cAMP response 
elements in the promoters of target genes.
4.2 CREB Regulation
Phosphorylation of serine 133 is generally accepted to be a key event in the regulation of
CREB as mutation of this serine to alanine (S-CREB—>A) abolishes the stimulus-induced
transcriptional activation by CREB (Gonzalez and Montminy 1989).
Protein phosphorylation is catalyzed by protein kinasesa which are enzymes that
phosphorylate proteins by transferring a phosphate group from ATP to the hydroxyl
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groups of the side chains of serine, threonine, or tyrosine residues. Most protein kinases 
phosphorylate serine, threonine or tyrosine residues. These enzymes are called protein- 
serine/threonine kinases or protein-tyrosine kinases, respectively. Protein phosphorylation 
is reversed by protein phosphatases, which are enzymes that reverse the action of protein 
kinases by catalyzing the hydrolysis of phosphate groups from phosphorylated amino acid 
residues. Like protein kinases, most protein phosphatases are specific either for serine and 
threonine or for tyrosine residues, although some protein phosphatases recognize all three 
phospho-amino acids.
Protein
iosi
Fig. 1.9
Basic steps in protein phosphorylation
The combined action of protein kinases and protein phosphatases mediates the reversible 
phosphorylation of many cellular proteins.
The phosphorylation of CREB on S133 is regulated by a balance between the action of 
proteins kinases and phosphatases. As already mentioned, upon activation of the 
adenylate cyclase (AC) pathway, the serine at position 133 of CREB is phosphorylated by 
PKA, which enhances the transcriptional activity of the protein. Two other important 
protein kinases strictly associated with phosphorylation of CREB on S133, are the dual 
phosphorylated mitogen activated protein (MAPK; i.e. ERK1 and ERK2) kinase and the 
calcium/calmodulin-dependent protein kinase II (CaMKII), which is a crucial mediator of
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synaptic plasticity (Choe and Wang 2001b; Colbran and Brown 2004; Dash et al. 1991; 
Sheng et al. 1991).
Because of the complexity of Ca2+ signal transduction, it is still unclear how Ca2+ signals 
are propagated to the nucleus to regulate CREB S133 phosphorylation. Ca2+ directly 
influences the activity of many key regulatory enzymes, such as Ca2+/ CaMKs, protein
04 -kinase C, and Ca -calmodulin-dependent AC, which in turn may activate PKA. Similar
to growth factor signals, Ca2+ can also activate the MAPK pathway (Finkbeiner and
Greenberg 1996), which involves Ras, raf kinases, MAP kinase kinase (MEK), MAPK,
and p90 ribosomal S6 kinase (RSK).
1
Despite phosphorylation on S represent the key event in CREB activation, CREB can 
be phosphorylated at a number of other sites including S129, S142 and S143, however, the 
physiological significance of phosphorylation at these sites is unknown (Johannessen et 
al. 2004; Johannessen and Moens 2007).
Several protein phosphatases have been shown to regulate de-phosphorylation of 
S133CREB. They act either directly on CREB, or they may govern the phosphorylation 
status of CREB indirectly by controlling the enzymatic activity of CREB’s kinases.
The serine-threonine protein phosphatase 2A (PP2A) and protein phosphatase 1 (PP1) 
directly dephosphorylates CREB at S133 (Alberts et al. 1994; Hagiwara et al. 1992). 
Studies in rat hippocampal neurons suggest an indirect role for the protein phosphatase 
2B (PP2B also known as calcineurine) in CREB dephosphorylation, as it potentiated the 
activity of PP1, presumably by dephosphorylating the PP1 inhibitor 1-1 (Bito et al. 1996; 
Johannessen et al. 2004). PP1 is involved in the dephosphorylation of calcium-activated 
CREB phosphorylation in vitro (Bito et al. 1996) and in vivo (Genoux et al. 2002). PP1
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and PP2A gave similar rates of in vitro dephosphorylation of both S133 and S142 
phosphoserines, while PP2B was most active towards phosphoserine S133.
4.3 Stimulus-Induced activation of CREB-dependent 
transcription requires the concerted action of multiple kinases
Multiple stimulus-dependent protein kinases have been implicated in CREB 
phosphorylation in neurons. Often, components of different molecular pathways interact, 
resulting in signaling networks. Indeed, protein kinases function as components of signal 
transduction pathways in which one kinase activates a second kinase, which may act on 
yet another kinase. An example of this cascade of events is represented by the MAPK 
pathways (Orton et al. 2005). The recruitment of CREB by a variety of intracellular 
pathways allows the integration of different transduction mechanism involved in cellular 
functions.
Strikingly, the same stimuli, such as PKA, may activate both CREB kinases and CREB 
phosphatases (Ahn et al. 2007). Furthermore, it is important to note that the final effect of 
CREB activity depends not only on the nature of the stimulus but also on the cellular 
context where the stimulation takes place. For example, activation of synaptic NMDAR 
induces CREB phosphorylation and CREB-dependent gene expression, while activation 
of extra synaptic NMDAR shut off CREB activity by increasing its dephosphorylation 
(Hardingham and Bading 2002a; Hardingham et al. 2002b; Riccio and Ginty 2002). The 
convergence of multiple intracellular signalling cascades on CREB, place this 
transcription factor in an ideal situation to integrate different stimuli and regulate
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neuronal responses. The next cartoon (Fig. 1.10) illustrates signalling to CREB via 
multiple pathways.
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Multiple pathways regulate signalling to CREB.
CREB activates protein synthesis and transcription of target genes in response to a vast 
array of stimuli, including glutamate. These stimuli activate a variety of intracellular 
signalling pathways, leading to activation of a number of protein kinases such as PKA, 
Ca2+/CaMKII and MAPK.
Abbreviations AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate; CaMKII, calcium/calmodulin- 
dependent kinase II; CREB, cAMP response element binding protein; MAPK, mitogen-activated protein 
kinase; NMDA, N-methyl-D-aspartate; PKA, protein kinase A; PKC, protein kinase C.
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4.4 CREB and Cognitive Functions
CREB is a component of intracellular signalling events that has been linked to a number 
of cellular processes and regulates a wide range of biological functions, from 
spermatogenesis to circadian rhythms as well as memory formation. CREB is expressed 
during development, so structural deficits caused by deregulation of these early processes 
could lead to memory abnormalities. Because CREB is central not only to cell survival 
but also to many other physiological processes, it is not surprising that the consequences 
of disrupting CREB function in vivo are quite severe. A numbers of “loss-of-function” 
and “gain-of-function” strategies have been designed to discern the necessity for CREB in 
learning, memory, and plasticity in vertebrates.
The evidence that supports a role for CREB in cognition falls into two experimental 
categories: negative manipulations (where the levels of CREB are lowered) and positive 
manipulations (where the levels of CREB are increased).
4.5 CREB loss-of-function studies
Genetic studies using recombinant viruses or mutant mice have shown that inhibition of 
CREB leads to deficits in object recognition (Pittenger et al. 2002), socially transmitted 
food preference (Brightwell et al. 2005), and conditional taste or odour preferences 
(Balschun et al. 2003; Brightwell et al. 2005).
Furthermore, fear-associated learning has been shown to increase phosphorylated CREB 
levels and CRE-mediated transcription in the hippocampus (Bemabeu et al. 1997; Impey 
et al. 1998; Taubenfeld et al. 1999). Dysregulation of CREB pathway has also been
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associated with age-dependent memory impairments (Brightwell et al. 2004; Chung et al. 
2002).
A line of mice with a targeted disruption of the a and 5 isoforms of CREB showed intact 
short-term memory, but disrupted long-term memory in several behavioural tasks, 
including contextual conditioning and spatial learning in the water maze, two 
hippocampal-dependent learning tasks (Bourtchuladze et al. 1994; Guzowski and 
McGaugh 1997). These studies clearly provide evidence for a direct role of CREB in 
memory formation in mice, and they were soon confirmed in rats (Josselyn et al. 2001; 
Pittenger et al. 2002; Silva et al. 1998).
Interruption of CREB signalling in rat hippocampus by infusion of antisense oligo- 
deoxynucleotides resulted in impairment of memory formation for water maze training 
(Guzowski and McGaugh 1997). Antisense oligonucleotides against hippocampal CREB 
mRNA can lower the levels of CREB and impair spatial memory. Interestingly, tests 
given immediately after training showed that the oligonucleotides against CREB do not 
disrupt short-term memory (Guzowski and McGaugh 1997). Also, injection of small 
interfering RNAs (siRNAs) directly into the hippocampus of wild-type mice, knocked 
down CREB’s expression and disrupted long-term, but not short-term, memory (Peters et 
al. 2009). Electrophysiological studies in Aplysia indicated that decreasing CREB 
function blocked long, but not short-term changes in synaptic function (Dash et al. 1990).
Another strategy for interfering with CREB function is the use of a dominant negative 
transgenic strategy. In this strategy, a modified fragment of the CREB gene can be 
inserted in specific regions of the mouse brain (Kida et al. 2002). Using a 
microelectroporation technique to overexpress dominant negative mutant CREB
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(mCREB) in the adult mouse brain, it has been found that overexpression of mCREB in 
the anterior cingulate cortex induced neuronal degeneration (Ao et al. 2006). These 
findings were surprisingly, and suggested that a balanced constitutively active CREB 
phosphorylation is important for the survival of mammalian cells in the brain (Ao et al. 
2006).
Recently, it has been shown that preventing CREB phosphorylation by viral-vector gene 
transfer in the PFC impaired attention (Paine et al. 2009) suggesting that a decreased 
activity of CREB has a negative influence on cognitive processes. These data are 
supported by findings showing that the PKA inhibitor Rp-cAMP disrupted attention in the 
same task (Paine et al. 2009). By contrast PCP-induced attention deficit was associated 
with increased p-CREB in the striatum (Pozzi et al. 2010).
While the complete disruption of CREB is lethal in mice (Rudolph et al. 1998) and is 
therefore not likely to be compatible with life, several pathological conditions exist in 
humans in which CREB function may be disrupted subtly or incompletely. In humans, 
some genetic disorders leading to mental retardation have been directly related to the 
CREB pathway. The gene encoding RSK-2 (p90 ribosomal S6 protein kinase 2), one of 
several putative CREB kinases, for instance, is mutated in Coffin-Lowry syndrome, a 
complex disorder characterized by multiple physical abnormalities and mental retardation 
(Trivier et al. 1996). In addition, a heterozygous mutation in the CREB binding protein 
(CBP) gene produces Rubenstein-Taybi Syndrome, which is similarly characterized by 
multiple deficits including mental retardation (Petrij et al. 1995).
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4.6 CREB gain-of-function studies
The role of over expression of CREB has not been examined systematically. While viral 
CREB rescued conditioning deficits in CREB knockout animals, additional CREB did not 
seem to enhance memory of the wild-type controls. Chronic enhancement of CREB, 
using genetic manipulations in mice, did not seem to enhance memory in a water maze 
task (Viosca et al. 2009). While additional CREB did not enhance acquisition, it 
interfered with retrieval, suggesting that there may be an optimal level of CREB 
activation that is compatible with normal memory function (Viosca et al. 2009).
Over expression of CREB can enhance the formation of long-term memory (Josselyn et 
al. 2001). Recent papers suggest that CREB is one factor that controls intrinsic 
excitability which provides an additional mechanism by which CREB can contribute to a 
gating function on memory acquisition and expression (Lopez de Armentia et al. 2007; 
Viosca et al. 2009; Zhou et al. 2009).
Some studies have also evaluated the role of CREB in response to performance or 
training on behavioural task. In particular evidences indicate that CREB pathway is a core 
component of the molecular switch that converts short- to long-term memory. Genetic 
studies in Drosophila also uncovered a role for CREB in memory, suggesting that this 
transcription factor has an evolutionary conserved role in memory (Yin et al. 1994). 
CREB was first implicated in learning and memory in flies by experiments in which 
inducible expression of a CREB activator was found to enhance and inducible expression 
of a CREB repressor was found to block the formation of long-term memory in the 
olfactory task (Yin et al. 1994 and 1995).
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Formation of memory for a place strategy, appears related to sustained phosphorylation of 
CREB in the hippocampus, whereas formation of memory for a response strategy is 
related to phosphorylation of CREB in the striatum (Colombo et al. 2003). CREB 
phosphorylation is increased by exposure to a novel environment (Vianna et al. 2000), 
contextual fear conditioning (Stanciu et al. 2001), inhibitory avoidance (Bemabeu et al. 
1997); (Cammarota et al. 2000; Taubenfeld et al. 2001), and radial arm maze training 
(Mizuno et al. 2002).
In conclusion, inhibition of CREB activity impairs behavioural performance in various 
memory tests across different species, while over expression of CREB had no effect or 
facilitated long-term memory. These studies indicate that memory formation require 
CREB and support its importance in complex cognitive processes.
4.7 Glutamatergic regulation of CREB
CREB activity has been demonstrated to be regulated by glutamate. Activation of 
glutamate receptors result in Ca2+ influx through ionotropic NMDA, AMPA/kainate 
receptors and voltage-gated Ca2+ channels. Ca2+ then activates kinases such as 
Ca2+/calmodulin-dependent kinases (CaMK) and mitogen-activated protein kinases 
(MAPK), resulting in activation of transcription factors including CREB, which mediate 
long lasting structural changes and function (Ghosh and Greenberg 1995; Mattson et al. 
1988; Soderling et al. 1994). Interestingly, it was found that neither AMPA/kainate 
receptors nor NMDAR were able to stimulate independently S133 CREB phosphorylation 
(Vanhoutte et al. 1999). Instead a series of connected events from AMPA/kainate 
receptors to NMDAR and from NMDAR to L-type Ca2+ channels was shown to be
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necessary. The AMPA/kainate receptors are involved in relieving the Mg2+ block of 
NMDAR, which in turn trigger the opening of L-type Ca2+ channels. The Ca2+ entry 
through L-type Ca2+ channels (Rajadhyaksha et al. 1999) most likely activates S133 CREB 
phosphorylation (Fig 1.11).
Fig. 1.11
Model of the interaction of glutamate receptors and CREB
(1) The activation of AMPA/kainite receptors causes Na+ influx and a local 
depolarization that relieves the Mg2+ block of the NMDAR. (2a) Activation of the 
NMDAR via ligand binding and depolarization leads to Na+ as well as Ca 2+ influx. 
Unlike the AMPA/kainate receptors, NMDAR do not rapidly desensitize and allow for a 
depolarization that is strong enough to trigger the opening of L-type Ca 2+channels. (3) L- 
type Ca2+ channels allow for Ca 2+ influx and activation of a kinase pathway that 
translocates to the nucleus to phosphorylate S133 CREB. (2b) A L-type Ca2+ channels- 
independent signal transduction cascade from NMDAR to CREB phosphorylation is 
negligible (From Rajadhyaksha, 1999).
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This NMDAR-mediated rise in postsynaptic Ca2+ concentrations activates a network of 
kinases and phosphatases that modulate CREB phosphorylation (Nijholt et al. 2002). 
Thus, it is conceivable that blockade of these receptors by competitive or non competitive 
antagonists should reduce the Ca2+ influx into the cell. As reported in fig. 1.10, Ca2+ 
influx trough NMDAR influenced the activity of various intracellular pathways such as 
CaMK, PKC and cAMP/PKA thus a decrease in Ca2+ concentration should lead to a 
decreased activity of these intracellular pathways and possibly to a decrease in CREB 
phosphorylation.
Accordingly, NMDAR antagonist decreased p-CREB on the active site S133 both in-vitro 
and in-vivo. In cells, MK-801 inhibited the p-CREB and the expression of CREB- 
regulated genes (Stepulak et al. 2005). Blocking the NMDAR in corticostriatal 
organotypic cultures with PCP also decreased p-CREB (Xia et al. 2010). Chronic blocked 
of NMDA receptor through systemic administration of the competitive antagonist, CGP 
39551, decreased p-CREB in the cerebellum of rat pups (Monti et al. 2002) and repeated 
PCP injections decreased of p-CREB levels in the rat PFC (Molteni et al. 2008).
Interestingly, NMDAR antagonists at doses that impair cognitive functions in rodents 
increased the phosphorylation of CREB on S133. For instance, it has been reported that 
acute PCP increases p-CREB in the FC and CPu of mice (Svenningsson et al. 2003). 
Accordingly, we found that that the dose of PCP and MK-801 that caused attentional and 
performance deficit in the 5-CSRT task increased p-CREB in the CPu of DBA mice 
(Pozzi et al. 2010) and rats (Pozzi, unpublished).
Although the mechanisms leading to increased S133CREB phosphorylation after blockade 
of NMDAR is not yet clear, it might likely be the consequence of activation of non-
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NMDAR by glutamate (such as mGluRs) or might involve NMDAR located 
extrasynaptically. Indeed, the localization of NMDAR on the synapses further 
complicates the relationship between NMDAR and CREB. While the activation of 
synaptic NMDAR supports robust phosphorylation of CREB on its critical transcriptional 
regulatory residue, S133, in dramatic contrast, when extrasynaptic NMDAR are activated, 
CREB is only transiently phosphorylated and CRE-dependent gene expression is not 
activated (Riccio and Ginty 2002). Thus, a 'shut-off signal from extrasynaptic NMDAR 
seems to selectively inhibit CREB-dependent transcription.
Glutamate also activates a different group of receptors i.e. the metabotropic glutamate 
receptors (mGluRs) that are G-protein receptors (GPCR) coupled via second messenger 
systems to biochemical pathways and ion channels (Pin and Acher 2002; Platt 2007). 
Specifically: group I  (mGluRl and mGluR5) receptors stimulate inositol trisphosphate 
IP3 hydrolysis/Ca2+ signal transduction; group II (mGJuR2 and mGluR3) receptors inhibit 
adenylyl cyclase and decrease cAMP (Platt 2007); on the other hand, it was also shown 
that stimulation of mGluR group II could increase cAMP accumulation in astrocytes 
(Moldrich et al. 2002). Glutamate group III (mGluR4, mGluR6, mGluR7 and mGluR8) 
receptors are negatively linked to AC activity (Platt 2007).
All these events might affect S133 CREB phosphorylation in the postsynaptic neurons. 
Furthermore, CREB phosphorylation may be also regulated by the interactions between 
both ionotropic and mGlu receptors. In cultured striatal neurons for instance, activation of 
NMDAR with NMDA increased the number of neurons expressing phosphorylated p- 
CREB. Co-incubation of a group I mGluR agonist 3,5-dihydroxyphenylglycine (DHPG)
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that itself did not alter basal p-CREB expression augmented NMDA-induced CREB 
phosphorylation (Mao and Wang 2002).
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5. AIMS OF THE PROJECT
This introduction has set out the general background to this work. This has included 
material from neuropsychology, pharmacology and behavioural psychopharmacology. 
With such diverse background it was essential to frame specific questions to which 
experiments were addressed. The main question was “does p-CREB play a role in the 
mechanisms that govern NMDAR antagonists-induced impairments in executive function 
and attention?”.
5.1 Statement of the Problem
Recent finding from my lab showed that blockade of NMDAR in the PFC, by infusion of 
the competitive NMDAR antagonist (R)-CPP, was sufficient to cause behavioural 
impairments in the 5-CSRT task. Thus, the first question to be asked was whether and 
how (R)-CPP (at the dose that impaired 5-CSRT task’s performance) affected p-CREB in 
the cortico-striatal circuit. The second question to be asked was whether the mGlu2/3 
agonist (LY379268) that prevented the (R)-CPP-induced attentional deficits in the 
behavioural task, also prevents the (R)-CPP-induced p-CREB changes and the (R)-CPP- 
induced release of glutamate in the PFC. Third question was whether and how 
performance on the 5-CSRT task may affect (R)-CPP-induced p-CREB changes.
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5.2 Aims
It is possible to summarize this PhD project by the following three aims:
AIM 1: To study the time course of the effects of the competitive NMDAR antagonist, 
(R)-CPP microinjected into the mPFC on levels of p-CREB, and its upstream kinases; p- 
ERK1/2, p-CaMKII, and p-PKA in the FC, CPu and NAC.
AIM 2: To test the hypothesis that cognitive deficit induced by blockade of NMDAR in 
the mPFC might be associated with increased glutamate release and changes in CREB 
phosphorylation I studied the ability of a mGluR2/3 agonist: (1) to reverse the (R)-CPP- 
induced attention performance deficit; (2) to interfere with CREB phosphorylation in FC, 
CPu and NAC, and (3) to prevent the (R)-CPP-induced rise in extracellular GLU in the 
PFC.
AIM 3: To investigate more directly the causal relationship between CREB 
phosphorylation and attention performance in the 5-CSRT task, I measured CREB 
phosphorylation in rats that were performing the task in condition of impaired attentional 
performance induced by intra mPFC infusion of (R)-CPP.
The experimental methods have concentrated on behavioural, neurochemical and 
immunoblotting techniques. It was hoped that these studies could provide new 
information on the molecular mechanisms involved in the control of attention and 
executive functions, possibly relevant to cognitive deficits associated with 
neuropsychiatric disorders such as schizophrenia.
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CHAPTER 2
GENERAL METHODS
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This chapter contains a description of the general methods and protocols used in this 
thesis. All behavioural experiments were supervised by Dr. Carli Mirjana head of the 
Pharmacology of Cognitive Behaviour Unit of the Neurochemistry and Behaviour 
Laboratory, at the Mario Negri Institute for Pharmacological Research.
Intracerebral microdialysis was done in collaboration with Dr. Calcagno Eleonora and 
supervised by Dr Roberto Invemizzi head of the Neurochemistry and Behaviour 
Laboratory, at the Mario Negri Institute for Pharmacological Research.
Some of the data presented in the thesis have already been reported and they were showed 
to support the hypothesis.
I contributed to the planning and execution of all the experiments discussed in this thesis.
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Fig. 2.1
General design of the study
This thesis is the result of a multidisciplinary approach which combines behavioral, 
biochemical and neurochemical assays to evaluate the role of the transcription factor 
CREB and cortical glutamate release in the ability of (R)-CPP to impair attention and 
response control in rats performing the 5-CSRT task.
INTRA mPFC 
INFUSION OF CPP
64
2.1. ANIMALS
Ethical Issues In Animal Research
The work described in this thesis involves experimentation in living animals. For decades 
rats have been the species of choice in experimental neuropharmacology research. This is 
in part due to the reliability and relative ease with which invasive, such as site-specific 
brain micro-infusion, and molecular techniques, can be applied, in combination with a 
wide range of well established behavioral models. Of course rodents are not miniature 
humans so it’s impossible to fully model the complexity of human neuropsychiatric 
diseases in experimental animals. Therefore the utility and validity of rodent’s models 
must be evaluated based on objective criteria such those first proposed by Robbins 
(Robbins and Sahakian 1979), and that cannot be established in a single experiment but 
are the results of many studies over time:
• Face Validity: the ability to mirror the human deficit.
• Construct Validity: comply with the fundamental or hypothesized
pathophysiological basis of the disorder.
• Predictive Validity: the most relevant case of predictive validity in research using 
animal models is pharmacological validity, which is the ability of a drug effect in the 
animal model to predict similar effects in humans.
Moreover, when animals are used for the benefit of humans, such as is the case in 
research, it is crucial that this is done in the most ethical manner possible. The “three Rs”, 
which were first described by Russell (1995), form the basis of the ethical laws: R as 
reduce the number of animal tested, or obtains more information from the same animal; R 
as replace the animal models with alternative methods whenever possible, to achieve
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same scientific aim; R as refine the methods used in order to reduce or eliminate 
discomfort and distress for the animals.
Animals All the rats used in these studies were male Lister Hooded weighing 250- 
350 g (Charles River, Italy). They were housed under temperature-controlled conditions 
(21 ± 2 °C) and constant humidity (50 ± 10%) with a 12-h light/dark cycle (light on 7:00 
am-7:00 pm). Rats used in behavioral experiments had limited access to food (pellets for 
rats, Altromin Riper, Italy) at the end of each day’s testing to keep them at 85-90% of 
their initial free-feeding weight. Rats used in biochemical and microdialysis experiments 
had free access to food. For all rats water was available ad libitum.
Laws And Policies Procedures involving animals and their care were conducted in 
conformity with the institutional guidelines that are in compliance with the national 
(Decreto Legislativo n. 116, Gazzetta Ufficiale, suppl., 40, 18 Febbraio 1992, Circolare 
No. 8, Gazzetta Ufficiale, 14 luglio 1994) and international laws and policies (EEC 
Council Directive 86/609, OJ L 358, 1, Dec. 12, 1987; Guide for the Care and Use of 
Laboratory Animals, US National Research Council, 1996). All efforts were made to 
minimize animal suffering and to reduce the number of animals employed in the study.
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2.2 SURGICAL PROCEDURES
Cannulae Implantation The Kopf stereotaxic frame (model 900, David Kopf, 
Tujunga, CA, USA) (Fig. 2.2) consists of a 3-D system based on the Cartesian 
coordinates system. Three arms move along the anterior-posterior (AP), lateral (L) and 
dorso-ventral (DV) axis and each is provided with a micrometric scale. Using a brain 
atlas (Paxinos and Watson, 2007) mapping rat’s central nervous system by coronal, 
sagittal and horizontal brain’s sections, it is possible to determine the exact position of the 
brain area of interest and the coordinate to follow in order to reach a desired locus. Such 
an approach allows the injection of drug solutions directly into the specific brain areas.
Rats were anesthetized with 3 mL/kg Equithesin (composition in mM: pentobarbital 39, 
chloral hydrate 256, MgSC>4.7H20 86, ethanol 10% v/v, propylene glycol 39.6% v/v). The 
rat head was shaved and secured in the stereotaxic frame with the incisor bar set at -3.3 
mm relative to the interaural line. Next, the scalp was incised on the midline of the 
occipito-frontal plane, thus the surface of the cranium was exposed. Bilateral 23-gauge, 
stainless-steel guide cannulae (Cooper’s Needles, UK) were implanted in the medial 
region of the prefrontal cortex (mPFC) (Fig 2.3) using standard stereotaxic techniques 
and secured to the skull using three bone screws and dental cement. The coordinates used 
were: anterior-posterior (AP)+3.8 mm from bregma, lateral (L)±0.8mm from midline, 
and dorsal-ventral (DV)-3.2 from dura (Paxinos and Watson, 2007). Thirty-gauge 
stainless-steel stylets were inserted in the guide cannulae. After surgery rats were housed 
singly and had few days of recovery.
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Fig. 2.2
Stereotaxic apparatus to 
performing brain 
surgery in rodents.
Recovery and post-operative care
Checks were made for any weight loss and rats that showed some discomfort were 
excluded from the experiment.
The rats used for the behavioral experiment and that were food-deprived during the 
experiments were kept food-deprived as before surgery and were re-trained on the 5- 
CSRT task to re-establish a pre-surgery level of baseline performance.
This took between 7 to 10 days.
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Fig. 2.3
A. Schematic representation of the prelhnbic 
(PrL)region in the medial prefrontal cortex.
B. Example of slice stained with Cresyl violet 
to visualize the location of the injection tips
C. High magnification of the injection sites.
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2.3 BEHAVIORAL STUDIES
The “5-choice serial reaction time” (5-CSRT) task for rats was first developed by 
Robbins and co-workers as an analogous of the Continuous Performance Test used with 
humans subjects (Carli et al. 1983; Robbins 2002).
Apparatus
The apparatus consisted of four specially designed boxes (Campden Ins. UK) controlled 
on-line by Whisker software. It consisted of two 25x25 cm aluminum chambers built in 
the Department of Experimental Psychology, University of Cambridge. The rear wall of 
each box was concavely curved, and had set into its full arc nine square holes, 4 cm deep 
and 2 cm above floor level. Each hole had an infrared beam crossing the entrance 
vertically and illuminating a photoelectric cell. A standard 3W bulb at the rear of each 
hole provided illumination. Food pellets were delivered to a tray at the front of the box. A 
hinged panel blocked the entrance to the tray. A 3W house-light was installed centrally in 
the box roof. Each apparatus was controlled on-line and data were collected by a Control 
Universal Cube microcomputer system (Cambridge, UK).
In this procedure, hungry rats are trained to monitor
Five Stimulus Locations
five locations for brief, randomly presented visual 
targets. Rats are placed in an operant chamber with a 
wall that has five nosepoke holes with stimulus lights 
inside. The rat must detect a light stimulus that 
appears randomly in one of the five nosepoke holes.
Entry
Fig. 2.4
Schematic apparatus for the 5-CSRT task.
Behavioral Procedures
Animals were trained on the 5-CSRT task to a stable performance. The start of the session 
was signaled by illumination of the house-light and the delivery of a single food pellet. 
Opening the panel to collect the pellet began the first trial. After a fixed delay (the inter­
trial interval, ITI), the light at the rear of one of the holes came on for a short period. The 
light stimulus was presented in each hole for an equal numbers of times during the course 
of a complete session, with the order of presentation randomized by the computer.
Fig. 2.5
Scheme of the different steps required to 
perform the 5-CSRT task.
Steps are: (1) scan for stimulus presentation,
(2) Stimulus presentation, (3) nose poke at 
stimulus location and, (4) panel press to collect 
reward. From Amitai and Markou,
2010
While the light was on, and for a short period 
afterwards (the limited hold), responses in the 
hole that was illuminated (<correct response) 
resulted in the delivery of a food pellet. 
Responses in the holes that had not been 
illuminated {incorrect responses) or failure to respond within the limited hold (omissions) 
caused the houselights to be turned off for a short period (time out).
Responses made in the holes while the house-light was off restarted the time out. After 
the delivery of food, or at the end of time out, the rat started the next trial by opening the 
panel at the front of the chamber.
1. I I
2 .  » »
4.
71
Responses made in the holes after a correct response (perseverative responses), or after 
the end of time out before opening the panel, resulted in a period of time out.
Responses made in the holes during the ITI (<anticipatory responses) also resulted in a 
period of time out. After anticipatory responses, however, opening the panel restarted the 
current trial.
Each daily session consisted of 100 trials or 30 min of testing, whichever was completed 
sooner, after which all lights were turned off and further responses had no effect. In the 
first session of the test schedule the stimulus and limited hold each lasted 1 min and, 
depending on individual performances, they were progressively reduced to 0.5 s.
The ITI and time out both lasted 2 s during the first session and the ITI was raised to 5 s 
in subsequent sessions; time out was not changed.
When the rats reached a stable performance with a mean of 80% correct responses and no 
more than 15% omissions, they were allocated to different treatment schedules. Each rat 
had only one session on the 5-CSRT task per day throughout the experiments.
The variables recorded and analysed were:
• The percentage of correct responses (total number of correct responses/total 
number of corrects+total number of incorrect responsesxlOO).
• The number of anticipatory responses (responses made in the holes during the 
waiting period before the presentation of the target)
• The number of perseverative responses (responses made in the holes after a 
correct response but before a nose-poke into the receptacle hole to collect the food 
reward).
• The number of omissions (total number of omissions/total number of correct+total
number of incorrect+total number of omissions)
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The animal must be mildly hungry at the time of testing. Following extensive training 
(i.e. 60-80 days) on the task, performance generally reaches high levels, with low within- 
and between subject variance. Nevertheless, at 80% correct, performance is not at ceiling 
and it is still possible in theory to detect improvements in accuracy. The difficulty of the 
5-CSRT task can be varied by reducing or increasing the brightness, duration or 
frequency of the target visual stimuli. Such manipulations clearly test the ability of the 
animal to “screen out” irrelevant stimuli and thus constitute tests of selective attention 
(reviewed by Robbins 2002).
The 5-CSRT task has been used in these studies to quantify cognitive deficits in rats 
treated with (R)-CPP alone or in combination with LY379268 or Sp-cAMP. Protocols 
and parameters for the 5-CSRT task have been extensively validated in our laboratory.
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2.4 IMMUNOASSAYS
An immunoassay is a biochemical test that measures the amount of a substance in a 
biological sample. To identify target proteins among a number of proteins that are not the 
target of interest, these assays take advantage of the specific binding of an antibody to its 
antigen (Fig. 2.6).
Immunoassays, such as western blot and immunohystochemistry share several 
fundamental steps: preparation of sample, blocking of unspecific proteins, binding with 
primary and secondary antibodies, and protein detection. Proteins can be separated by 
electrophoresis or stained on brain slices properly treated to avoid protein degradation. In 
this thesis both Western blot and immunohystochemistry techniques were used.
Secondary Antibody 
(labelled)
Antigen —>
Visualizing Agent
Prim aiy Antib o dy 
(unlabelled)
Fig. 2.6
Antigen-antibodies binding
Schematic representation of a conventional competition immunoassay with primary and 
labelled secondary antibodies used in immunoblotting detection.
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2.4.1 WESTERN BLOT
General Principles Western blot is an efficiently and useful method to detect and 
characterize proteins in the cerebral tissue even in small amounts (Towbin et al. 1979). 
Compared to other immunoassays approaches, it has higher specificity due to the 
identification of the single protein by its molecular weight.
Western blot is a very delicate process requiring the correct amounts of each component 
in order for successful identification of the target proteins. An imbalance in any step of 
the procedure may skew the entire process.
Protocol To examine the effects of treatments on p-S133CREB rats were implanted 
with bilateral cannulae in the mPFC as described previously. Rats were killed by 
decapitation; the brains were removed and immediately immersed in ice-cold saline for 
few seconds. The FC (comprising prefrontal, orbitofrontal, cingulate and primary motor 
cortex), CPu and the NAC were rapidly dissected, frozen on dry ice and stored at -70 °C 
for further analyses.
H o m o g en ized  
in 1m l S D S  1%
H o m o g en ized  
in 1m l S D S  1%
> NAG—>
V
H o m o g e n iz e d  
in 0 .5  m l S D S  1%
Fig. 2.7
Samples preparation for western blot analysis
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Briefly, tissues samples were homogenized as indicated in figure 2.7. Twenty pg of 
protein were separated by 10% polyacrylamide SDS-PAGE gels, transferred onto PVDF 
membrane (0.45 pm, Amersham, GE Healthcare) then incubated overnight with primary 
antibodies against phosphorylated or total (native) protein.
The next day, after lh incubation with appropriate horseradish peroxidase-labelled 
secondary antibodies, immunoreactivity was visualized with a chemiluminescent home 
made luminol/p-coumaric acid solution. Membranes were exposed in the dark room to 
autoradiography films (Hyperfilm ECL, Amersham GE Healthcare) for 30 sec, 1, 3 and 5 
min then developed for 1.5 min.
Fig. 2.8
Sequence of steps in p erformi a western 
blot experiment.
The western blot procedure involves samples 
loading onto polyacrylamide gels (1), binding 
with unlabelled primary antibody against the 
protein of interest (2), followed by HRP- 
peroxidase-linked secondary antibody (3). The 
antigen/antibodies binding is then visualised by 
light emission (chemiluminescence) (4).
Densitometric analysis of immunoblots was done to quantify the changes in protein levels 
using the public domain ImageJ program (Image Processing and Analysis in Java at
MWCTRCPP
H
>
<Q
OJOJ
>
<o
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http://rsbweb.nih.gov/ij/). The optical density of the band for each antibody was linear in 
the range between 15 and 60 pg/total protein/well as calculated by rigorous linearity tests. 
Phosphorylated and total proteins were measured in the same samples.
Western blot has been used in this thesis to measure phosphorylated and total CREB, 
PKA, ERK1/2 and CaMKII in samples from FC, CPu and NAC after various treatments 
All the conditions used in this thesis has been validated in our laboratory as follows.
Antibodies Test Linearity Although western blot has the advantage of using antibodies 
that are usually highly specific to the proteins of interest, is difficult to load a standard 
curve onto each gel together with the samples under analysis which are assayed, out of 
necessity, in separate gels. Thus, it is considered a semi quantitative technique.
We therefore developed a method that affords the standardization of the best antibody 
dilution for each brain region (figure 2.9). Our stringent methodology includes 
constructing a standard curve of at least three protein concentrations incubated with 
different antibody dilutions to reach the optimal ratio protein loaded/ antibody 
concentration with the highest signal-to-noise ratio to estimate the optical density of the 
samples in the best way. Such a curve serves two purposes: the first, to choose the right 
amount of samples to load for each brain region. The second, to choose the right dilution 
of both primary and secondary antibodies thus avoiding saturation of the signal with high 
levels of immunoreactivity that could result in a ceiling effect.
Antibodies dilutions used in this thesis fall within the linear range of the curve calculated 
for each antibody.
77
A. psl33CREB B. pT197PKAc
FC 1 u SB 43 kDa FC 42 kDa
CPu CPu
NAC NAC
10 20 40 pg protein
Q pT202/Y204 ERK1/2
FC
CPu
NAC
44kD a(ER K l)
42kDaCEEK2)
D.
FC
CPu
NAC
20 40 60 pg protein
pT286CaMKIIa
50kDa
10 20 40 60 pg protein 10 20 40 60 pg protein
E.
40000 FC
30846
53 30000
25109
20000
14173
10000
►4328
p g  protein  loaded
40000 C P u
3282030000
2231820000
1272710000
■5168
0 10 20 30 40 50 60
NAC40000
30736
21S34
20000
10000
0 10 20 30 40 50 60
p g  protein loaded p g  protein loaded
Fig 2.9
Antibodies test linearity
Representative immunoblots of p-CREB (A, 1:4000 dilution), pPKAc (B, 1:4000 
dilution), pERK 1/2 (C, 1:8000 dilution) and pCaMKII (D C, 1:10000 dilution) linearity in 
the FC, CPu and NAC. Ten to 60 pg of total proteins were loaded in consecutive wells.
E. Example of quantification (black line) of pCREB antibody linearity test in the FC, CPu 
and NAC. Protein amount is plotted against the optical density measured after 1 min 
exposition time. Data are expressed as MEAN±SE of arbitrary optical density. N=4 per 
group.
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Mouse monoclonal antibodies against p-CREB (S133, diluted 1:4000; Upstate 
Biotechnology USA; Cod. 05-667) and CREB (diluted 1:4000; Cell Signaling 
Technology, IT, Cod.9104) were used for western blot. Antibody binding was detected 
using an anti-mouse-IgG-HRP secondary antibody (diluted 1:8000; Cell Signaling 
Technology, IT, Cod.7174).
The following antibodies against proteins kinases were purchased from Cell Signaling 
Technology (IT). Dilutions of phospho primary antibodies were as follows: p-PKAc 
(T197rabbit polyclonal, 1:4000; Cod. 4781); p-44/42MAPK (ERK1/2 T202/Y204 rabbit 
polyclonal, 1:10000; Cod. 9101) and p-CaMKIIa (T286 rabbit polyclonal, 1:10000; Cod. 
3361). Antibodies against total amount of proteins (i.e. phosphorylated plus not 
phosphorylated) were also used and were as follows: PKAc (rabbit polyclonal, 1:4000; 
Cod.4782), MAPK (ERK1/2 , rabbit polyclonal, 1:10000; Cod. 9102) and CaMKII (rabbit 
polyclonal, 1:10000; Cod. 3362). Antibody binding was detected using anti rabbit-IgG- 
HRP secondary antibodies (Cell Signaling Technology, Beverly, MA, USA; Cod: 7074). 
Phosphorylated and total proteins were measured in the same samples.
All antibodies were dissolved in 2% albumine, 5% Tween-20 in Tris buffered saline 
(TBS; pH 7.6) and stored at +4°C. At these dilutions, the optical density of the band for 
each antibody was linear in the range between 15 and 60 pg/total protein/well as 
calculated by linearity tests.
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2.4.2 IMMUNOHISTOCHEMISTRY
General Principles Immunohistochemistry or IHC refers to the process of localizing 
proteins of interest in a tissue section exploiting the same principle of antibodies-antigens 
binding in biological tissues (Ramos-Vara 2005). It takes its name from the roots 
"immuno," in reference to antibodies used in the procedure, and f'histo," meaning tissue. 
IHC is widely used in basic research to understand the distribution and localization of 
proteins in different parts of a biological tissue. Immunohistochemistry is an excellent 
detection technique and has the tremendous advantage of being able to show exactly 
where a given protein is located within the tissue examined providing higher resolution 
imaging of antigen localization (Ramos-Vara 2005). It is also low cost, relative easy to 
perform, and widely used. Moreover, the possibility to label multiple antigens 
simultaneously is another advantage.
Its major disadvantage is that, unlike western blot, where staining is checked against a 
molecular weight ladder, in immunohistochemistry it’s impossible to show that the 
staining corresponds to the protein of interest. For this reason, primary antibodies must be 
first well-validated before in western bot or similar procedure.
Protocol Unlike western blot, animals used in IHC are anaesthetized. Brain tissue 
samples require fixation procedures prior to processing. Fixing prevents enzymatic and 
other postmortem changes that degrade the tissue. Proper fixation facilitates 
immunohistochemical analyses, saves time and is an important step for histological 
processing.
Rats were intracardially perfused , which means that the blood is drained from the body 
by pumping the fixative solution into the vascular system (figure 2.10). Removing the
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blood improves the results of staining, and the fixative preserves and usually hardens the 
brain so that it can be sectioned (cut into thin slices) without tearing. Moreover, because 
blood is responsible for the transport of myriad of other cells, and because these cells all 
contain endoplasmic reticulum (Nissl substance, see Hystology section), any remaining 
blood in the tissue will be deeply stained by cresyl violet and could obscure the structures 
under analysis. Intracardiac perfusion is a technique that allows the delivery of a fixative 
solution (e.g. paraformaldehyde -  PAF) throughout the whole body, including brain. 
Intracardiac perfusion requires the preparation of a fixative (4% PAF) and PBS buffer 
that have to be made fresh on the day of its use or the night before and has to kept at 
+4°C.
_C p
perfusion
pump
perfusion
solution'
Fig. 2.10
Sequence of steps in performing immunohystochemistry experiment
Immunohystochemistry protocols require that the brain is perfused with fixative solution 
by a perfusion pump via the circulatory system to achieve penetration of the fixative into 
the brain.
After an incision made in the diaphragm, the sternum is clamped with a hemostat to 
expose the heart. Perfusion is started very slowly (i.e., 20 to 40 mL/min). Immediately 
after the peristaltic pump begins pumping the fixative, the right atrium is cut to allow an 
escape route for the blood and perfusion fluid.
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To examine the effects of treatments on the number of p-S133CREB-positive cells, rats 
were implanted with bilateral cannulae in the mPFC as described previously. On the 
experimental day, 1 pL side vehicle or 50 ng/pL side CPP were delivered bilaterally into 
rats’ mPFC at a rate of 0.5 pL/min. Forty minutes after vehicle or CPP injection, animals 
were anaesthetized with Equithesin (3 mL/kg, i.p.) and secured on a silicon support. The 
chest cavity was opened by cutting across the abdomen just below the sternum and then 
the diaphragm was carefully cut. The body cavity was exposed by clamping the ribs on 
each side and, if necessary, any connective tissue was cut to free the heart from the chest 
cavity. A butterfly needle (25 gauges) was inserted into the left ventricle, the right auricle 
was cut and animal was slowly perfused. The needle in fact was connected, by a plastic 
tube, to a peristaltic pump that allows a controlled-speed efflux of the perfusion solutions 
into the whole body. Ice-cold PBS was first delivered for 2 minutes to wash out blood and 
then 4% PAF for 4 minutes allowed the cross-linking of tissues, therefore their 
preservation. After perfusion was completed, the animal was decapitated and the brain 
quickly removed and placed in 4% PAF for 2-3 h for post-fixation.
After post-fixation procedure, brains were dipped in a solution of 20% sucrose (O/N). 
This step allows water removal from the brain, preventing tissue damage during freezing. 
Brains were frozen in n-pentane at - 45°C for 3 minutes and stored at - 80°C. The slicing 
of the brain is usually accomplished through the use of a cryostat that is a microtome 
housed in a freezing chamber that allows the sectioning to be performed at a temperature 
of -20° C. Brain sections for IHC analysis were obtained from frozen tissue using a 
cryostat (Leica Microsystems, Wetzlar, Germany). In the IHC procedure the thickness of 
the sections, may vary from 5 to 40 pm. Thirty pm free-floating slices (slices that are not 
mounted on slides) have been used in these studies.
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Cells Detection And Count Protocols for IHC detection of a protein are based on the 
same work steps described for Western blot techniques which are: saturation of the 
membrane (blocking), immune detection (staining by antibodies) and visualization (figure 
2.11). Free-floating sections (30 pm) were washed with TBS and then blocked with 2% 
normal goat serum (NGS, Vector Laboratories, UK). Sections were incubated overnight 
with anti mouse p-S133CREB monoclonal antibody (diluted 1:500, Upstate 
Biotechnology, USA) at +4°C. The next day they were incubated with the secondary 
biotinylated goat anti-mouse antibody (diluted 1:300) for 1 hr at room temperature after 
which 1% avidin-biotin horseradish peroxidase complex (Vector Laboratories, UK) was 
added for 1 h. Peroxidase activity was determined by reaction with a solution containing 
diaminobenzidine (DAB, Sigma, IT) and nickel ammonium sulphate (Sigma, IT). The 
sections were mounted on slides, dried, dehydrated and covered with mounting medium 
(Permount, Fisher Scientific, USA). The procedures applied to count p-S133CREB- 
positive cells are described below.
Because the immunohistochemical reaction and staining density may vary from time to 
time, all drug-treated and control were processed simultaneously with the same batch of 
reagents. Using a light microscope (Olympus BX51, Germany), 10X images (219x164 
pm size) were captured by a video camera (Colour View, Olympus, Germany), and 
projected onto a computer monitor. Cell count was done using the Cell*F Image software 
(Olympus, Germany).
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Fig. 2.11 Steps performed to detect positive 
cells
The immunohystochemistry procedure 
involves several steps: washing (1), quencing 
of peroxidases (2), binding with unlabelled 
primary antibody against the protein of interest
(3) followed by washing (4) and incubation 
with avidin-peroxidase conjugate secondary 
antibody (red dots) (5). The biotinylated 
antigen bound to the immobilized primary 
antibody is then reacted with. The activity of 
the bound peroxidase is then visualised and the 
results are black-stained dots (6).
Briefly, a grid was applied onto single acquired image and cells counted in a fixed frame 
made of six squares of the grid (40x40 pm each) for a total area of 0.96 mm2 (panel A in 
the (figure 2.12).
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Fig. 2.12 
Cells Count
(A) Representative photomicrograph (10X magnification) of p-S133CREB-positive cells in 
the CPu of saline-infused rat. A six-framed grid was applied onto each acquired image. 
Inset represent positive cells counted in the sampling area (0.96 mm2) by an automatic 
counting method, generated by the program after manual definition of positive nuclei by 
density and size criteria.
(B) High magnification (60X) of p-S133CREB-positive, heavy stained, immunoreactive 
cell (arrow).
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The number of positive cells was counted by automated selection of those cells within the 
unit area which fulfilled the two following criteria: (1) grey values (resolution: 256 
levels) were required to be higher than the threshold value, (2) to exclude cell debris and 
other artifacts such as dye crystals, only nuclei with a perimeter between 0 and 5 pm, and 
area between 0 and 1 pm2 were included.
Finally, the net grey values and the numbers of positive cells of all analyzed unit areas 
were averaged to obtain an average grey value and an average number of positive cells 
for each brain region of each individual animal.
Two sections per animal were counted and averaged to obtain the mean for each animal. 
Phospho S133-CREB-positive cells were counted in each animal at two different AP levels 
corresponding to bregma +1.8 mm (anterior striatum) and -0.80 mm (posterior striatum 
and cortices) (Paxinos and Watson, 2007). To control for variations in staining between 
sections, the background (i.e. an area containing no staining) was subtracted in each 
section. P-S133CREB immunoreactivity was found to be exclusively nuclear (figure 2.12 
B). No trace of nuclear labeling was detected in sections in which the primary antibody 
was omitted.
Mouse monoclonal antibody against p-CREB (S133, diluted 1:500; Upstate Biotechnology 
USA; Cod. 05-667) was used for IHC. Antibody binding was detected using a secondary 
biotinylated goat anti-mouse antibody (diluted 1:300).
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2.5 INTRACEREBRAL MICRODIALYSIS
General Principles Intracerebral microdialysis is a well-established technique which 
can be used in awake, freely moving animals. Since its introduction in routine 
experimental basic research it has been widely used in rodents to monitor extracellular 
levels of neurotransmitters and endogenous compounds, levels of drugs and their 
metabolites, to locally deliver drugs and toxins in the brain, to alter local ionic 
environment and to correlate behavioral changes to neurotransmission.
The procedure for the in-vivo microdialysis experiments in the rodent brain requires: the 
selection and construction of the microdialysis probe; implantation of the probe into the 
target brain region; collection of dialysate samples and quantification of the analytes 
(neurotransmitters, metabolites) contained. Attention to the details of each of these facets 
is critical for the achievement of accurate and reproducible results.
The key element in this technique is the microdialysis probe, a tiny tube made of a semi- 
permeable membrane which is inserted into the tissue (figure 2.13). A semi-permeable 
membrane has tiny "pores" in it through which low molecular weight solutes can pass. 
During the microdialysis experiment, the inside of the membrane is perfused with 
artificial cerebrospinal fluid (aCSF), and the outside of the membrane is in direct contact 
with the compartment to be sampled. Briefly, the idea of microdialysis is to mimic the 
passive function of a capillary blood vessel by perfusing a thin dialysis tube implanted 
into the tissue. The concentration of compounds in the perfusate thus reflects the 
composition of the extracellular fluid due to the diffusion of substances back and forth 
over the membrane (Ungerstedt, 1982).
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The recovery of substances from the extracellular compartment depends on the length and 
molecular weight cut-off of the membrane as well as the composition and flow rate of the 
perfusate.
Anatyzcr Vial
Microinfusion Pump
25 G Tubing
Dialysis M embrane Brain
wm m
Fig. 2.13
The microdialysis probe_Schematic 
representation of a concentric 
microdialysis probe.
The probe consists of an inflow (1) 
and outflow (2) tube separated by a 
tube made of dialysis membrane (3).
Microdialysis probes can be divided 
into four types on the basis of their 
geometry: concentric, side-by side, U-shaped, and horizontal. The concentric probes are 
more suitable for studies in rodents; can be used in combination with a guide cannula, 
which can be inserted into the brain sometime prior to the actual experiments (up to 2 
months). The surgical procedure is straightforward and can be completed within 20 min. 
Although ready-to-use probes of varying dimensions can be obtained from commercial 
sources, our choice falls onto handmade concentric probes types, which are of course less 
expensive. Calibration of handmade probes is essential, thus pilot in-vitro recovery 
studies were conducted to determine the flow rate of the perfusate that yields optimal
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quantification of the analyte under study. In-vitro recovery data also provide important 
information on probe efficiency.
Protocol In these studies I used a concentric dialysis probes made of Cuprophan 
membrane (216 pm outer diameter, 3000 Da cutoff, Sorin Biomedica, Mirandola, Italy) 
prepared essentially as described elsewhere (Robinson and Whishaw 1988). The 
membrane exposed to the brain tissue was 4 mm long. The day before the experiment, 
rats were anesthetized by intraperitoneal (IP) injection of 3 mL/kg Equithesin and placed 
on a stereotaxic frame.
The dialysis probe was implanted in the mPFC at: AP +3.7 and L ±0.7 mm from bregma 
and DV -4.8 mm from dura surface (Paxinos and Watson 2007).
About 20 h after surgery, the probe was perfused with aCSF (composition in mM: NaCl 
140, CaCl2 1.26, KC1 3, MgCl2 1, Na2HP04 1.2, glucose 7.2, pH 7.4 with 0.6 M 
NaH2P04) at 1 pL/min with a CMA/100 pump. After an equilibration period of 2 or 3 hr 
samples collection began. At least three stable baselines were collected before drug 
treatment.
A schematic diagram of the apparatus is shown in figure 2.14.
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Fig. 2.14
Sequence of steps to perform a microdialysis experiment.
Artificial CSF, is pushed through the probe at a slow flow rate by a syringe pump (1) 
across the dialysis membrane. Analytes in the extracellular space are collected into the 
perfusate and then pushed through the outflow tubing into a collection vial 
(microcentrifuge tube) (2). The collected sample is then analyzed by HPLC-fluorometry 
(3).
GLU was separated through a 4.6 x 80 mm C l8 reverse-phase column. The mobile phase 
contained 0.05 M Na2HP0 4 , 28% methanol, pH 6.4 with 85% phosphoric acid at a flow 
rate of 1 mL/min with a LC20-AD HPLC pump.
Since glutamate is not natively fluorescent, samples were derivatized with o- 
phthalaldehyde (OPA) in the presence of a thiol group such as p-mercaptoethanol which 
allowed for transformation of glutamate into fluorescent product (Donzanti and 
Yamamoto 1988). Five pL of derivatizing reagent were added to 5 pL sample, 
thoroughly mixed and immediately injected into the HPLC by a refrigerated autosampler 
set at 4°C.
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GLU was measured by a fluorescence detector. Excitation and emission wavelengths 
were 335 and 450 nm. Detection limit was 0.1 pmol/5 jiL (signal-to-noise ratio = 2). The 
peak of the glutamate was recognized by the retention time compared with the retention 
time of the standard. The concentration of GLU in the sample, not corrected for the in- 
vitro recovery, was calculated automatically by a data analysis system based on the 
calibration curve calculated on three different standard prepared daily. Intracerebral 
microdialysis has been used in these studies to measure GLU release in cortical samples 
from rats treated with (R)-CPP alone or in combination with LY379268. The protocol 
used has been extensively validated in our laboratory.
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2.6 DRUGS, MICROINJECTION AND TREATMENT 
SCHEDULE
Drugs Drugs used in these studies were the following: (R)-CPP [3-(R)-2-
carboxypiperazin-4-propyl-l-phosphonic acid] (Tocris Cookson Inc. MO); LY379268 [(- 
)-2-oxa-4-aminobicyclo (3.1.0) hexane-4, 6-dicarboxylate] (Eli Lilly, USA) and Sp- 
cAMP [Sp-(adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt 
hydrate)] (Sigma Aldrich, USA). All drugs were dissolved in a solution of phosphate 
buffered saline (PBS, pH=7.4).
(R)-CPP (50 ng/ pL) and Sp-cAMP (10.5 or 21 nmol/0.5 pL) were microinfused into the 
mPFC, LY379268 (0.1 mg/kg) was administered peripherally by a subcutaneous 
injection. In the microdialysis experiment (R)-CPP (100 pM) was dissolved in the aCSF 
and perfused through the probe implanted in the mPFC.
The dose of (R)-CPP was chosen based on previously published results from our 
laboratory (fig. 2.15).
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Effects of intra mPFC (R)-CPP on behavioural performance
Effects of 1, 10, and 50 ng/pL of (R)-CPP or 1 pL vehicle injected into the mPFC 10 min 
before the test session on correct responses (a), anticipatory responses (b), and 
perseverative responses (c). (R)-CPP and vehicle were administered at least 48 h apart, 
according to a Latin-square design.
Infusion of (R)-CPP, had profound effects on rats’ attentional performance in the 5-CSRT 
task. Although the following data have been already published (Mirjana et al. 2004) they 
are reported as they represent the starting point of this thesis. (R)-CPP injected into the 
mPFC had profound effects on rats’ attentional performance: it impaired attention as 
shown by a decrease in accuracy of visual discrimination (measured by % correct 
responses) and it caused a loss of inhibitory response control exemplified by enhanced 
anticipatory and perseverative responding.
The histograms show mean±SEM of eight rats. *P<0.05 vs 0 (Tukey’s test).
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Microinjection Procedures On testing days, while the rat was held, the stylets were 
removed and two injection units terminating 2 mm below the tip of the guides were 
inserted. A volume of 1 pL per hemisphere of (R)-CPP, Sp-cAMP or appropriate vehicles 
was delivered at a rate of 0.5 pL/min by a 10 pL Hamilton syringe, mounted in a 
CMA/100 infusion pump connected by PP10 tubing to the injection units. Injection units 
were left in place for 1 min after infusion to allow for drug diffusion.
Treatment Schedule Rats were given vehicle or LY379268 20 min before the bilateral 
injection of 1.0 pL side vehicle or 50 ng/pL side (R)-CPP into the mPFC. Rats were 
given vehicle or Sp-cAMP 2 min before the bilateral injection of (R)-CPP into the mPFC. 
The behavioural session started 10 minutes after (R)-CPP.
In the behavioural experiments residual effects of drugs were minimized by allowing a 
sufficient number of between treatments days. In addition any residual effect of a drug 
was determined by behavioural testing of the animals on these intervening days. To 
control for the carry-over effects caused by the order of task conditions or drug injections, 
a randomized repeated measurements design was used. The procedure that was chosen as 
appropriate was the Latin-square design.
With the exception of microdialysis study in which (R)-CPP was infused in the FC 
through the probe, in the rest of the experiments performed in this thesis, (R)-CPP was 
microinjected into the mPFC. This procedure is extensively employed and has many 
advantages. A major advantage is the reversibility of the effects that could not be found 
with other techniques such as neurotoxic or neurochemically selective lesions.
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2.7 HISTOLOGY
Histology refers to the microscopic study of tissue. The visualization of the brain’s 
cytoarchitecture is an important complement to the studies in neuroscience, which permits 
to identifying areas affected by a lesion and verifying the placement of an injection. At 
the end of experiments (except for western blotting experiments), rats were deeply 
anesthetized with chloral hydrate (400 mg/kg, i.p.) and killed by decapitation. The brain 
was removed and frozen on dry ice. Frozen brains were sliced into 30 pm thick slices by 
a cryostat, and then mounted on polylysine-coated slides.
In this study I used cresyl violet, a Nissl stain that colours cell bodies a brilliant violet. 
Nissl is a term used by classical cytologists for the endoplasmic reticulum (ER). Since all 
cells contain ER, cresyl violet will stain both neurons and glia. Cresyl violet staining on 
adjacent cryostat cut sections was carried out according to published procedures 
(Kawamura and Niimi 1972).
The staining procedure consists of sequentially dipping the slides in about a dozen 
different solutions for specified amounts of time: 1 min H2O; 5 min EtOH 70%, 5 min 
EtOH 100% and 5 min xylene. The steps were repeated in reverse order then slides were 
dipped for 3 min in 0.5% Cresyl-violet solution. Slides were washed ten times in H2O 
and ten times in EtOH 70% followed by 1 min EtOH 95% plus 3% acetic acid, 3 min 
EtOH 100% and 5 min xylene.
The sequence of solutions is designed to accomplish the following: an initial alcohol soak
removes lipids (fats) and fixation chemicals from the tissue; submersion of sections in
stain; tissue dehydration by a series of alcohol baths. Finally the unstained parts of the
tissue are made transparent by a clearing agent (xylene). Sections were then mounted with
Permount and observed by light microscopy (Olympus BX51, Germany). Correct probe
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and cannula placement was checked by visual inspection of the tracks on the stained 
coronal sections. Only rats with correct cannula and probe placements were considered in 
the results.
2.8 STATISTICAL ANALYSIS
Statistical analysis was performed using the StatView 5.0 software. One-way or two-way 
ANalysis Of VAriance (ANOVA) was used, followed by the appropriate post-hoc test. 
The significance limit was set at p<0.05. The application of a specific post-hoc test (e.g. 
Tukey's test) is needed after the achievement of a significant main effect (one- and two- 
way ANOVA) or interaction, (two-way ANOVA) in order to determine differences 
between single means.
The main dependent behavioural variables selected for analysis were: choice accuracy 
(the proportion of correct responses / number of correct + incorrect responses), the 
proportion of omissions (the number of omissions / number of correct + incorrect + 
omissions), the number of anticipatory and perseverative responses, the correct response 
latency (the time from the stimulus onset to a correct response). All the behavioural data 
were analysed using SAS-V9 statistical software package.
Data from biochemical experiments were expressed as mean percentage of controls (± 
S.E.M.). The effects of (R)-CPP, LY379268 and Sp-cAMP were compared to vehicle 
controls by unpaired Student’s t-test. The effects of (R)-CPP in combination with
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LY379268 were analyzed by between-subjects two-way ANOVA with factors LY379268 
and (R)-CPP.
Extracellular levels of GLU expressed as percentages of basal values were analyzed by 
ANOVA for repeated measures with treatments ((R)-CPP and LY379268) as the 
between-subject factors and time as the within-subject factor. The analysis was applied to 
the part of the curve from 20 to 80 min after systemic drug injection, which corresponded 
to the duration of (R)-CPP infusion.
On all occasions when the ANOVA indicated a significant effect of main factors or (R)- 
CPP x LY379268, or (R)-CPP x Sp-cAMP interactions (the significance level for F  
values was set at P<0.05), the treatments mean values were compared between them by 
Tukey’s test.
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CHAPTER 3
EFFECTS OF BLOCKADE 
OF NMDAR IN THE mPFC 
ON CREB PHOSPHORYLATION
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CREB phosphorylation has been implicated in numerous cognitive functions: learning, 
various aspects of memory such as short and long term as well as working memory, 
memory formation for response and place strategy, appetitive and fear conditioning, 
cocaine self-administration and in the control of attention and impulsivity (see General 
Introduction).
In mice, acute systemic administration of NMDAR antagonist increase the 
phosphorylation of CREB on the active site S133 (p-CREB) both in the striatum and PFC 
as shown by Svenningsson et al. (2003) an effect that has been associated with 
impairments in pre-pulse inhibition and hyperactivity. Similarly, the NMDAR antagonist- 
induced attention performance deficit in the 5-CSRT task was associated with increased 
p-CREB level in the striatum of DBA mice (Pozzi et al. 2010), indicating a likely 
relationship between p-CREB and attention.
I set to further investigate this relationship by examining the effects of conditions that 
impair attention such as blockade of NMDAR in the mPFC on CREB phosphorylation at 
some nodes of cortico-striatal projection such as PFC, dorsal (CPu) and ventral (NAC) 
striatum which have been shown to importantly contribute to executive functions 
including attention (see General Introduction).
The competitive NMDAR antagonist (R)-CPP was injected into the mPFC of 
behaviourally naive rats at the same dose and conditions employed in the behavioural 
experiments. In an attempt to examine the dynamics of the effects of (R)-CPP on p-CREB 
levels, two time points have been selected: the first corresponding to the beginning of the
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behavioural test (10 min after (R)-CPP injection) and the second corresponding to the end 
of the behavioural test (40 min after (R)-CPP injection).
Immunohystochemical technique was used to detect the number of p-CREB-positive cells 
in coronal sections comprising cortical and striatal regions and western immunoblotting 
method to measure p-CREB levels in tissue homogenate from cortical and striatal 
samples of (R)-CPP-infused rats.
I also attempted to identify the likely signalling cascade through which (R)-CPP may 
have influenced CREB phosphorylation on serine 133 by examining its effects on some 
kinases such as c-AMP-dependent protein kinase A (PKA), calcium/calmodulin- 
dependent kinase II (CaMKII) and extracellular-regulated MAP kinase (ERK1/2) which 
are regulated by GLU and dependent on Ca2+-permeable NMDA receptor activity (see 
General Introduction).
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3.1 EFFECTS OF (R)-CPP ON p-CREB STUDIED BY IHC
The experimental timeline is reported below.
Brain perfusion for 
I immunohistochemistry 
analysis of p-CREB
40 min
A comprehensive description of experimental procedures (animals, surgery, 
microinjections and western blot) is reported in General methods (Chapter 2). Briefly, rats 
were bilaterally implanted with stainless steel cannulae in the mPFC then they had 3 days 
to recover from surgery. On the day of the experiment 50 ng/pL (R)-CPP or 1 pL vehicle 
(PBS) were infused bilaterally in the mPFC. Forty min after (R)-CPP infusion rats were 
anaesthetized and intracardially perfused with a fixative solution for 
immunohistochemical analysis of the number of p-CREB-positive cells.
The number of p-CREB-positive cells was counted in cortical and some subcortical 
regions such as caudate-putament (CPu) and nucleus accumbens (NAC) that receive 
glutamatergic excitatory afferents from the FC. In particular p-CREB positive cells were 
counted in the motor and cingulate cortices, in two different aspects of the CPu (i.e. 
medial and lateral) and in the core and shell regions of the NAC (fig.3.1). Phospho-CREB 
immunoreactivity was not measured in slices containing the medial regions of the frontal 
cortex (which is the precise site of (R)-CPP infusion) because as a consequence of 
cannulae implantation and (R)-CPP injection, the area showed some sign of gliosis along 
the injection needle track that could prevent a precise quantification of cells.
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SURGERY 50 ng/pL CPP
RECOVERY
3 days
The prelimbic (PL) and infralimbic (IL) cortices send their axons rostrally to the motor 
and the cingulate cortices thus changes in p-CREB in these areas may reflect at least in 
part the changes in PL and IL regions of PFC (fig.3.1).
Coronal sections showing distribution of retrogradely labeled cells in posterior 
cortical areas
Coronal sections showing distribution of retrogradely labeled cells in posterior cortical 
areas following delivery of Fluoro-Gold (red) and Fast Blue (blue) in frontal cortical 
areas as indicated by the coloured insets.
Abbreviations: PL, prelimbic cortex; IL, infralimbic cortex; Cgl, cingulate cortex; Ml, motor cortex; ac, 
anterior commissure; cc, corpus callosum; CPu, caudateputamen; LV, lateral ventricle.
Fig.3.1
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(R)-CPP increased p-CREB in the FC and CPu but not in the NAC
Fig.3.2
A schematic drawing that illustrate the areas where p-CREB-positive cells were 
counted.
Areas considered for cells counting were as follows: a, motor cortex 1; b, cingulate cortex 
1; c, medial striatum; d, lateral striatum (at bregma -0.80); e, nucleus accumbens core and 
f, nucleus accumbens shell (at bregma +1.80).
The size of the counting frame was fixed at 0.96 mm2. See materials and methods for 
details.
Quantification of p-CREB-positive cells in the cortical regions, CPu and NAC after 
intracortical (R)-CPP is shown in fig.3.3.
Forty minutes after (R)-CPP infusion, p-CREB-positive cells were increased across 
primary motor and cingulate regions of FC (both P<0.05; Student’s t-test). In contrast, the 
number of p-CREB-positive cells was decreased both in the medial and lateral region of 
the CPu (both P<0.05; Student’s t-test). No changes in the number of p-CREB-positive 
cells were detected in the core or the shell regions of the NAC (both P>0.05; Student’s t- 
test).
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(R)-CPP-induced changes in the number of p-CREB-positive cells in cortical and 
striatal areas
Quantitative effects of (R)-CPP on p-CREB-positive cells in the cortical and striatal 
regions compared to saline (V). V or (R)-CPP were bilaterally infused in the mPFC and 
rats sacrificed 40 min later. Histograms represent the number of positive cells 
(mean±SEM). *P<0.05 vs saline (V) (Student’s t-test).
The number of p-CREB-positive cells was as follows: a, MCtl V=197±35 and 
CPP=380±75; b, CgCtl V=256±43 and CPP=566±110; c, MedCPu V=375±99; 
CPP=124±32; d, LatCPu V=238±58; CPP=96±25; e, Nac core V=360±146; 
CPP=310±87; f, Nac shell V=113±15; CPP=130±10.
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p-CREB in the orbitofrontal cortex was increased by (R)-CPP
Recently, Sun et al. (2010) reported a positive association between impulsivity measured 
in the 5-CSRT task (ie. increased anticipatory responding) and S133CREB 
phosphorylation in the orbitofrontal cortex (OFC). They showed that yohimbine (a 
noradrenergic a2 antagonist) at the dose, which increased impulsive responding in rats, 
selectively increased p-CREB within the OFC but not mPFC or NAC.
They also reported that over-expression of the dominant negative antagonist mCREB 
within the OFC blocked yohimbine's effects on impulsivity, whereas viral-mediated gene 
transfer to regionally overexpress CREB in this region increased impulsive responding 
and potentiated the pro-impulsive actions of yohimbine.
Thus, I measured the effect of (R)-CPP, which also increased impulsivity as shown in fig. 
3.1 on the number of p-CREB-positive cells in the rat OFC. I found that 40 min after 
(R)-CPP the number of p-CREB-positive cells was increased in the lateral and ventral 
OFC (Fig 3.4 C and C’) compared to saline-infused rats (fig 3.4 B and B’). Only slices of 
2 control and 2 treated rats were analyzed, making impossible a statistical analysis. 
Therefore it could not be excluded that (R)-CPP-induced impulsivity may reflect at least 
in part changes in p-CREB in the OFC.
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Fig. 3.4
(R)-CPP-induced p-CREB-positive cells in the rat orbitofrontal cortex.
(A) Schematic drawing of the coronal section showing orbital region of the frontal cortex 
(bregma 4.20; Paxinos and Watson 2007) and representative images illustrating 
immunostaining of p-CREB-positive cells 40 min after intracortical infusion of saline (B, 
B’) or CPP (C, C’). Areas in the inset represent the lateral (LO) and the ventral (VO) 
orbitofrontal cortex.
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3.2 EFFECTS OF (R)-CPP ON p-CREB STUDIED BY  
WESTERN BLOT
In the following experiment western blot was used to measure levels of p-CREB as well 
as phosphorylation of various protein kinases in tissue samples at different time points 
after (R)-CPP infusion.
The experimental timeline is reported below.
SURGERY 50 ng/|iL  CPP
Brain dissection for western 
blot analysis of p-CREB and 
protein kinases.
3 days 10 min 40 min
A comprehensive description of experimental procedures (animals, surgery, 
microinjections and western blot) is reported in general methods (Chapter 2). Briefly, rats 
were bilaterally implanted with stainless steel cannulae in the mPFC then they had 3 days 
to recover from surgery. On the day of the experiment 50 ng/pl (R)-CPP or vehicle (PBS) 
1 pi were infused bilaterally in the mPFC. Ten or 40 min after (R)-CPP infusion rats were 
sacrificed and their brain rapidly dissected out. FC, CPu and NAC samples were stored at 
-80°C until phosphorylation of CREB and of various protein kinases was measured by 
western blot.
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(R)-CPP induced changes in p-CREB in the FC and CPu but not in the NAC
Figure 3.5 shows that blockade of NMDAR in the mPFC by (R)-CPP has differential 
effects on p-CREB levels in the FC, CPu and NAC.
The time-course analysis showed that (R)-CPP had biphasic effects on p-CREB in the FC. 
Ten minutes after intra-mPFC injection of (R)-CPP (fig. 3.5 A), p-CREB was decreased 
while 40 minutes after (R)-CPP (fig. 3.5 B) it was significantly increased (both P<0.05, 
comparison between V and CPP by Student’s t-test).
CREB phosphorylation in the CPu was also affected by intra-mPFC (R)-CPP but in 
contrast to what reported for FC, levels of p-CREB were significantly and uniformly 
decreased at both time points (10 min shown in fig. 3.5 A and 40 min shown in fig. 3.5 B) 
(both P<0.05, comparison between V and CPP, Student’s t-test).
No changes in p-CREB levels in the NAC were reported either at 10 min (fig. 3.5 A) or 
40 min (fig. 3.5 B) after (R)-CPP injection in the mPFC (both P>0.05, comparison 
between V and CPP, Student’s t-test).
CREB (T-CREB) levels in the FC, CPu and NAC were not affected by (R)-CPP (data not 
shown).
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Fig 3.5
Effects of (R)-CPP on p-CREB levels.
Representative immunoblots and quantification of p-CREB levels in the FC, CPu and 
NAC of saline- (V) and (R)-CPP-infused rats (CPP). V or (R)-CPP were infused 
bilaterally in the mPFC and rats sacrificed 10 (A) or 40 (B) min later. Histograms 
represent the mean±SEM of 6 rats per group expressed as percentage of controls.
*P<0.05 vs V (Student’s t-test).
The values for (R)-CPP expressed as the percentage of controls (V) are: A, FC 39±9%; 
CPu 68±8%; NAC 100±11%. B, FC 205±29%; CPu 71±9%; NAC 93±11%.
Total levels of CREB were not modified by (R)-CPP (not shown).
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3.3 EFFECTS OF (R)-CPP ON PROTEIN KINASES 
STUDIED BY WESTERN BLOT
It is well known that CREB phosphorylation on serine 133 can be regulated by several 
signalling proteins thus representing an important convergence element for different 
intracellular pathways. Among the activators of CREB, the cAMP-dependent protein 
kinase A (PKA), calcium/CaM-dependent kinases (CaMKs) and extracellular regulated 
kinase (ERK) pathways play an important role.
Therefore, the effects of (R)-CPP on the phosphorylation of PKA (T197 on the catalytic 
subunit), ERK1/2 (T202/Y204), and CaMKII (T286), were examined in the same tissue 
homogenates where p-CREB levels were previously measured. Among the kinases 
measured in the FC, CPu and NAC after (R)-CPP only the catalytic subunit of PKA 
phosphorylated on T197 (p-PKAc) was significantly decreased by (R)-CPP 10 and 40 min 
after (R)-CPP.
(R)-CPP decreased p-PKAc in the FC and CPu but not NAC
I used an antibody against the phosphorylated form of the catalytic subunit of PKA (p- 
PKAc). PKA normally exists in the cytoplasm as an inactive tetrameric holoenzyme 
which is dissociated into two free catalytic and two regulatory subunits. The PKA 
catalytic subunit (c) once activated, moves into the cell nucleus and phosphorylates serine 
residue 133 on CREB (Skalhegg and Tasken 2000). Figure 3.6 shows that 10 min after 
(R)-CPP infusion levels of p-PKAc were decreased both in the FC (fig. 3.6 A) (compared 
to V; P<0.05; Student’s t-test) and in the CPu (fig. 3.6 A) (compared to V; P<0.05; 
Student’s t-test) and this decrease lasted for at least 40 min (fig. 3.6 B) in both FC and 
CPu (both compared to V; P<0.05; Student’s t-test).
109
No changes in p-PKAc in the NAC were detected either 10 (fig. 3.6 A) (compared to V, 
P>0.05; Student’s t-test) or 40 min after (R)-CPP injection in the mPFC (fig. 3.6 B) 
(compared to V, P>0.05; Student’s t-test).
(R)-CPP had no effect on total PKA levels in the FC, CPu and NAC (data not shown).
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Effects of (R)-CPP on p-PKAc levels
The effects of CPP injection in the mPFC on the levels of the catalytic subunit of PKA 
phosphorylated on p-PKAc in the FC, CPu and NAC
Representative immunoblots and quantification of p-PKAc levels in vehicle (V) and (R)- 
CPP-infused rats (CPP) 10 (A) or 40 (B) min later.
Histograms represent the mean±SEM of 5-6 rats per group expressed as percentage of 
controls. *P<0.05 vs V (Student’s t-test).
The values for (R)-CPP expressed as the percentage of controls (V) are: A, FC 51±8%; 
CPu 48±10%; NAC 102±15%. B, FC 57±19%; CPu 57±3%; NAC 105±6%.
Total levels of PKA were not modified by (R)-CPP (not shown).
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(R)-CPP had no effect on p-ERKl/2 levels in the FC and CPu but increased p-
ERK1 levels in the NAC
It is well known that activation of the extracellular signal-regulated protein kinase 1 and 2 
(ERK1/2), causes phosphorylation of CREB on S133, and the subsequent transcription of 
CRE-driven genes (Impey et al. 1996; Impey et al. 1998; Davis et al. 2000). Thus I 
investigated whether this kinase might be involved in the CPP-induced changes in p- 
CREB.
Western blot data show that levels of p-ERKl and p-ERK2 were unchanged in FC and 
CPu 10 min (fig 3.7 B and C) or 40 min (fig 3.8 B and C) after infusion of CPP.
Levels of p-ERKl in the NAC were significantly increased at 40 (fig 3.8 B) but not 10 
min (fig 3.8 C) after (R)-CPP, whereas levels of p-ERK2 in the same region were 
unchanged at both time points (fig 3.7 C and 3.8 C).
No changes in total ERK1/2 levels were detected in the FC, CPu and NAC (data not 
shown).
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Fig. 3.7
Effects of (R)-CPP on p-ERKl and p-ERK2 (10 min time point)
(R)-CPP had no effects on p-ERKl and p-ERK2. Representative immunoblots (A) and 
quantification of p-ERKl (B) and p-ERK2 (C) levels in vehicle (V) and (R)-CPP-infused 
rats (CPP). V or (R)-CPP were bilaterally infused in the mPFC and rats sacrificed 10 min 
later. Histograms represent the mean±SEM of 6-8 rats per group expressed as percentage 
of controls.
Total levels of ERK1/2 were not modified by (R)-CPP (not shown).
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Effects of (R)-CPP on p-ERKl and p-ERK2 (40 min time point)
Representative immunoblots (A) and quantification of p-ERKl (B) and p-ERK2 (C) 
levels in vehicle (V) and (R)-CPP-infused rats (CPP). V or (R)-CPP were bilaterally 
infused in the mPFC and rats sacrificed 40 min later. Histograms represent the 
mean±SEM of 6-8 rats per group expressed as percentage of controls. *P<0.05 vs V 
(Student’s t-test).
Total levels of ERK1/2 were not modified by (R)-CPP (not shown).
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(R)-CPP had no effect on p-CAMKII
I also investigated the effects of (R)-CPP on the phosphorylation of CaMKII on T286 (p- 
CaMKII) an enzyme associated with the calcium influx through the NMDA receptor and 
responsible for CREB phosphorylation on serine 133.
Figure 3.9, shows that injection of (R)-CPP in the mPFC 10 min (A), or 40 min (B) after 
had no effects on p-CaMKII levels in the FC, CPu or in the NAC.
Total CaMKII levels were not affected by (R)-CPP (data not shown).
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(R)-CPP did not affect p-CaMKII
Representative immunoblots and quantification of p-CaMKII levels in vehicle (V) and 
(R)-CPP-infused rats (CPP). V or (R)-CPP were bilaterally infused in the mPFC and rats 
sacrificed 10 or 40 min later. Data are expressed as percentage of controls. Histograms 
represent mean±SEM of 5-7 rats per group. *P<0.05 vs V (Student’s t-test).
Total levels of CaMKII were not modified by (R)-CPP (not shown).
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3.4 DISCUSSION
The data provide evidence that the effects of the competitive NMDAR antagonist (R)- 
CPP injected in the mPFC on CREB phosphorylation were regionally specific; it was 
biphasic in the PFC, a decrease followed by an increase, it consistently decreased in the 
CPu and it was unaffected in the NAC. The analysis of p-CREB’s upstream protein 
kinases show that in regions where p-CREB levels were affected by (R)-CPP such as FC 
and CPu, p-PKAc levels were significantly and consistently decreased. The data also 
show that intracellular pathways dependent on ERK1/2 or CaMKII kinases were not 
involved in the (R)-CPP-induced changes in p-CREB.
Biphasic effects of (R)-CPP in the mPFC on p-CREB levels in the FC.
Blockade of NMDAR in the mPFC by (R)-CPP had a biphasic effect on p-CREB levels 
in the FC: 10 min after intracortical infusion p-CREB levels decreased whereas 40 min 
later they increased. The decrease in p-CREB levels was surprising, as no other in vivo 
studies have ever reported a decrease after NMDAR antagonists.
The increase in p-CREB levels 40 min after (R)-CPP as measured by western blot 
technique was confirmed and extended by immunohistochemical determination. P- 
CREB-positive cells were increased across primary motor (MCtl) and cingulate (CgCl) 
regions of the FC. I also found that the number of p-CREB-positive cells was increased in 
lateral (LO) and ventral (VO) regions of the orbitofrontal cortex (OFC), which is 
consistent with the findings of Sun et al. (2010). Similar increases in p-CREB levels in 
the FC have been reported after non-competitive NMDAR antagonists such as PCP and
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MK-801 in mice (Pozzi et al. 2010; Svenningsson et al. 2003) but also in rats (Pozzi et al. 
unpublished results).
CREB is activated by phosphorylation on serine residue 133 (S133) through many 
different signalling cascades among which is the cAMP / protein kinase (PKA) pathway 
(Mayr and Montminy 2001). Interestingly p-PKAc levels in the FC were also decreased 
10 min after (R)-CPP injection. The phosphorylation of T197 is a necessary step in the 
catalytic activity of PKA (Jin 2007; Moore et al. 2002) thus its reduction may play a role 
in the (R)-CPP-induced decrease of p-CREB. Surprisingly, p-PKAc levels were reduced 
in the FC 40 min after (R)-CPP. Despite the decrease in p-PKAc p-CREB levels were 
increased suggesting that other non-PKA dependent mechanisms are involved in the (R)- 
CPP-induced increase in p-CREB.
Biphasic CREB phosphorylation has been observed in electrophysiological but also 
behavioural studies. For example, CREB phosphorylation shows a distinct temporal 
dynamics with fast increase, a return to baseline followed by a sustained and long lasting 
increase during hippocampal LTP tetanic stimulation in rats or long term facilitation 
(LTF) in Aplysia as well as during aversive learning in rats (Bemabeu et al. 1997; Liu et 
al. 2007; Schulz et al. 1999). In addition, single brief application of DA induced first a 
decrease and then an increase in depolarisation evoked firing of PFC neurons (Gulledge 
and Jaffe 1998 and 2001). This biphasic course may be a general feature of responding of 
neuronal tissue to DA as it has been observed in striatal (Williams and Millar 1990), 
hippocampal (Gribkoff and Ashe 1984) and PFC neurons (Gorelova and Yang 2000; 
Gulledge and Jaffe 1998 and 2001; Seamans et al. 2001).
Interestingly, administration of NMDAR antagonists causes first a rapid decrease in the 
firing of fast spiking putative GABA intemeurons and subsequently an increase in the
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firing of glutamatergic pyramidal neurons (Homayoun and Moghaddam 2007). Although 
the effects of decreased and increased firing of cortical intemeurons and pyramidal cells 
respectively on p-CREB has yet to be determined, bursts of synaptic activity has been 
shown to increase p-CREB in hippocampal neurons (Bito et al. 1996). Over-expression of 
CREB in slice-cultures of the NAC and locus coeruleus (LC) neuronal cell types 
increased membrane excitability (Dong et al. 2006; Han et al. 2006). Sustained activation 
of cAMP-PKA pathway by forskoline or 8-Br-cAMP has also been shown to increase LC 
neurons firing (Cao et al. 2010). On the other hand, knockdown of CREB in slice cultures 
from floxed CREB mice decreased the firing of LC neurons and prevented the effects of 
cAMP stimulation (Cao et al. 2010). Thus it could not be excluded that the biphasic 
course of action of (R)-CPP on p-CREB may reflect the decrease followed by the increase 
in neuronal firing in the PFC and that different neuronal populations (GABA vs GLU) 
may be involved.
(R)-CPP infused in the mPFC has been shown to strongly increase neuronal GLU efflux 
in this cortical region (Ceglia et al. 2004) (see also Chapter 4). There is evidence that 
behavioural deficit and neurochemical changes such as increased DA release in the PFC 
induced by NMDAR antagonists are reversed by blockade of (S)-a-amino-3-hydroxy-5- 
methyl-4-isoxazolpropionic acid (AMPA) or stimulation of type II mGlu receptors (Greco 
et al. 2005; Homayoun et al. 2005; Moghaddam and Adams 1998; Moghaddam et al. 
1997) (see also data presented in Chapter 4). Thus it could be hypothesised that GLU 
released frompresynaptic terminals can enhance the intracellular Ca2+ levels by activating 
AMPA and mGlu receptors positively coupled to CREB phosphorylation (Choe and
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Wang 2002; Ginty et al. 1993; Lindemeyer et al. 2006; Perkinton et al. 1999; Uslaner et 
al. 2009; Zirpel et al. 2000).
In addition to enhancing GLU efflux NMDAR antagonists increase the release of DA and 
5-HT in the PFC (Martin et al. 1998; Moghaddam et al. 1997). Cortical DA and 5-HT 
modulate GLU and GAB A transmission in the PFC through diverse signalling cascades 
that target numerous intracellular substrates to regulate cellular excitability (Greengard et 
al. 1999; Svenningsson et al. 2002). A key actor in the integration of DA and GLU is 
DARPP32 (Fernandez et al. 2006), the DA and cAMP-regulated phosphoprotein of 32 
kDa. DARPP32 is a phosphatase inhibitor and a major target for GLU signalling (Nishi et 
al. 2005). Although DARPP32 impacts cortical inhibition through D2-dependent 
regulation of GABA current in pyramidal cells, the Dl-PKA modulation of GAB A fast 
spiking intemeurons in the PFC occurs independently of DARPP32 (Trantham-Davidson 
et al. 2008). The ability of NMDA receptor antagonists to increase p-CREB has been 
linked to an interaction with DARPP32, as T34 -> A_DARPP32 point mutation abolished 
the effects of PCP on p-CREB (Svenningsson et al. 2003). In the same study 
Svenningsson showed that the effects of amphetamine (but not those of PCP) on p- 
DARPP32 was abolished in brain slices made from Di KO mice suggesting that the 
effects of PCP on p-DARPP32 were independent of increased DA tone on Dl receptor.
In our previous study we showed that the ability of PCP to increase p-CREB might be
linked to an interaction with 5-HT2A receptors as a consequence of PCP increasing
endogenous 5-HT tone (Pozzi et al. 2010). Consistently, the 5-HT2A receptor agonists
DOI and LSD increased p-CREB (Chalecka-Franaszek et al. 1999; Svenningsson et al.
2003). Moreover, PCP was not able to increase p-CREB in animals depleted of 5-HT by
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the 5-HT synthesis inhibitor PCPA (Pozzi et al. 2010). DARPP32 appears essential also 
for 5-HT transmission as behavioural and gene transcription effects induced by 
compounds that selectively release 5-HT were greatly reduced in DARPP32 KO mice 
(Svenningsson et al. 2002). Furthermore stimulation of 5-HT2A receptors by DOI 
increases the phosphorylation of Ser137 on DARPP32 which in turn controls the 
phosphorylation state of DARPP32 at Thr34 site, while ketanserine a 5-HT2A antagonist 
blocks the effects of 5-HT on Ser137-DARPP32 (Svenningsson et al. 2002). However, the 
PCP-induced increase in p-CREB but not p-DARPP32 was completely abolished by 
blockade of 5-HT2A receptors (Pozzi et al. 2010). Together, these data indicate that 5-HT 
mechanisms modulate p-CREB independently of changes in DARPP32 phosphorylation.
Effects of (R)-CPP on p-CREB levels in the dorsal (CPu) and ventral (NAC) 
striatum
I report that local blockade of NMDAR in the PFC by (R)-CPP decreased p-CREB in the 
CPu at both 10 min and 40 min time points whereas it had no effects in the NAC.
The decrease in striatal p-CREB levels contrast with previous studies showing that 
systemic PCP increased p-CREB in the striatum of mice (Pozzi et al. 2010; Svenningsson 
et al. 2003). The reason for this discrepancy are most likely due to local versus systemic 
administration of NMDAR antagonists although I cannot disregard altogether, the 
competitive versus non-competitive nature of the NMDAR antagonists and species 
differences (mice versus rats) employed in these studies. It should be noted that the 
effects of intracortical (R)-CPP on p-CREB, p-PKA, p-ERKl/2 and p-CaMKII in dorsal 
and ventral striatal regions were indirect and most likely due to changes in the 
corticostriatal neurotransmission.
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It is conceivable that (R)-CPP-induced GLU release in the mPFC could be reflected in 
changes in neuronal activity in the CPu. Interestingly, intracortical infusion of (R)-CPP 
(50 ng/gL) increased GLU, DA and GAB A release in the CPu as measured by 
intracerebral microdialysis in rats (Agnoli and Carli unpublished) indicating a 
disinhibition of corticostriatal neurotransmission. Local application of GLU in the CPu, 
increases CREB phosphorylation via CaMK (Mao and Wang 2002; Vanhoutte et al. 
1999) that acts through L-type Ca2+ channels (Rajadhyaksha et al. 1999) and MAPK 
(Choe and Wang 2001b; Mao et al. 2004; Wang et al. 2004). However, as I found a 
decrease in p-CREB it is unlikely that the increased GLU efflux contributed to it.
There is evidence that descending GLU pathways from the FC modulate the release of 
DA in subcortical areas such as the CPu but also in NAC (Karreman and Moghaddam 
1996; Murase et al. 1993; Taber and Fibiger 1993 and 1995). In rats, this occur both 
directly, via GLU-ergic corticostriatal projections (Cheramy et al. 1986; Taber and 
Fibiger 1995), and indirectly through a direct cortical GLU projection to mesostriatal DA 
neurons in the substantia nigra (SN) and ventral tegmental area (VTA) (Karreman and 
Moghaddam 1996; Murase et al. 1993). Notably, intracerebral microdialysis experiments 
showed that intracortical infusion of 50 ng/pL (R)-CPP increased DA release in the CPu 
of rats (Agnoli and Carli unpublished).
A possible explanation for this decrease in p-CREB levels implicates the involvement of 
DA receptors in the CPu. The integration of corticostriatal information in the CPu by DA- 
ergic mechanisms depends critically on the class of DA receptor. In particular in the CPu, 
stimulation of D1 receptors (a receptor family positively coupled to the cAMP) or 
blockade of D2 receptors (negatively coupled to the cAMP) increased p-CREB (Chartoff 
et al. 2003; Konradi et al. 1994; Pozzi et al. 2003; Schmidt et al. 1998; Stoof and
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Kebabian 1981). In the medium spiny neurons of the CPu, the PKA-dependent 
phosphorylation of DARPP32 on threonine 34 (T34) site has been shown to induce p- 
CREB (Fernandez et al. 2006; Nishi et al. 2005; Valjent et al. 2005). Interestingly, a 
recent report has shown that activation of D2 receptor triggers divergent signalling 
cascades that inhibit multiple synaptic Ca2+ sources; it attenuates Ca2+ influx through 
NMDAR via a reduction of PKA activity but also through a PKA-independent pathway 
(voltage-gated calcium channels) (Higley and Sabatini 2010).
Both immunohystochemistry and western blot data show that p-CREB levels in the NAC 
were not affected by (R)-CPP. Accordingly, I found that in rats the acute systemic 
administration of PCP or MK-801 had no effect on p-CREB levels (see Table 1). This 
lack of effects on p-CREB levels in the NAC is surprising in view of cortical GLU 
afferents to NAC and to DA neurons of the VTA that in turn project to the NAC (Vertes
2004). In addition, intra-PFC (R)-CPP (albeit at a dose 20 times higher) increased DA 
efflux in the NAC (Del Arco et al. 2008), which is not substantially different to what has 
been reported for CPu (Agnoli and Carli, unpublished results).
Modulation of protein kinases by (R)-CPP
In an attempt to identify the intracellular pathways that may have lead to changes in p- 
CREB I examined some kinases that are regulated by GLU and depend on Ca2+- 
permeable NMDA receptor activity such as the protein kinase A (PKA), the 
calcium/calmodulin-dependent kinase II (CaMKII) and the extracellular-regulated MAP 
kinase (ERK1/2), (Dash et al. 1991; Sheng et al. 1991; Vanhoutte et al. 1999).
I used an antibody against the phosphorylated form of the catalytic subunit of PKA 
(PKAc). PKA normally exists in the cytoplasm as an inactive tetrameric holoenzyme
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which is dissociated into two free catalytic and two regulatory subunits. The PKA 
catalytic subunit (c) once activated, moves into the cell nucleus and phosphorylates 
residue SI33 on CREB (Skalhegg and Tasken 2000). Among the kinases measured in the 
FC, CPu and NAC after (R)-CPP only the catalytic subunit of PKA phosphorylated on 
T197 (p-PKAc) was significantly decreased at both time points (10 and 40 min after CPP). 
The effects of (R)-CPP on p-PKA were discussed in the previous paragraphs of this 
chapter.
Despite the fact that the MAPK/ERK pathway can be activated in response to increased 
Ca2+ levels (Fiore et al. 1993; Vanhoutte et al. 1999) the present results show that there 
were no changes in phosphorylation of T202/Y204-ERKl/2 in the FC and CPu in response 
to (R)-CPP infusion thus ruling out the involvement of these kinases in the (R)-CPP- 
induced changes in p-CREB levels. Accordingly, PCP had no effect on p-ERKl/2 in 
mice’ FC and CPu (Pozzi et al. 2010; Svenningsson et al. 2003).
However, the ability of PCP to affect ERK1/2 phosphorylation in other brain regions has 
been reported. Administration of PCP dose-dependently increased p-ERKl/2 in the rat 
cerebellum without affecting those in the hippocampus, brainstem, and FC (Kyosseva et 
al. 2001), whereas Enomoto et al. (2005) found elevated level of p-ERKl/2 in the 
hippocampus of PCP-treated mice. The p-ERKl was increased in the NAC 40 min after 
(R)-CPP. This effect appears to be independent of p-CREB as no changes in p-CREB 
levels in this region were detected. However, it could not be excluded that p-ERKl in the 
NAC might participate in the (R)-CPP-induced behavioural impairments.
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Another protein strictly associated with the calcium influx through NMDA receptor is 
CaMKII, which is a crucial mediator of synaptic plasticity (Colbran and Brown 2004). 
Consistent with my previous data with systemic PCP (Pozzi et al. 2010), (R)-CPP had no 
effect on phospho-T286-CaMKII in FC, CPu and NAC thus ruling out the involvement of 
this kinase in (R)-CPP-induced changes in p-CREB levels. However, it cannot be 
excluded that other CaMK isoforms such as CaMKIV and VI might be involved.
Table 3.1.
ACCURACY vi, 4, 4/
IMPULSIVITY t t t
COMPULSIVTrY t ?
10 min 4, 'I' N.E. N.E. 4s t  _
40 min 4, N.E. 'h N.E. N.E. N.E. N.E.
Summary of behavioural and biochemical effects of NMDAR antagonists
NMDAR antagonists-induced behavioural responses in the 5-CSRT task and CREB 
phosphorylation
This table summarized the effects of (R)-CPP (50 ng/pL intra mPFC), PCP (2.5 mg/kg 
i.p.) and MK-801(0.15 mg/kg i.p.) on 5-CSRT task performance and p-CREB levels in 
the rat FC, CPu and NAC.
I reduction; t  increase; N.E. no effect;
124
Phosphorylation of CREB was affected by (R)-CPP and by non-competitive NMDAR 
antagonists PCP and MK-801, which share the ability to impair attention and executive 
functions in the 5-CSRT task. As can be appreciated in summary Table 3.1, there are 
discrepancies between the behavioural effects of NMDAR antagonists and the dynamics 
of qualitative changes in the levels of p-CREB in the various regions of rat brain. Indeed, 
10 min after intracortical (R)-CPP p-CREB was significantly decreased in the FC, by 
contrast it was increased or not changed after MK-801 and PCP, respectively. On the 
other hand, all compounds increased p-CREB levels in the FC 40 min after their 
administration (Table 3.1). In the CPu p-CREB was decreased 10 and 40 min after (R)- 
CPP, whereas it was increased at 10 but not at 40 min after PCP or MK801 (Table 3.1). 
Likewise, discrepancies in the effect of NMD A receptor antagonists on p-CREB levels in 
cortical and subcortical regions of the brain have been observed also in mice. Acute 
systemic administration of PCP significantly increased p-CREB levels in the FC and CPu 
of CD1 mice (Svenningsson et al. 2003). These results suggest that although p-CREB 
might be involved in the mechanisms by which NMDAR antagonists induced behavioural 
impairments in the 5-CSRT task, its role is still undefined and somewhat controversial. 
Indeed, it is not clear whether the genetic make-up of animals (rats versus mice), the 
competitive or uncompetitive nature of the NMDAR antagonists or the route of 
administration (i.e intra mPFC versus systemic) play a major role in determining the 
direction and time course of changes in p-CREB levels across different brain areas. 
Recently, it has been shown that preventing CREB phosphorylation by viral-vector gene 
transfer in the FC, accuracy measured in the 5-CSRT task was impaired (Paine et al. 
2009). This finding partially contrasts with what is suggested by the present data. 
However, in the study by Paine et al. (Paine et al. 2009) inhibition of CREB
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phosphorylation was made in rats performing the task while I examined the effects of (R)- 
CPP on p-CREB in rats that were behaviourally naive. Thus it could not be excluded that 
(R)-CPP may have different effect on p-CREB depending on whether or not rats are 
performing the task. This aspect has been addressed in Chapter 5.
In conclusion, it is suggested that changes in CREB phosphorylation in the cortex and 
dorsal striatum induced by blockade of NMDAR in the mPFC may be not directly linked 
to attention performance deficits but might likely reflect changes in the activity of 
corticostriatal circuitry involving many diverse actors among which are PKA signalling 
and neurotransmitters.
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CHAPTER 4
EFFECTS OF LY379268 ON (R)-CPP-INDUCED 
COGNITIVE DEFICITS, p-CREB CHANGES 
AND GLUTAMATE RELEASE
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In the previous chapter (Chapter 3) I have reported that NMDAR antagonists at doses that 
affected attention and response control in the 5-CSRT task affect phosphorylation of 
CREB on S133 in the FC and CPu. In particular I showed that in rats, (R)-CPP infused in 
the mPFC both increased and decreased p-CREB in the FC (10 and 40 min after infusion, 
respectively) and reduced it in the CPu.
Interestingly, I recently reported that in mice the attentional performance deficit induced 
by PCP in the 5-CSRT task and the PCP-induced p-CREB changes in the CPu were 
prevented by the same dose of the serotonin 5HT2A receptor antagonist, M l00907, 
suggesting that up-regulation of p-CREB may be associated with impairment in 
attentional performance in the 5-CSRT task (Pozzi et al. 2010).
As mentioned in the General Introduction (Chapter 1), administration of NMDAR 
antagonists increased GLU release in the FC. Accordingly, recent work in my laboratory 
has shown that an increased GLU efflux in the PFC was associated with (R)-CPP-induced 
impairments in accuracy of visual discrimination, but not impulsivity or perseveration in 
the 5-CSRT task (Ceglia et al. 2004; Calcagno et al. 2009; Calcagno et al. 2006; Carli et 
al. 2006; Mirjana et al. 2004) (see Table 4.1).
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Table 4.1
Summary of the effects of different agents on (R)-CPP-induced deficits on various 
aspects of attentional performance in the 5-CSRTT and on GLU efflux in the rat 
PFC.
5-CSRTT G L U
ACCURACY IMPULSIVITY COMPULSIVTTY Efflux (PFC)
Intra mPFC 
(R)-CPP 4 t t t
Haloperidol1 
(D2 antagonist)
NO EFFECT R R NO EFFECT
M 100907b* 
(5HT2A antagonist)
R R NO EFFECT R
8-OH-DPAT d,e 
(5HTia agonist)
R NO EFFECT R R
Ro60-0175 1 
(5HT2C agonist)
R R NO EFFECT R
SB242084 s 
(5HT2C antagonist)
NO EFFECT NO EFFECT NO EFFECT NO EFFECT
4  reduction; T increase; R reversal
aBaviera et al, 2008; b Mirjana et al, 2004;c Ceglia et al, 2004; d Carli et al, 2006; 
e Calcagno et al, 2006; f Calcagno et al, 2009; 8 Higgins et al, 2003 (in this study 
MK801was administered systemically)
The metabotropic GLU receptors (mGluRs) are classified into three groups (I, II
and III) based on structural homology, signal transduction mechanisms and
pharmacological properties (Nakanishi 1992). These receptors modulate GLU
neurotransmission in an anatomically and functionally distinct manner (Conn and
Pin 1997; Schoepp and Conn 2002). The group II family of mGluRs consist of
mGluR2 and mGluR3 highly expressed in cortical neurons (Ohishi et al. 1994;
Petralia et al. 1996) and functions as a presynaptic negative regulatory mechanism,
modulating excitatory GLU and inhibitory GAB A transmission (Anwyl 1999;
Schoepp 2001). The mGluR2/3 mediated inhibition of evoked GLU release in PFC
is thought to be one possible mechanism through which the agonists at these
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mGluRs prevent NMDAR antagonists-induced rise in cortical GLU efflux. Indeed, 
in pharmacological studies, the systemically active mGlu2/3 receptor agonists 
LY354740 and LY379268 attenuated the disruptive effects of PCP on cognitive 
functions, stereotypy, locomotion and cortical GLU efflux (Moghaddam and Adams 
1998; Schoepp 2001). Interestingly the selective mGlu2/3 receptor agonist 
LY379268 prevented PCP-induced impairment in attention and response control in 
mice performing the 5-CSRT task (Greco et al. 2005).
In this chapter I present the results of the experiments investigating the hypothesis 
that activation of mGlu2/3 receptors using LY379268, might be sufficient to 
prevent (R)-CPP-induced attention deficits via a modulation of CREB 
phosphorylation and cortical GLU release.
Specifically, I examined the effect of LY379268 given systemically on (R)-CPP- 
induced attention performance deficit and executive control over performance (such 
as anticipatory “impulsive” and perseverative responses) in the 5-CSRT task. In 
addition, by western blot technique and intracerebral microdialysis in awake 
animals I examined whether and how the behaviourally active dose of LY379268 
interfered with the (R)-CPP-induced p-CREB changes in the FC and CPu and the 
(R)-CPP-induced rise in GLU efflux in the FC.
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4.1 LY379268 PREVENTED (R)-CPP-INDUCED
COGNITIVE DEFICITS
The 5-CSRT task was used to investigate whether (R)-CPP-induced cognitive 
deficits were prevented by LY379268. The timeline of this experiment is reported 
below.
SURGERY
I
cvJT,/
LY CPP 
or V or V
L 1
TRAINING RECOVERY TRAINING 20 10*
6 0 -8 0  days 3 days 7 days min min TEST (30 min)
A comprehensive description of experimental procedures is reported in General 
Methods (Chapter 2). Briefly, rats were trained on the 5-CSRT task for several days 
until they reached a baseline performance of 80% correct responses. Then they were 
bilaterally implanted with stainless steel cannulae in the mPFC and had 3 days to 
recover from surgery. Rats were then re-trained for a week to re-establish their pre­
surgery baseline performance.
On the experimental days rats received the combinations of subcutaneous injections 
of PBS (2 mL/kg) or LY379268 (0.1 mg/kg) 20 min before bilateral injection of 
PBS (1 (iL/side) or (R)-CPP (50 ng/pL/side) into the mPFC. Ten minutes after 
intra-mPFC injection rats were put into the box and the test session started. Each rat 
received all drugs combinations according to a Latin-square design. At least two 
days were left between experimental days. Rats were always tested on these “free” 
days to re-establish the baseline and check for the lasting effects of drugs.
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RESULTS
LY379268 prevented (R)-CPP-induced impairments in accuracy and 
anticipatory but not perseverative responding.
Figure 4.1 shows that 0.1 mg/kg LY379268 alone administered subcutaneously 20 
min before bilateral injections of vehicle (V) into the mPFC had no effect on any 
measure of rats’ performance. When LY379268 was administered in combination 
with intra mPFC 50 ng/pL (R)-CPP, it reversed the (R)-CPP-induced impairments 
in accuracy (% correct) (A) and anticipatory responding (B) but was without effects 
on (R)-CPP-induced increase in perseverative responses (C). A two-way ANOVA 
performed on % correct response data showed a significant interaction between 
LY379268 and CPP (Fi,24=11.5 P=0.002) and significant effects of (R)-CPP 
(F 1,24=43.0 P0.0001) and LY379268 (Fi,24=6.5 P=0.01). Post-hoc multiple 
comparisons of various treatments means by Tukey’s test revealed that (R)-CPP 
significantly decreased % correct responses compared to vehicle controls (V+CPP 
compared to V+V; P<0.05) and that (R)-CPP-injected rats pre-treated with 0.1 
mg/kg LY379268 but not vehicle made significantly more correct responses than 
(R)-CPP-injected rats (LY+CPP compared to V+CPP; P<0.05) (Fig.4.1A).
Similarly, ANOVA performed on the anticipatory response data showed a 
significant interaction between LY379268 and (R)-CPP (Fi,24=4.3; P=0.05) a 
significant effect of CPP (Fi,24=19.2; P=0.00021) but no effect of LY379268 
(Fi,24=2.9; P=0.1). Again, anticipatory responding was increased by (R)-CPP 
(V+CPP compared to V+V, P<0.05) and LY379268 decreased it (LY+CPP 
compared to V+CPP, P<0.05) (Fig.4.1B).
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Statistical analysis of perseverative responses data by ANOVA indicated that 
LY379268 had no effect on (R)-CPP-induced perseverative over-responding 
(LY379268 x CPP, Fi,24=0.1; P=0.8; CPP, FU4=13.9; P=0.001; LY379268, 
F i,24=0.6; P=0.4) (Fig.4.1C). Post-hoc comparison of treatment means showed a 
significant increase in perseverative responses due to (R)-CPP (V+CPP compared 
to V+V, PO.05) injection but no effect of LY379268 on its own (LY+V compared 
to V+V, P>0.05) or on (R)-CPP-induced increase (LY+CPP compared to V+CPP; 
P>0.05).
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Fig. 4.1
LY379268 prevented (R)-CPP-induced cognitive deficits
Histograms represent the effects of LY379268 alone or in combination with (R)- 
CPP on correct responses (A), anticipatory (B) and perseverative responses (C).
One pL of saline (V+V) or (R)-CPP (50 ng/pL; V+CPP) was bilaterally infused in 
the mPFC. Rats received LY379268 alone (LY+V) or in combination with (R)-CPP 
(LY+CPP). LY379268 0.1 mg/kg was injected subcutaneously twenty min before 
(R)-CPP.
Ten min after (R)-CPP rats started the test session. (R)-CPP and LY379268 singly 
or combined were administered at least 48 h apart, according to a Latin-square 
design. The histograms show mean ± S.E.M. of 9 rats. * P<0.05 vs. V+V; # P<0.05 
vs. V+CPP; (Tukey’s test).
Omissions showed in Table 4.2, were increased by (R)-CPP (1^24=116.0; 
PO.OOOl) but not 0.1 mg/kg LY379268. However, the proportion of omissions 
made by rats receiving (R)-CPP was not further affected by LY379268 (LY379268 
x CPP, Fi524=2.2; P=0.15). Table 4.2 also shows that rats receiving (R)-CPP into the 
mPFC had longer correct response latencies (Fi524=55.1 PO.OOOl) but that pre­
treatment with LY379268 had no effect (LY379268, Fi ;24=1.9 P=0.18; LY379268 x 
CPP, Fi,24=0.13 P=0.7).
TREATMENT OMISSIONS
(%)
CORRECT RESPONSE 
LATENCY (s)
V + V 10.0 ± 1.4 0.54 ± 0.03
LY 0.1 + V 16.4 ± 2.0 0.60 ±0.05
V + CPP 33.7 ± 4.2 * 0.95 ± 0.07 *
LY 0.1 + CPP 43.2 ± 3.9 1.05 ± 0.09
Table 4.2
(R)-CPP-increased omissions and correct response latency
Each value is the mean ± SEM of 9 rats. LY379268 at a dose of 0.1 mg/kg (LY 0.1) 
or vehicle (V) were injected subcutaneously 20 min before bilateral injections of 
vehicle (V, lpL) or (R)-CPP (CPP, 50 ng/pL) into the mPFC. Ten min later the rats 
started the test sessions. The various doses were administered at least 48 h apart, 
according to a Latin-square design.
* P < 0.05 vs. V+V; Tukey’s test.
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The effects of 0.3 mg/kg LY379268 on (R)-CPP-induced deficits were also tested. 
At this dose LY379268 by itself had no effect on accuracy and on anticipatory or 
perseverative responses but greatly increased the percentage of omissions (from 
10.0±1.4 to 22.1±4.4; P<0.05) and correct response latencies (from 0.54±0.03 to 
0.70±0.08 sec; P<0.05). When given in combination with (R)-CPP 0.3 mg/kg 
LY379268 had additive effects on omissions and latencies. Many rats performed 
only few trials doing mostly omissions. Six out of 9 animals made about 80 % 
omissions. The mean proportion of omissions and correct response latencies after 
0.3 mg/kg LY379268 plus (R)-CPP reached 60.3±5.3 % and 1.47±0.11 sec 
respectively. However, 0.3 mg/kg LY379268 greatly reduced anticipatory (from 
14.0±3.4 to 3.7±1.7; P<0.05) but not perseverative over-responding (from 49.3±7.1 
to 41.7±7.5; P>0.05) of (R)-CPP-injected rats. Accuracy data were not reliable due 
to a very low number of correct and incorrect trials and are not reported.
Rats’ baseline performance before starting intra-cortical (vehicle or (R)-CPP; n=9) 
and subcutaneous (vehicle or LY379268; n=9) injections was stable across days 
(Fig. 4.2). They performed the task with very high accuracy (between 78-96 % 
correct responses; 5-17 % omissions, respectively) and a low number of 
anticipatory (between 1-17) and perseverative (between 10-40) responses. Rats 
were fast to make a correct response (0.46-0.7 sec) and to collect the earned food 
pellet (0.44-2.0 sec).
During the “free between-treatment” days rats’ performance was similar to that 
during baseline, suggesting that there were no carry-over effects of various 
treatments and their combinations.
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Fig. 4.2
Baseline behavioural performance
Accuracy (A) (% CORRECT RESPONSES) and omissions (B) (% OMISSIONS) 
of individual rats (n=9) for the 2 days before the start of injections in the mPFC (bl 
and b2) and during the 2 days after each treatment day (al, after the first treatment 
day -  a6 after the last treatment day).
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4.2 LY379268 PREVENTED (R)-CPP-INDUCED p-CREB 
CHANGES IN THE FC
I next investigated the effect of LY379268 at the dose that prevented (R)-CPP- 
induced attention deficits in the 5-CSRT task on (R)-CPP-induced p-CREB changes 
in the rat FC and CPu. The timeline of this experiment is reported below.
SURGERY CPP
LY379268
!
Western blot Western blot 
analysis analysis
I RECOVERY 20m in
3 days 10 m in 40 min
A comprehensive description of experimental procedures is reported in General 
Methods (Chapter 2). Briefly, rats were bilaterally implanted with stainless steel 
cannulae in the mPFC and had 3 days to recover from surgery. A group rats was 
pretreated subcutaneously with PBS (2 mL/kg) or LY379268 (0.1 mg/kg) 20 min 
before intra-PFC injections of PBS (1 pL side) or (R)-CPP (50 ng/pL side). These 
rats were sacrificed 10 or 40 min after (R)-CPP (i.e. 30 min and 1 h after 
LY379268, respectively).
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RESULTS
LY379268 prevented (R)-CPP-induced p-CREB changes in the FC
As shown in figure 4.3, p-CREB levels in the FC were decreased 10 min (A) and 
increased 40 min (B) after intracortical (R)-CPP infusion thus replicating the data 
presented in Chapter 3. Both effects were abolished by pre-treatment with a 
subcutaneous dose of 0.1 mg/kg LY379268 as indicated by the significant 
interaction between LY379268 and (R)-CPP at both 10 (Fig.4.3A) (Fi3i8=4.4; 
P<0.05) and 40 (Fig.4.3B) min (Fi32i=10.4; P<0.05) after (R)-CPP. Furthermore, 
comparison between treatment means by Tukey’s test indicated that p-CREB levels 
of (R)-CPP-injected rats decreased compared to those after saline-injection at 10 but 
increased at 40 min (comparison between V+CPP with V+V; P<0.05). Comparing 
treatment means of rats that had LY+CPP with those that received V+CPP showed 
that at 10 min time point p-CREB levels were increased (P<0.05) whereas at 40 min 
time point the p-CREB levels were decreased (P<0.05). However, on its own 
LY379268 significantly increased the levels of p-CREB but only 30 min after 
injection (Fig. 4.3A) (comparison between V+LY and V+V; P<0.05, Tukey’s test). 
One hour after LY379268 injection (Fig.4.3B) levels of p-CREB were similar to 
those measured in saline injected rats (comparison between LY+V and V+V; 
P>0.05, Tukey’s test).
Levels of T-CREB were not modified by any treatments (not shown).
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LY379268 prevented (R)-CPP-induced pCREB changes in the FC
Representative immunoblots and quantification of (R)-CPP-induced p-CREB 
changes in the FC of rats pre-treated with 0.1 mg/kg LY379268.
LY379268 was given 20 min before (R)-CPP and rats were sacrificed 10 (A) or 40 
min (B) after (R)-CPP. Data are expressed as percentage of values in saline-treated 
rats (V+V). Histograms represent mean±SEM of 6 rats per group.
*P<0.05, vs V+V; # p<0.05, vs V+CPP (Tukey’s test).
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LY379268 did not prevent (R)-CPP-induced p-CREB decrease in the CPu
LY379268 was unable to reverse the effects of (R)-CPP on p-CREB levels in the 
CPu. Figure 4.4 shows that (R)-CPP-induced decrease in p-CREB levels in the CPu 
were not prevented by pretreatment with 0.1 mg/kg LY379268 both at 10 (A) and 
40 min (B) as indicated by the two-way ANOVA (LY379268xCPP, Fisi9=2 .2 ; 
P>0.05 and LY379268xCPP, F i 52 o= 0 . 0 8 ;  P>0.05, respectively).
However, the F values for the main effect of (R)-CPP were significant at both time 
points and further analysis by Tukey’s test indicated that (R)-CPP decreased the 
levels of p-CREB 10 and 40 min after injection (comparison between V+V and 
V+CPP, P<0.05). Although at 10 min time-point (Fig.4.4A) levels of p-CREB in 
rats receiving 0.1 mg/kg LY379268 plus (R)-CPP were higher than those receiving 
saline plus (R)-CPP this difference was not statistically significant (P>0.05; 
Tukey’s test).
Figure 4.4B shows that 40 min after (R)-CPP p-CREB levels in rats receiving the 
combination of LY379268 plus (R)-CPP were not different from those receiving V 
plus (R)-CPP (P>0.05; Tukey’s test).
LY379268 had no effect on p-CREB levels in rats injected with intra-cortical saline 
at either 10 (A) or 40 (B) min time points (comparison between LY379268+V and 
V+V; P>0.05, Tukey’s test). Levels of T-CREB were not modified by any 
treatment (not shown).
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LY379268 did not prevent (R)-CPP-induced p-CREB decrease in the CPu.
Representative immunoblots and quantification of (R)-CPP-induced p-CREB 
changes in the CPu of rats pre-treated with 0.1 mg/kg LY379268.
LY379268 was given 20 min before (R)-CPP and rats were sacrificed 10 (A) or 40 
min (B) after (R)-CPP. Data are expressed as percentage of values in saline-treated 
rats (V+V). Histograms represent mean±SEM 
of 6  rats per group.
* P<0.05, vs V+V; (Tukey’s test).
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4.3 LY379268 SELECTIVELY INCREASED p-CaMKII 
IN THE FC
To unveil the signal pathways recruited by LY379268 in its ability to prevent (R)- 
CPP-induced changes in p-CREB, I tested whether LY379268 might interfere with 
the upstream kinases that regulate phosphorylation of CREB on serine 133, such as 
PKA, ERK1/2, and CaMKII.
Levels of phosphorylated kinases in the FC and CPu were measured 1 hour after 
LY379268 (the time point corresponding at 40 min after (R)-CPP in the previous 
experiment). Dilutions of antibodies for protein kinases were as follows: p-T - 
CaMKII (1:10000), p-T197-PKAc (1:4000) and p-T202/Y204-ERKl/2 (1:10000). 
Levels of phosphorylated kinases and CREB were measured in the same samples.
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RESULTS
The effects of LY379268 on p-CREB and protein kinases are reported in Fig.4.5.
I found that levels of p-CREB were not changed lh after LY379268 administration 
both in the FC (A) and in the CPu (B) thus confirming my previous results (see Figs 
4.3B and 4.4B).
Administration of LY379268 increased the levels of p-CaMKII in the FC 
(Fig.4.5A) (P<0.05, Student’s t-test; comparison V versus LY379268) while it was 
without effect on p-CaMKII levels in the CPu (Fig.4.5B) (P>0.05, Student’s t-test; 
comparison V versus LY379268).
One hour after LY379268, levels of p-PKAc were increased both in the FC 
(Fig.4.5A) and in the CPu (Fig.4.5B) compared to vehicle-injected rats (P<0.05, 
comparison between V and LY379268, Student’s t-test).
LY379268 did not affect levels of p-ERKl/2 either in the FC (Fig.4.5A) or in the 
CPu (Fig.4.5B) (P>0.05, Student’s t-test).
The effects of LY379268 on these kinases in the NAC were not examined.
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Fig. 4.5
Effects of LY379268 on phosphorylated CREB and protein kinases
Histograms depict quantitative effects of LY379268 on p-CREB, p-CaMKII, p- 
PKAc and p-ERKl/2 levels in the FC (A) and CPu (B), compared to vehicle (V). 
Vehicle or LY379268 (0.1 mg/kg) were given s.c. and rats were sacrificed 1 hour 
later.
Data are expressed as percentage of values (mean±SEM) in vehicle-injected rats 
(V). N=6 / 8  replications each bar.
*P<0.05 vs V (Student’s t-test).
144
4.4 LY379268 PREVENTED (R)-CPP-INDUCED
GLUTAMATE RELEASE
In the following experiment I tested the hypothesis that LY379268, at the dose that 
prevented (R)-CPP-induced attention deficits and (R)-CPP-induced p-CREB 
changes in the FC might be effective in preventing (R)-CPP-induced cortical GLU 
release. The timeline of the experiment is reported below.
SURGERY LY379268 HISTOLOGY
100 pm CPP 
infusion I
Start
Sampling
24 hours recovery 20 min lh  lh
Intracerebral Microdialysis
A detailed description of experimental procedures is reported in General Methods 
(Chapter 2). Briefly, rats were implanted with a microdialisys probe in the mPFC 
(Fig.4.6).
/ ? A
♦
Microdialysis 
“  probe
Fig. 4.6
Localization of the microdialysis probe 
in the mPFC.
The picture shows the exact localization 
of the concentric microdialysis probe in 
the rat mPFC. Coordinates are as 
follows: AP+3.7, L±0.7 mm from 
bregma and DV-4.8 mm from dura 
surface (Paxinos and Watson 2007).
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On the experimental day (24 h after surgery) (R)-CPP was dissolved in aCSF and 
infused for 60 min through the probe into the mPFC at the concentrations of 100 
(iM. Control rats were perfused for the same time with aCSF alone.
LY379268 (0.1 mg/kg) was dissolved in PBS and injected S.C. 20 min before (R)- 
CPP, during the phase of stable GLU output (defined as three consecutive baseline 
samples not differing by more than 20%). Control rats were given PBS s.c.
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RESULTS
LY379268 prevented (R)-CPP-induced rise of extracellular GLU in the mPFC
Basal levels of extracellular GLU in the rats’ mPFC are reported in Table 4.3.
aCSF+PBS 17± 3  (N=6)
LY+aCSF 1 9 ± 2  (N=6)
PBS+CPP 2 2 ± 4  (N=5)
LY+CPP 2 5 ± 3 (N = 6 )
Table 4.3
Basal levels of extracellular GLU in the mPFC in each group of rats implanted with 
the microdialysis probe. Data are expressed as pmol/20 pL (5-6 rats).
The mean basal level of GLU was 21±3 pmol/20 pL (not corrected for recovery) 
(N=23). The number of animals in each group is shown in brackets.
Figure 4.7 shows that infusion of artificial CSF trough the probe and systemic 
administration of PBS had no effects on extracellular GLU in the rat mPFC (A). 
The infusion of 100 pM (R)-CPP trough the probe increased extracellular GLU in 
the rat mPFC reaching 250% of basal values at 40 min (B).
LY379268 (0.1 mg/kg), which had no significant effect by itself (A) (Fisi9= 1 .8 , 
p=0.2), abolished the (R)-CPP-induced rise of extracellular GLU (B). ANOVA 
showed highly significant effects of (R)-CPP ^ 19=6 .2 , P=0.02), LY379268 x (R)- 
CPP (FU9=17.4, P=0.0005) and LY379268 x (R)-CPP x time (F7,i33=7 .2 , 
PO.OOOl).
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Fig 4.7
Effect of (R)-CPP alone and in combination with LY379268 on GLU efflux in 
the mPFC.
(A) LY379268 alone has no effect on basal GLU in the mPFC. LY379268 or PBS 
was injected S.C. 20 min before aCSF perfusion (arrow). a-CSF was perfused 
through the probe for 60 min, starting 20 min after LY379268 or PBS, as indicated 
by the horizontal bar.
(B) LY379268 prevented (R)-CPP-induced rise of extracellular GLU.
LY379268 was injected S.C. 20 min before (R)-CPP (arrow). (R)-CPP was 
perfused through the probe for 60 min, starting 20 min after LY379268 or PBS, as 
indicated by the horizontal bar.
Extracellular levels of GLU, not corrected for in vitro recovery of the probe, were 
expressed as percentages of basal values. Basal values (time 0) are the mean of 
three stable consecutive samples.
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Fig 4.8
Graph showing the results reported in fig.4.7 expressed as raw data.
LY379268 or PBS was injected S.C. 20 min before (R)-CPP (arrow). (R)-CPP was 
perfused through the probe for 60 min, starting 20 min after LY379268 or PBS, as 
indicated by the horizontal bar. Basal levels of GLU (time 0), not corrected for in 
vitro recovery of the probe, were calculated as the average of three stable 
consecutive samples.
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4.5 DISCUSSION
The findings from these experiments show that (R)-CPP-induced cognitive 
dysfunctions in the 5-CSRT task are associated with changes in the phosphorylation 
of CREB on residue S133 and excessive GLU release in the FC. Indeed, activation of 
mGluR2/3 by the group II selective agonist LY379268 ameliorated accuracy and 
some aspects of response control such as impulsivity disrupted by the blockade of 
NMDAR in the mPFC and prevented (R)-CPP-induced p-CREB changes and the 
increased GLU release in FC.
LY379268 and cognitive deficits
The results of the behavioural experiment show that LY379268 reversed accuracy 
impairments and anticipatory over-responding induced by intra-mPFC (R)-CPP but 
had no effect on perseverative responses. This pattern of effects contrast with those 
reported by Amitai and Markou (2010) using Wistar rats. They found that 1.0 
mg/kg LY379268 administered concomitantly with repeated PCP treatment 
exacerbated accuracy impairment. LY379268 has been reported to exacerbate also 
PCP-induced ataxia (Cartmell et al. 2000a). Intriguingly, 1.0 mg/kg LY379268 had 
additive effects on PCP-induced increase in omissions, and correct response latency 
(Amitai and Markou, 2010), which is similar to what reported in the present study 
with 0.3 mg/kg. In addition, the dose of 0.3 mg/kg (present study) and that of 3.0 
mg/kg in Amitai and Markou (2010) administered on their own increased the 
percentage of omissions and correct response latency to a similar degree. Thus it 
could be argued that compared to Wistar rats, Lister hooded rats, may be more 
sensitive to the effects of LY379268.
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We previously reported that in mice performing the same behavioural task 
LY379268 at doses 10 time higher than those used in the present experiment had no 
effect on PCP-induced accuracy deficit but completely abolished the increase in 
anticipatory and perseverative responses (Greco et al. 2005). Furthermore, in mice 
the 5 -HT2A receptor antagonist, M l00907 abolished PCP-induced accuracy 
impairment and the increase in anticipatory and perseverative responses whereas in 
rats M l00907 abolished accuracy impairment and anticipatory responding but was 
not able to decrease perseverative over-responding induced by systemic MK-801 
(Higgins et al. 2003) or intra-mPFC (R)-CPP (Carli et al. 2006; Mirjana et al. 2004; 
Pozzi et al. 2010). The contrasting findings are not surprising as differences in 
effective drugs doses and qualitative effects across species and strains have been 
reported. The route of administration, the schedule of treatment (acute or repeated) 
and the competitive/non-competitive nature of NMDAR antagonists may have 
contributed to the reported inconsistencies.
Although LY379268 have been used at higher doses in some previous studies 
(Amitai and Markou, 2010) the doses used in the present study are close to those 
significantly reducing DOI-induced head-twitches (Klodzinska et al. 2002) and 
supposed to yield brain concentrations close to the IC50 (10 nM) for the 
displacement of [3H]341495 binding to mGlu2/3 receptors and the EC50 (3-6 nM) 
for the inhibition of forskolin-stimulated cAMP production (Imre 2007). Non- 
selective effects of LY379268 can be ruled out as doses of LY379268 close to those 
used in the present study or even higher were prevented by the selective mGluR2/3 
antagonist LY341495 (Di Liberto 2010; Molinaro et al. 2009).
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Injected in the mPFC (R)-CPP has been shown to increase motor activity (Del Arco 
et al. 2008; Mirjana et al. 2004) suggesting that LY379268 could have prevented 
accuracy deficit by blocking (R)-CPP-induced hyperactivity. However, it is difficult 
to explain the accuracy deficit as a simple motor effect as correct and incorrect 
responses in this task have the same motor requirements. In addition we have 
shown that accuracy deficit and increased omissions induced by 50 ng/side (R)-CPP 
were completely abolished when the attentional load on performance was 
decreased, by increasing stimulus duration from 0.5 to 1.0 sec (Mirjana et al. 2004). 
Furthermore LY379268 prevents hyperactivity at doses at least 10 times higher than 
those used in the present study (Cartmell et al. 1999 and 2000b; Imre et al. 2006; 
Lorrain et al. 2003a). The (R)-CPP-induced increase in omissions and latency to 
make a correct response might reflect motivational factors. However, decreasing the 
motivation for food by pre-feeding the animals increases the proportion of 
omissions and response latency but had no effect on accuracy and response control 
(Carli and Samanin 1992). Therefore, it is unlikely that (R)-CPP-induced 
impairments were a consequence of hyperactivity, poor motivation or a failure to 
make associations or remember the general rules of the task as well as that 0 . 1  
mg/kg LY379268 prevented attention deficit by decreasing hyperactivity or 
interfering with motivation. At 0.3 mg/kg LY379268 greatly increased omissions 
and latencies to make a correct response and to collect the earned food pellet 
suggesting that at high doses LY379268 may interfere with motivational factors. 
Despite differences in behavioural processes under study, the present findings are 
largely compatible with the behavioural studies showing that mGluR2/3 agonists 
such as LY354740 and LY379268 reduced hyperlocomotion, stereotypy and
152
deficits in working memory, induced by non-competitive NMDAR antagonists 
given systemically (Moghaddam and Adams 1998; Swanson and Schoepp 2002). 
However, no effects of mGluR2/3 agonists on NMDAR antagonists-induced pre­
pulse inhibition deficit and hyperlocomotion have also been reported (Imre et al. 
2006; Henry et al. 2002).
LY379268 prevented (R)-CPP-induced p-CREB changes in FC: possible role 
of CaMKII
Using western blot analysis I found that the dose of LY379268 that prevented (R)- 
CPP-induced accuracy impairments in the 5-CSRT task also prevented (R)-CPP- 
induced changes of p-CREB in the FC but not in the CPu. This indicates that p- 
CREB in the rat FC, but not in the CPu, might be specifically associated to aspects 
of accuracy.
I found that 30 min, but not lh, after LY379268, p-CREB levels were significantly 
increased in the FC. Although this increase was significant only at the time point 
corresponding to the start of the behavioural task (i.e. 30 min after LY379268), this 
result shows that p-CREB can be increased without there being a behavioural 
deficit.
Although mGluR2/3 belongs to a class of inhibitory G protein-coupled receptors 
that are negatively linked to adenylyl cyclase (Conn and Pin 1997; Pin and Acher 
2002; Schoepp et al. 1996a; Schoepp et al. 1996b), the ability of LY379268 to 
increase p-CREB was not surprising. Indeed, some studies have shown that 
activation of mGluRII can increase cAMP levels in cat visual cortex (Reid et al.
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1996), in slices of the neonatal rat hippocampus (Schoepp et al. 1996c) and in 
cellular population of hypothalamic origin (Sortino et al. 1996).
Moreover, stimulation of mGluR2/3 by agonists such as DCG IV and 1-CCG-I, 
produced an approximately 70% decrease of basal cAMP levels with a concomitant 
increase in the p-CREB/CREB ratio in neuronal cell cultures, an effect similar to 
that elicited by a group I mGluR agonist (Harris et al. 2004). Cultured cortical 
neurons express both group I and II mGlu receptors and evidences for synergism 
between them have been found (Cartmell et al. 1993). Thus it is possible that the 
LY379268-induced increase in p-CREB, might be due to a synergistic interaction 
between mGluR group I and II receptors. However, the activation of group II 
mGluR can result in a variety of others physiological effects that can influence p- 
CREB, including the modulation of voltage-dependent conductance (Charpak et al. 
1990) and, at higher doses, neurotransmitter release (Imre et al. 2006).
Western blot analysis was performed to identify the protein kinases recruited by 
LY379268 to prevent (R)-CPP-induced changes in p-CREB levels. In the FC I 
found that both p-PKA and p-CaMKII protein levels were significantly increased by 
LY379268. Yet only p-CaMKII was selectively increased in the FC after 
LY379268 suggesting that the ability of LY379268 to prevent (R)-CPP-induced p- 
CREB changes in the FC, but not in the CPu, might originate from a specific 
modulation of the Ca2+-dependent CaMK signaling in that region. Interestingly, 
recent findings indicate that, among the various mGlu receptors, the group II 
mGluR subtypes mGluR2 and mGluR3 play an important role in the modulation of 
spontaneous Ca2+ spikes (Koga et al. 2010).
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Although speculative, the hypothesis that LY379268-induced changes in CaMKII 
signalling in the FC may be responsible of its ability to alleviate (R)-CPP-induced 
p-CREB changes, is supported by the findings that antipsychotic drugs such as 
haloperidol, clozapine and risperidone significantly impact the calcium second 
messenger system as shown by in-situ hybridization studies where these drugs 
selectively increased mRNA isoform II (but not isoforms I and III) of CaMK (Lee 
et al. 2007; Rushlow et al. 2009).
Interestingly, CaMKII is known to regulate GLU receptors as it induces the 
phosphorylation of the channel domain of the NMDA receptor/channel in the
^ i
postsynaptic densities thus causing an enhancement of Ca influx through the 
channel (Kitamura et al, 1993).
Moreover, CaMK can regulate PKA and others signaling pathways, such as 
PKB/Akt and MAPK, which are also affected by haloperidol and clozapine 
(Dwivedi and Pandey 1999; Emamian et al 2004; Pozzi et al 2003; Soderling 1999).
In conclusion, although, the exact mechanism by which LY379268 reversed the 
effects of (R)-CPP on cortical p-CREB remains to be identified, these data shown 
that is sufficient to restore levels of p-CREB in the FC to reduce the attention 
deficits induced by (R)-CPP as the effects of LY379268 were restricted to the FC.
LY379268 prevent (R)-CPP-induced GLU efflux in the FC
Intracortical perfusion of (R)-CPP significantly increased extracellular GLU in the 
mPFC consistently to previous experiments in my laboratory (Ceglia et al. 2004). 
The intracortical concentration of (R)-CPP that significantly increased extracellular
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GLU (i.e. 100 fiM) fit well with those used in vitro and in vivo to selectively block 
NMDAR (Lehmann et al. 1987; Del Arco and Mora 2002). The effect of (R)-CPP is 
mimicked by intracortical infusion of the competitive NMDAR antagonist AP7 
(Ceglia et al. 2004; Perkins et al. 1982) and (RS)-CPP (Abekawa et al. 2006). 
However, systemic but not intracortical non-competitive NMDAR antagonists such 
as ketamine (Lorrain et al. 2003b) and MK-801 (Lopez-Gil et al. 2007) increased 
cortical GLU efflux. Although it is not known whether the different mode of 
blocking NMDAR or other factors may account for these discrepancies, these 
results indicate that selective blockade of NMDAR in the mPFC is sufficient to 
increase extracellular GLU in this brain region.
As discussed in the General Introduction (Chapter 1) it has been suggested that the 
apparently paradoxical effect of NMDAR antagonist on GLU release depends on 
the inhibition of NMDAR predominantly on the fast spiking putative GABA 
intemeurons that in turn decrease the inhibitory drive on PFC pyramidal output 
neurons (Homayoun and Moghaddam 2007). Indeed, NMDAR antagonists, 
including (R)-CPP, reduced extracellular GABA in the mPFC (Calcagno et al. 
2009; Yonezawa et al. 1998) and induced cortical excitation in humans (Breier et al. 
1997; Holcomb et al. 2005; Vollenweider et al. 1997) and in behaving animals 
(Gozzi et al. 2008b). Accordingly, the GABAa receptor antagonist bicuculline 
injected in the PFC of monkey has been shown to disrupt the performance of a 
delayed response task (Sawaguchi et al. 1988) and loss of spatial tuning in neurons 
engaged by working memory (Rao et al. 2000).
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The mGluR2/3 are primarily distributed in forebrain regions (Petralia et al. 1996) 
and autoradiographic studies using H3-LY354740 have shown a substantial binding 
within layer V of the mPFC (Marek et al. 2001; Marek et al. 2000) where they are 
associated with presynaptic membranes (Ohishi et al. 1994; Petralia et al. 1996). 
Their activation mediates presynaptic depression and inhibits electrically evoked 
GLU release both in vivo and in vitro (Cartmell and Schoepp 2000; Marek et al. 
2000). LY379268 which by itself had no effect on GLU efflux prevented the (R)- 
CPP-evoked GLU release in the PFC. The data are consistent with previous reports 
showing that activation of cortical pre-synaptic mGluR2/3 by LY354740 or 
LY379268 reduces PCP- or ketamine-induced GLU efflux (Lorrain et al. 2003b; 
Moghaddam and Adams 1998) and MK801-induced changes in firing rate of 
pyramidal mPFC neurons (Homayoun et al. 2005).
A possible limitation is the difference in the (R)-CPP administration between 
behavioural and microdialysis experiments. As in behavioural experiments (R)-CPP 
was injected into the mPFC for 1 min while in microdialysis experiment (R)-CPP 
was continuously infused through the probe for 60 min. Thus it may be argued that 
the two conditions are not comparable. However, we found that the injection of (R)- 
CPP at the same dose (i.e. 50 ng/pL) and route of administration (i.e. intra mPFC) 
used in the 5-CSRT task, induced a rapid increase of extracellular GLU which was 
similar in magnitude to that observed after its infusion through the probe (Calcagno 
etal. 2009).
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LY379268 mimics the effects of the 5 -HT2A receptor antagonist M100907 which 
prevented the NMDAR antagonists-induced impairments in attention performance, 
the increase in GLU efflux in the PFC and the changes in p-CREB (Ceglia et al. 
2004; Mirjana et al. 2004; Pozzi et al. 2010). This is consistent with previous 
findings showing that the 5-HT-evoked excitatory post-synaptic currents were 
enhanced by the mGluR2/3 antagonist LY341495 and inhibited by agonists 
(1S,3S)-ACPD and LY354740 and by 5 -HT2A receptor antagonist M100907 
(Aghajanian and Marek 2000; Marek et al. 2000). Additionally, activation of 5- 
HT2A receptors by DOI increased excitatory postsynaptic currents and potentials, 
GLU release (Scruggs et al. 2003), activated c-fos in PFC and induced a 
behavioural syndrome characterized by head twitches. All these effects were 
blocked by LY354740 and LY379268 (Aghajanian and Marek 2000; Gewirtz and 
Marek 2000; Klodzinska et al. 2002; Zhai et al. 2003).
The interaction between 5 -HT2A and mGlu2/3 receptors might reside in their co­
localization on the apical dendrites of neocortical layer V pyramidal cells 
(Aghajanian and Marek 1999) rich in 5-FIT terminals and 5 -HT2A receptors 
(Aghajanian and Marek 1997; Blue et al. 1988). This functional analogy may also 
derive from the mGluR2 interaction through the specific transmembrane helix 
domain with the 5 -HT2A receptor (Gonzalez-Maeso et al. 2008). This neuronal 
location is opposed to that found in other cortical regions such as fronto-parietal 
where mGlu2/3 and 5 -HT2A binding appears to localize to different laminas (II-IV 
and Va, respectively) (Marek et al., 2000). Thus, mGluR2/3 receptors may play an 
important role in the integration of synaptic activity. These findings are of special
158
significance in light of a recent phase II clinical trial showing some efficacy of an 
mGlu2/3 agonist in treatment of schizophrenia (Patil et al. 2007).
In conclusion, by behavioural, biochemical and neurochemical studies I showed 
that (R)-CPP-induced cognitive deficits in the 5-CSRT task were associated with 
changes in p-CREB levels and increased GLU release in the FC. It can be 
hypothesised that (R)-CPP-induced increase in p-CREB might be secondary to the 
rise of extracellular GLU, which in turn activate non-NMDA GLU receptors such 
as AMPA or mGlu positively coupled to CREB phosphorylation (Choe and Wang, 
2002; Perkinton et al., 1999; Uslaner et al., 2009). Thus, LY379268 by suppressing 
GLU release may have prevented the changes in p-CREB levels with the possible 
involvement of CaMKII and PKA cascades (see scheme in Fig. 4.9).
Thus, the evidences that LY379268 has attention enhancing effect and modulates p- 
CREB and GLU efflux in the FC may contribute to an emerging understanding of 
the molecular mechanisms that regulate different aspects of the executive functions 
such as attention and response control but also in cognitive deficits dependent on 
NMD A receptor hypofunction in the PFC. They also point to the potential that 
novel approaches aiming at molecular mechanisms to modify CREB 
phosphorylation in the FC may lead to a new generation of treatments for cognitive 
disorders of schizophrenia.
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Fig 4.9
Putative mechanisms involved in (R)-CPP-induced rise of p-CREB levels in the 
FC and its attenuation by the activation of mGlu2/3 receptor with LY379268.
The effect of (R)-CPP could reflect the increase of glutamate (GLU) release and 
cortical pyramidal cells firing which in turn stimuluates CREB phosphorylation 
presumably through the activation of glutamatergic non-NMDAR such as mGlu and 
AMPA.
By suppressing the effect of (R)-CPP on extracellular GLU and cellular activity or 
by j)hosphorylating CaMKII, LY379268 may prevent CREB phosphorylation on 
S .
A role of PKA in (R)-CPP effects on frontocortical p-S133CREB is unlikely as the 
reduction in p-T197PKA levels is not compatible with enhanced p-S133CREB. 
However, PKA may play a major role in (R)-CPP-induced reduction of p- 
S133CREB in the CPu. (—>) Activation; (-y) Inhibition; (X) Unlikely pathway.
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CHAPTER 5
EFFECTS OF Sp-cAMP ON 
(R)-CPP-INDUCED ACCURACY DEFICITS 
IN THE 5-CSRT TASK
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There is substantial evidence that phosphorylation of CREB on SI33 might have a role in 
the GLU NMDAR antagonist-induced inattention and executive function deficits. In the 
previous chapters (Chapters 3 and 4) I have reported that local blockade of cortical 
NMDAR by intra-mPFC administration of the competitive antagonist (R)-CPP, at the 
dose that impair attentional functioning and response control in the 5-CSRT task (Mirjana 
et al. 2004), increased and decreased p-CREB levels in the FC and decreased it in the CPu 
of behaviorally naive rats compared to controls.
Moreover, in behaviourally naive mice, acute systemic administration of PCP and MK- 
801, increased levels of p-CREB both in the FC and CPu, an effect that has been 
associated with impairments in pre-pulse inhibition and hyperactivity (Svenningsson et al. 
2003). Similarly, I found that PCP- and MK-801-induced attention performance deficits 
in the 5-CSRT task were associated with increased p-CREB level in the CPu of mice 
(Pozzi et al. 2010), indicating a likely role of p-CREB in the control of attention and 
executive functions.
Recently, it has been shown that preventing CREB phosphorylation on SI33 by viral - 
vector gene transfer in the PFC, accuracy in the 5-CSRT task was impaired (Paine et al. 
2009). This latter finding contrasts in part with the evidences that behavioural deficits 
induced in the same task by (R)-CPP, PCP and MK-801 were associated to increased p- 
CREB levels in the FC (this thesis; Pozzi et al. 2010; Svenningsson et al. 2003). 
However, in the study by Paine et al. (2009) inhibition of CREB phosphorylation was 
made in rats performing the behavioural task while the effects of (R)-CPP, PCP and MK- 
801 on p-CREB were examined in rats that were behaviorally naive (Pozzi et al. 2010;
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Svenningsson et al. 2003). Thus it could not be excluded that the effects of NMDAR 
antagonists on p-CREB levels depend on whether or not rats are performing the task.
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5.1 EFFECTS OF (R)-CPP ON p-CREB IN RATS 
PERFORMING THE TASK
To address the possibility that (R)-CPP-induced p-CREB changes might depend on the 
behavioral status of the rats, the next experiment was settled out to evaluate p-CREB 
levels in the FC, CPu and NAC of trained rats (rats infused with (R)-CPP and performing 
the 5-CSRT task) compared to (R)-CPP-induced p-CREB changes in untrained rats (rats 
habituated to the testing chambers but not performing the task). Two experimental 
manipulations (i.e. behavioural status and drug treatment) lead to four experimental 
groups: untrained+vehicle; untrained+CPP; trained+vehicle and trained+CPP. The 
timeline of this experiment is represented below.
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I L  M
C P P or
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recovery BEHAVIOURAL
TEST (3 0  min)
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B. UNTRAINED
SURGERY
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W estern Blot 
Analysis
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A comprehensive description of experimental procedures is reported in General Methods 
(Chapter 2). Briefly, after two weeks of food deprivation (when the body weight had 
stabilized to about 85-90% of their initial weight) rats were divided in two groups. One 
group of rats was trained in the 5-CSRT task until they reached a baseline performance of 
80% correct responses (A), while the other group was kept food-deprived and habituated 
to the testing chamber (B). Then they were bilaterally implanted with stainless steel 
cannulae in the mPFC and had 3 days to recover from surgery. On the days of the 
experiment (R)-CPP or vehicle was infused in the mPFC as described previously. Ten 
min after (R)-CPP infusion, trained rats started the behavioural session that last for 30 
min while untrained rats were exposed to the behavioural box for 30 min. Forty minutes 
after (R)-CPP infusion both groups of rats were sacrificed and their brains dissected for 
western blot analysis of p-CREB and T-CREB levels in the FC, CPu and NAC.
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RESULTS
Confirming my previous findings with behaviourally naive rats, figure 5.1 (A) shows that 
intra-mPFC infusion of 50 ng/pL (R)-CPP increased p-CREB in the FC in untrained rats 
(P<0.05, versus V, Student’s t-test) but decreased p-CREB in trained rats (P<0.05, versus 
V; Student’s t-test). As shown in figure. 5.1 (B), levels of p-CREB were increased in the 
CPu of untrained rats but this increase was not statistically significant (P>0.05, versus V; 
Student’s t-test). p-CREB levels in the CPu of trained rats were not affected by R-CPP 
(P>0.05, versus V; Student’s t-test). Interestingly, p-CREB levels in the NAC of trained 
rats were strongly increased (P<0.05, versus V; Student’s t-test) compared to no effect in 
untrained rats (Fig. 5.1; C).
Figure 5.2 shows that (R)-CPP had no effect on T-CREB levels in the FC (A), CPu (B) 
and NAC (C) of untrained rats (all P>0.05, versus V; Student’s t-test). In rats performing 
the task (trained) (R)-CPP decreased T-CREB levels in the FC (Fig. 5.2 A), but increased 
it in the NAC (Fig. 5.2 C) (both P<0.05, versus V ; Student’s t-test). No effects were 
detected in the CPu (Fig. 5.2 B) of trained rats (P>0.05, versus V ; Student’s t-test).
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Fig 5.1
Quantification of p-CREB levels in untrained and trained rats
Histograms depict quantitative effects of saline (V) or (R)-CPP (CPP) on p-CREB levels 
in the FC, CPu and NAC in untrained and trained rats. Saline or CPP were bilaterally 
infused in the mPFC and rats sacrificed 40 min later. Data are expressed as the percentage 
of controls (V). The histograms show mean ± S.E.M. of 5-7 rats.
*P<0.05 vs V (Student’s t-test).
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5.2
Quantification of T-CREB levels in untrained and trained rats
Histograms depict quantitative effects of saline (V) or (R)-CPP (CPP) on T-CREB levels 
in the FC, CPu and NAC in untrained and trained rats. Saline or CPP were bilaterally 
infused in the mPFC and rats sacrificed 40 min later. Data are expressed as the percentage 
of controls (V). The histograms show mean ± S.E.M. of 5-7 rats.
*P<0.05 vs V (Student’s t-test).
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5.2 EFFECT OF INTRACORTICAL INFUSION OF Sp- 
cAMP ON p-CREB LEVELS
In the previous experiment I found that in contrast to increasing p-CREB levels in 
untrained or behaviourally naive rats (Chapters 3 and 4) (R)-CPP decreased levels of p- 
CREB in the FC of rats performing the 5-CSRT task. This finding led to the hypothesis 
that increasing p-CREB levels in this region might be sufficient to prevent (R)-CPP- 
induced attention deficits.
As discussed in the General Introduction (Chapter 1), phosphorylation of residue SI 33 on 
CREB protein can be achieved by the intervention of various protein kinases. One 
prominent and well-characterized mechanism is activation of adenylate cyclase, which 
increases production of cyclic adenosine 3 ',5 '-monophosphate (cAMP). 
cAMP can have intracellular actions activating various proteins like EPAC (Exchange 
Protein Activated by cAMP; Seino and Shibasaki 2005), MAP kinases and the PKB 
pathway (Pearson and Cobb 2002; Hansen et al. 1999; Frodin et al. 1994) that might 
influence CREB activity. Moreover, cAMP induces the release of Ca2+ that in turn may 
stimulate CaMK and PKC (Sheng et al. 1990) but also it activates cAMP-dependent 
protein kinase (PKA) (Greengard et al. 1999). PKA can in turn phosphorylate many 
intracellular proteins and translocate into the nucleus where it phosphorylates CREB. 
Many compound have been developed that interact with this signaling pathway. Rolipram 
increases cAMP and PKA activity by inhibiting the phosphodiesterase type IV enzyme 
(PDE4), preventing the breackdown of cAMP. A different drug, Sp-adenosine-3',5'-cyclic 
monophosphorothioate (Sp-cAMP), acts as a competitive agonist of the cyclic 
nucleotide-binding domains on PKA. It mimics the effects of cAMP, including activation 
of PKA and PKA-dependent intracellular cascades (Van Haastert et al. 1984; Punch et al.
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1997; Huang and Kandel 1998; Self et al. 1998). Downstream consequences of PKA 
activation by Sp-cAMP include phosphorylation of CREB on S133 (Carlezon et al. 2005). 
Its enatiomer, Rp-cAMP, inhibits cAMP actions and PKA activity (Fig. 5.3).
Compared to other cAMP analogues (i.e. dibutyryl-cAMP or 8-Br-cAMP), Sp-cAMPS is 
a cell permeable, potent and specific activator of PKA and has a higher resistance against 
cyclic nucleotide-dependent phosphodiesterases (PDEs) (Fig 5.3).
Fig. 5.3
Schematic drawn showing the compounds frequently used to modulate cAMP-PKA 
activity
(Arnsten et al 2005)
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Sp-cAMP acts downstream of cAMP and its activity is independent from levels of cAMP 
in the cell as it binds directly to the PKA regulatory subunits (“R” in Fig 5.4). This 
avoids non-specific effects of cAMP on other protein kinases and ion channels. Thus, by 
specifically increasing the activity of PKA, Sp-cAMP represents a unique tool for the 
activation of S133-CREB phosphorylation in vivo.
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Fig.5.4
Mechanisms of actions of Sp-cAMP
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A. In its inactive state, PKA consists of a tetramer of two regulatory (R) and two catalytic 
(C) subunits. Each regulatory subunit has two cAMP-binding sites; cAMP binding 
releases the catalytic subunits, which become bound to ATP and go on to phosphorylate 
serine and threonine residues on the substrate sequence.
B. Binding of Sp-cAMP (Sp) to PKA release the two catalytic subunits (C) which become 
bound to ATP and go on to phosphorylate serine and threonine residues on the substrate 
sequence.
Consistent literature indicates that the intracerebral administration of Sp-cAMP impaired 
some types of cognitive performance. For example, post-training infusions of Sp-cAMP 
into the mPFC markedly impaired delayed alternation performance in rats (Taylor et al. 
1999); impaired cortical function in both rats and monkeys (Ramos et al. 2003), and 
exacerbated working-memory deficits in aged rats (Amsten et al. 2005). Moreover, the 
study of Paine et al, (2009) showed that the post-training infusion of Sp-cAMP into the
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mPFC had no effect on accuracy but it did increase omissions in rats performing the 5- 
CSRT task (Paine et al. 2009), while Rp-cAMP had the opposite effect.
As Sp-cAMP do not penetrate the blood-brain barrier when given systemically, the 
compound was injected directly into the mPFC. Therefore, I determined the dose 
response effects and the time course of intracortically infused Sp-cAMP on p-CREB 
levels in the FC, CPu and NAC of rats. The timeline of this experiment is reported below.
Briefly, rats were implanted monolaterally with stainless steel cannulae in the mPFC and 
had 3 days to recover from surgery. On the experimental day rats were gently held and 
the infusion needle was inserted into the cannula after removing the stylet.
Rats received saline (0.5 pL) or Sp-cAMP at 10.5 or 21 nmol dissolved in 0.5 pL saline 
in the mPFC. Sp-cAMP and vehicle were delivered at a rate of 0.5 pL/min. Injection unit 
was left in place for 1 min after infusion to allow for drug diffusion. Ten or 40 min after 
Sp-cAMP or saline rats were killed by decapitation. The FC, CPu and the NAC from both 
hemispheres were rapidly dissected out, frozen on dry ice and stored at -70 °C for 
western blot analysis. The non-injected hemisphere was used as the control.
SURGERY 10 .5  or 21 m n'uL  
Sp-cA M P
Brain dissection for western  
blot analysis of p-CREB and 
p-PKA.
RECOVERY
3 days 10 min 40 min
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RESULTS
Effect of Sp-cAMP on p-CREB levels
Figure 5.5 shows the effects of intracortical infusion of Sp-cAMP on p-CREB levels 10 
(left) and 40 (right) min after infusion as measured by western blot. I found that 21 
nmol/0.5 pL Sp-cAMP increased p-CREB levels in the FC (A) and CPu (B) (both P<0.05 
compared to V; Dunnett’s test). P-CREB levels were decreased in the NAC 10 min after 
21 nmol Sp-cAMP (C) (P>0.05 compared to V; Dunnett’s test). At 10.5 nmol Sp-cAMP 
had no effect on p-CREB in the FC (A), CPu (B) and NAC (C) 10 min after injection (all 
P>0.05 compared to V; Dunnett’s test).
Forty min (right) after the infusion of 21 nmol of Sp-cAMP, p-CREB levels were still 
increased in the FC (A) (P<0.05 compared to V; Dunnett’s test), while in the CPu (B) and 
in NAC (C) p-CREB returned to basal levels (both P>0.05 compared to V; Dunnett’s 
test). Lower doses of Sp-cAMP were not tested.
The effects of Sp-cAMP on cortical p-CREB levels were restricted to the infused 
hemisphere as in the FC taken from the contralateral hemisphere p-CREB levels remained 
unchanged (not shown).
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Fig. 5.5
Effects of Sp-cAMP on p-CREB levels.
Representative immunoblots and quantification of p-CREB levels in the FC (A), CPu (B) 
and NAC (C) of rats infused with vehicle (V), 10.5 or 21 nmol/0.5 pL Sp-cAMP in the 
mPFC. Histograms represent mean±S.E.M. of 5-6 rats per group expressed as percentage 
of controls (V). *P<0.05 vs V (Dunnett’s test and Student’s t-test for 10 and 40 min, 
respectively).
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Effect of Sp-cAMP on p-PKAc levels in the FC
As Sp-cAMP is supposed to increase the phosphorylation of CREB on SI33 by 
increasing the availability of the catalytic (c) subunits of PKA, I measured levels of PKAc 
phosphorylated on threonine T197 in the same samples of the FC used to assess the effects 
of Sp-cAMP on p-CREB.
Forty minutes after infusion of 21 nmol Sp-cAMP in the mPFC, levels of p-PKAc were 
significantly increased compared to controls (V=100±2.5 and Sp-cAMP=150±26, PO.05; 
Student’s t-test) (Fig.5.6).
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Fig 5.6
Effects of Sp-cAMP on p-PKAc levels.
Quantification of p-T197PKAc levels in the FC of rats infused with vehicle (V) or 21 
nmol/0.5 pL Sp-cAMP in the mPFC. Rats were sacrificed 40 min later for western blot 
analysis.
Data are expressed as percentage of controls (V). Histograms represent mean ± S.E.M. of 
4 rats. *P<0.05 vs V (Student’s t-test).
The results of this experiment clearly indicated that 21 nmol Sp-cAMP significantly 
increased p-CREB and p-PKAc levels in the FC. Therefore, this dose was selected for the 
behavioural experiment.
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5.3 EFFECTS OF Sp-cAMP ON (R)-CPP-INDUCED 
ATTENTION DEFICITS
I showed that in the FC of rats performing the task, (R)-CPP decreased p-CREB levels as 
opposed to the increase found in the FC of behaviourally naive rats at the same time point 
(i.e. 40 min after (R)-CPP) indicating that the (R)-CPP-induced behavioural impairment 
in rats performing the 5-CSRT task might be associated to low levels of p-CREB in this 
region. Thus it might be hypothesized that increasing the levels of cortical p-CREB by 
Sp-cAMP might prevent the behavioural deficit induced by (R)-CPP.
The timeline of this experiment is reported below.
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(4 0  min after CPP)
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Briefly, on each experimental day rats trained to perform the task received a bilateral 
infusion of 0.5 pL vehicle or 21 nmol/0.5 pL side Sp-cAMP into the mPFC and after 2 
min they received an additional infusion of 1 pL PBS or 50 ng/pL side (R)-CPP. Ten 
minutes after (R)-CPP infusion rats were put into the boxes and the test session started. 
Each rat received all drugs combinations according to a Latin square design. At least two 
days were left between test days. Rats were always tested on these “free” days to re­
establish the baseline and check for the lasting effects of drugs.
176
RESULTS
Sp-cAMP prevents (R)-CPP-induced impairments in the 5-CSRT task
Fig. 5.7 shows that (R)-CPP (V+C) injected in the mPFC decreased the percentage of 
correct responses (A) and increased anticipatory responding (B). In contrast to the 
previously published reports (but see also Chapter 4), in this experiment (R)-CPP only 
marginally increased perseveratives responses (C) and the percentage of omissions (D). 
Sp-cAMP reversed the (R)-CPP-induced impairment in accuracy (A) and the increase in 
anticipatory responding (B).
A two-way within-subject ANOVA performed on accuracy (% correct response) showed 
a significant interaction between Sp-cAMP and (R)-CPP (Fi;2i=13.9, PO.Ol) (A). Post- 
hoc comparisons of treatments means showed that (R)-CPP decreased accuracy (V+C 
versus V+V; P<0.05) and that rats receiving Sp-cAMP+CPP had higher accuracy than 
rats injected with (R)-CPP alone (Sp+C versus V+C). Sp-cAMP alone had no effect on 
accuracy (comparison Sp+V versus V+V, P>0.05) (A).
A two-way ANOVA showed a significant effect of (R)-CPP on the number of 
anticipatory responses (V+C versus V+V; P<0.05). This increase was prevented by Sp- 
cAMP as indicated by the significant interaction between Sp-cAMP and (R)-CPP 
(Fi,2i=7.13, P<0.05) (B). On its own Sp-cAMP had no effect on anticipatory responses 
(Sp+V versus V+V; P>0.05) (B).
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There was no significant main effect of Sp-cAMP (Fi,2i=0.07, P>0.05) or (R)-CPP 
(Fi,21=0-02, P>0.05) or interaction between Sp-cAMP and R-CPP (Fi;2i=3.25, P>0.05) for 
perseverative responses (C) indicating that Sp-cAMP and (R)-CPP alone or in 
combination had no effect on perseverative responding (both P>0.05; V+C and Sp+V 
versus V+V) (C).
Statistical analysis on the percentage of omissions (D) showed a significant interaction 
between Sp-cAMP and (R)-CPP (Fi52i=13.3, P<0.01) and main effects of Sp-cAMP 
(Fi,2i=0.25, P>0.05) and (R)-CPP (Fi32i=0.25, P>0.05). The proportion of omissions was 
increased by (R)-CPP (even if it did not reach statistical significance) (V+CPP versus 
V+V; P>0.05) and Sp-cAMP (Sp+V versus V+V; P<0.05), when they were administered 
together their effect on omissions was not more apparent (D).
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Fig 5.7
Effects of Sp-cAMP on (R)-CPP-induced performance deficit in the 5-CSRT task.
Histograms represent the mean±S.E.M (n=8 rats per group) of correct responses (A), the 
number of anticipatory (B), perseverative (C) and omissions responses (D).
Rats were intracortical infused with vehicle (V) or 21 nmol Sp-cAMP (Sp) 2 min before 
bilateral infusion of 1 pL of V or 50 ng/pL side (R)-CPP (C). Ten min later rats started 
the test session. Vehicle, (R)-CPP and Sp-cAMP in combination were administered 
according to a Latin-square design. Test sessions were at least 48 h apart. * P<0.05 vs. 
V+V; # P<0.05 vs. V+C; (Tukey’s test).
179
5.4 DISCUSSION
The main findings of these series of experiments were that (R)-CPP had different effects 
on p-CREB levels in the FC and NAC depending whether or not the rats were performing 
the 5-CSRT task. In the FC of untrained rats p-CREB levels were increased whereas in 
rats performing the task levels of p-CREB in the FC were decreased. Remarkably only in 
rats performing the 5-CSRT task (R)-CPP increased the levels of p-CREB in the NAC.
The fact that intracortical infusion of the cAMP analogue Sp-cAMP, which increased p- 
CREB and p-PKAc levels in the FC, prevented (R)-CPP-induced deficits in accuracy and 
the increase in anticipatory responses in rats performing the 5-CSRT task, gives support 
to the hypothesis that p-CREB mechanisms within the FC may contribute to selective 
attention.
Effect of (R)-CPP in rats performing the 5-CSRT task
In the FC of rats performing the task (R)-CPP decreased p-CREB as opposed to the 
increase found in the FC of behaviourally naive rats at the same time point (i.e. 40 min 
after (R)-CPP) indicating that the impaired attention performance on the 5-CSRT task 
might be associated to low levels of p-CREB in this region. These results are in 
accordance with those of Paine et al. (2009) who showed that reducing p-CREB levels in 
the FC cause attention deficits in the 5-CSRT task and with the evidences that regions of 
the FC such as prefrontal (PFC) and orbitofrontal (OFC) are critical for attention but also 
for aspects of executive control over performance such as impulsivity and compulsivity 
(Birrell and Brown 2000; Chudasama et al. 2003; Muir et al. 1996a; Passetti et al. 2002; 
Sun et al. 2010).
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That low levels of p-CREB might contribute to impaired attention and aspects of 
executive control over performance is supported by data showing that Spontaneously 
Hypertensive Rats (SHR) have lower levels of p-CREB in the FC and lower accuracy in 
the 5-CSRT task compared to normotensive Wistar Kyoto Rats (WKY; Pozzi 
unpublished).
Impulsivity induced by (R)-CPP was also decreased by Sp-cAMP suggesting that in 
addition to attention, decreased p-CREB in the FC may contribute to impulsivity. 
However, these findings are in contrast with those reported recently by Sun et al. (2010) 
who found that over-expressing CREB protein within the OFC increased impulsivity. 
However, it should be noted that Sun et al. (2010) used a simplified version of the 5- 
CSRT, one-choice task, which places differential emphasis on attention and response 
control compared to the 5-CSRT task used presently. It could be argued that differences 
in the emphasis on response control or the cognitive processes engaged by the task may 
explain the observed differences in p-CREB.
Interestingly level of T-CREB were also decreased after (R)-CPP in the FC of rats 
performing the task. This finding was surprising since in behaviourally nai've rats we 
never found any change in total levels of CREB (this thesis). However, it could not be 
excluded that increased T-CREB in the FC might be due to extensive training itself or the 
actual performance on the 5-CSRT task when compared to untrained controls.
I found that (R)-CPP significantly decreased p-CREB in the CPu of naive rats (Chapters 3 
and 4). However, in the present experiment the same dose of (R)-CPP (50 ng/pL) had no 
effect on p-CREB in the CPu of rats that were either performing or not performing the
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task. This result suggest that p-CREB in this region might have a minor role in the 
attentional deficits induced by (R)-CPP.
Whether this lack of effect might depend on the experimental procedures employed in the 
two different experiments is at present unknow. Indeed, compared to behaviourally naive 
rats used in the previous experiments the untrained control used here were food-deprived, 
manipulated and exposed to the testing chamber for few days.
While (R)-CPP had no effects on p-CREB in the NAC of untrained rats (see Chapters 3 
and 4), it strongly increased p-CREB levels in the NAC of rats performing the task. These 
data are in accordance with findings showing that cortico-striatal projections to NAC 
importantly contribute to affective modulation of attentional performance (Christakou et 
al. 2004).
It has been reported that food restriction increased NMDAR-dependent CREB 
phosphorylation mediated by CaMKII and ERK1/2 in the NAC (Habemy and Carr, 
2005). However, it’s unlikely that the food restriction regimen used in this experiment 
might have induced specific changes in (R)-CPP-induced CREB phosphorylation in the 
NAC because both untrained and trained rats were food-deprived for the same period. 
Table 5.1 summarized the results.
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Untrained+CPP 5-CSRT+ CPP
FC CPu NAC FC CPu NAC
T-CREB N.E. N.E. N.E. + N.E. T
p-CREB t N.E. N.E. \ | / N.E. t
Table 5.1.
Effects of (R)-CPP on CREB levels in rats not performing or performing the 5- 
CSRT task.
Effects of intra mPFC infusion of (R)-CPP (50 ng/pL) on T-CREB and p-CREB levels in 
the FC, CPu and NAC of rats not performing (Untrained+CPP) or performing (5- 
CSRT+CPP) the behavioural task.
I reduction; f increase; N.E. no effect.
Effects of Sp-cAMP on p-CREB levels in the FC, CPu and NAC
I found that the infusion of 10.5 nmol Sp-cAMP into the rat mPFC was without effects on 
p-CREB levels in the FC, CPu and NAC, while the higher dose of 21 nmol significantly 
increased p-CREB levels in the FC and CPu but reduced it in the NAC.
To my knowledge this is the first evidence that infusion of Sp-cAMP into the mPFC 
increased S133-CREB phosphorylation in these regions. Despite the fact that Sp-cAMP 
has been widely used to activate S133-CREB in various behavioural studies (Aujla and 
Beninger 2001; Paine et al. 2009; Taylor et al. 1999) no attempt has been made in these 
studies to document that phosphorylation of CREB on S133 in the target region was 
effectively increased by Sp-cAMP.
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Opposed to the increase in p-CREB levels found in the FC and CPu, p-CREB levels in 
the NAC were decreased after Sp-cAMP. Sp-cAMP infused in the NAC at a high dose of 
80 nmol had no effect (Misra and Pandey 2006) or increased (Self et al. 1998) p-CREB 
and PKAc in this area (Misra and Pandey 2006). Reciprocal regulation of cortical versus 
subcortical regions is well established, for example, for levels of neurotransmitters such 
as dopamine; therefore it is unsurprising to find evidence of reciprocal changes in 
molecular signals in these brain regions.
Effect of Sp-cAMP on 5-CSRT task performance
I found that Sp-cAMP by itself had no effect on accuracy but increased the number of 
omissions in rats performing the 5-CSRT task. These results are consistent with a recent 
report showing that activation of cortical PKA by Sp-cAMP (0.021, 0.21 and 2.1 nmol) 
did not affect accuracy but increased omission errors (Paine et al. 2009).
In the behavioural study I used 21 nmol of Sp-cAMP a dose which was ten times higher 
to that used by Paine et al. (2009). This dose of Sp-cAMP was selected based on previous 
work in rats, which had shown that 21 nmol/0.5 pL Sp-cAMP significantly impaired rat’s 
performance in a delayed alternation performance, whereas 0.21 and 2.1 nmol/0.5 pL had 
no effect (Taylor et al. 1999). In a preliminary study done in my laboratory we found that 
intra-mPFC infusion of 2.1 and 21 nmol/0.5 pL Sp-cAMP had no effect on accuracy in 
the 5-CSRT task (Carli unpublished). Importantly, 21 nmol of Sp-cAMP but not a lower 
dose of 10.5 nmol increased both p-PKAc and p-CREB of in the FC.
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Sp-cAMP prevented (R)-CPP-induced behavioural deficits
The data from the behavioural experiment showed that Sp-cAMP, at a dose that increased 
p-CREB and p-PKAc in the FC, prevented (R)-CPP-induced accuracy deficit and 
anticipatory responding in the 5-CSRT task (see summary table 5.2).
These results suggest that a decreased activity of the PKA/CREB signalling pathway 
might have a negative influence on attention and impulsivity. This interpretation is 
supported by findings showing that the PKA inhibitor Rp-cAMP disrupted accuracy in 
the same task (Paine et al. 2009).
ACCURACY N.E. R
IMPULSIVITY N.E. t R
COMPULSIYTTY N.E. N.E. N.E.
OMISSIONS t N.E. N.E.
Table 5.2.
Effects of (R)-CPP and Sp-cAMP (Sp) alone or in combination on 
5-CSRT task performance.
I reduction; f increase; N.E. no effect; R reverted.
It is not clear whether the beneficial effects of Sp-cAMP on (R)-CPP-induced behavioural 
impairments are the results of an exclusive action of Sp-cAMP on CREB 
phosphorylation. Indeed, the functional effects of increased PKA activity is an increased 
neuronal excitability (Dong et al. 2006; Lopez de Armentia et al. 2007; Trantham- 
Davidson et al. 2004 and 2008). As a consequence, activation of PKA might enhance 
synaptic transmission by increasing neurotransmitter release at synapses (Chavez-Noriega 
and Stevens 1992). Interestingly, NMDAR-mediated excitatory postsynaptic currents
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(EPSCs) are increased by activation of PKA through stimulating G-protein coupled 
receptors (GPCRs), by forskolin or cAMP analogs or direct intracellular administration of 
PKA (Ceme et al. 1993; Tong et al. 1995).
PKA phosphorylates NRi and NR2 NMDAR subunits (Leonard and Hell 1997) thus, 
activation of PKA with Sp-cAMP may transiently increase the activity of NMDAR 
resulting in increased Ca2+ influx into the cell. This aspect is particularly interestingly in 
view of the ability of LY379268 (that also prevented (R)-CPP-induced behavioural 
deficits) to increase the phosphorylation of CaMKII in the FC (see results chapter 4).
Sp-cAMP has been also shown to potentiate GLU release from nerve terminals (Herrero 
and Sanchez-Prieto 1996; Wang 2002). These results suggested the presence of a PKA- 
dependent facilitatory pathway in the nerve terminals from the cerebral cortex that might 
affect GLU release. However, as (R)-CPP increased GLU release in the mPFC, a 
facilitatory role of Sp-cAMP on GLU release should impair rather than improve the 
behavioural responses induced by (R)-CPP.
The relationship between Sp-cAMP-induced increase in CREB and PKAc 
phosphorylation and improvement of (R)-CPP-induced behavioural deficits deserve more 
attention. However, the results of these experiments suggest that reduced signalling in the 
PKA/CREB pathway in the FC has deleterious effects on attention and aspects of control 
over performance.
In conclusion these data suggest that alterations in CREB signalling pathway impaired the 
5-CSRT task performance in rats and that modulation of cortical PKA activities that 
favour phosphorylation of CREB on SI33 could be beneficial.
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CHAPTER 6
SUMMARY AND CONCLUDING REMARKS
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6.1 Summary of Findings
Hypofunction of NMDAR has been implicated in schizophrenia (Javitt and 
Zukin 1991; Tsai and Coyle 2002) and in cognitive deficit associated with this 
disease (Krystal et al. 2003). Administration of NMDAR antagonists has 
become a widely used pharmacological model of schizophrenia-like cognitive 
deficits in experimental animals. Micro injections of the competitive NMDAR 
antagonist (R)-CPP into the mPFC is sufficient to induce attentional 
impairment and increase impulsivity and perseverative over-responding in the 
five choice serial reaction time (5-CSRT) task, an analogue of the continuous 
performance test used to study attention in humans (Mirjana et al. 2004; 
Murphy et al. 2005). In this thesis I report an association between the 
transcription factors CREB, NMDAR antagonists and performance on the 5- 
CSRT task.
The present thesis was built with the aim of understanding to what extent the 
impairments in attention and inhibitory responses control induced by blockade 
of glutamate NMDAR in the rat PFC may actually depend on changes in 
CREB phosphorylation occurring in the cortico-striatal circuitry.
In order to achieve a better comprehension of the phenomena the approach has 
been characterized by experiments performed both in vivo and ex-vivo, in 
behaviourally naive rats as well as in rats trained to perform the behavioural 
task.
In Chapter 3 I report that in behaviourally naive rats, (R)-CPP at the dose that 
impairs attentional functioning and inhibitory response control (Mirjana et al.
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2004), affected p-CREB in the FC and CPu but not in the NAC (summarized in 
Table 6.1). These results are compatible with previous findings showing that 
systemic PCP and MK-801 increase p-CREB in the FC and CPu (Pozzi et al. 
2010; Svenningsson et al. 2003).
I also report (Chapter 3) that (R)-CPP infused in the mPFC increased p-CREB 
in the orbitofrontal cortex, a result compatible with the study of Sun et al. (Sun 
et al. 2010) showing a positive association between impulsivity measured in 
the 5-CSRT task (increased anticipatory responding) and p-CREB levels in the 
same region.
Amongst the three major CREB’s upstream kinases that were measured (i.e. p- 
PKA, p-ERKl/2 and p-CaMKII), I found that only p-PKA was significantly 
decreased by (R)-CPP within the FC and CPu (Table 6.1). However, the 
precise role of PKA in the (R)-CPP-induced CREB phosphorylation in the FC 
was not clearly established. Indeed, while the decreased levels of p-PKA 
correlate with decreased levels of p-CREB in the CPu, in the FC a decrease in 
p-PKAc was associated with increased p-CREB levels suggesting that other 
mechanisms participate to (R)-CPP-induced CREB phosphorylation.
The fact that phosphorylation of ERK1/2 and CaMKII was not modified by 
(R)-CPP was not surprising as also the PCP- and MK-801-induced p-CREB 
changes were independent from these kinases (Pozzi et al. 2010; Svenningsson 
etal. 2003).
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Table 6.1.
Effect of (R)-CPP on p-CREB and p-PKA levels.
10 min 4 ' 4 / N.E.
40 mill t 4^ N.E.
10 min 4 , 4 . N.E.
40 min 4 , 4 . N.E.
I reduction; f increase; N.E. no effect.
In Chapter 4 ,1 report that LY379268 ameliorated accuracy and some aspects of 
response control such as impulsivity disrupted by (R)-CPP (results summarized 
in Table 6.2). These results confirm and extend our previous findings in mice 
(Greco et al. 2005). I also report that LY379268 significantly prevents (R)- 
CPP-induced changes in p-CREB in the FC, but not in the CPu (Table 6.2). 
Moreover, the microdialysis experiments presented in Chapter 4, confirm that 
disinhibition of GLU transmission in the FC could account for the behavioural 
impairments induced by blockade of NMDAR in the FC (Baviera et al. 2008; 
(Calcagno et al. 2009; Calcagno et al. 2006; Carli et al. 2006; Ceglia et al. 
2004; Mirjana et al. 2004), as pretreatment with LY379268, which prevented 
(R)-CPP-induced behavioural impairments in the 5-CSRT task, also prevented 
GLU release in the same region (Table 6.2).
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Table 6.2.
Effects of (R)-CPP alone or in combination with LY379268 on 5-CSRT task 
performance, p-CREB levels and GLU release.
ACCURACY R
IMPULSIVITY R
COMPULSIVITY
OMISSIONS
ir reduction; t  increase; R reversal.
Interestingly, by studiyng the p-CREB’s upstream protein kinases, I found that 
LY379268 increased p-PKA levels in FC and CPu while levels of p-CaMKII 
where selectively increased in the FC. These results suggest that the ability of 
LY379268 to prevent the (R)-CPP-induced p-CREB changes in the FC, might 
involve alterations in Ca2+/ CaM signals in that region (Table 6.3).
Table 6.3.
Effects of LY379268 on protein kinases levels.
p-PKAc t t
p-CnMKII t N.E.
1" increase; N.E. no effect.
The results report in Chapters 3 and 4 were obtained in behaviourally naive rats 
and, together with some published evidences (Pozzi et al. 2010; Svenningsson
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et al. 2003), suggested that the NMDAR antagonists induced deficits in the 5- 
CSRT task may be associated to increased levels of p-CREB in the FC. 
However, it has been shown that accuracy measured in rats performing the 5- 
CSRT task was impaired when levels of p-CREB in the FC were reduced by 
viral vector gene transfer (Paine et al. 2009).
Thus, to address the possibility that the effect of (R)-CPP on p-CREB might 
depend on the behavioral performance of the rats, p-CREB levels were 
measured in rats doing the 5-CSRT task (Chapter 5). Interestingly (R)-CPP- 
induced p-CREB levels were decreased in the PFC in rats performing the task 
as opposed to those that were food deprived, exposed to the box but were not 
trained on the task. There was also a significant increase in p-CREB levels in 
the NAC of (R)-CPP-treated rats performing the task, which I never found in 
the same region in behaviourally naive rats.
Thus as summarized in Table 6.4, the data show that the direction of changes in 
p-CREB and the regions involved after blockade of NMDAR in the PFC may 
critically depend on the behavioural state of animals.
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Table 6.4.
(R)-CPP-induced CREB changes in rats performing the task
Effects of intra mPFC infusion of (R)-CPP on T-CREB and p-CREB levels rats 
not performing (CPP alone) or performing (5-CSRT+CPP) the behavioural 
task.
Untrained +CPP 5-CSRTT+CPP
T-CREB
p-CREB
FC CPu NAC FC CPu NAC
N.E. N.E. N.E. N.E. t
t N.E. N.E. 4 - N.E.
•I reduction; t  increase; N.E. no effect.
The c-AMP analogue Sp-cAMP was then used as a pharmacological tool to 
specifically increase p-CREB levels in the FC to see whether this was 
sufficient to prevent the deficits induced by (R)-CPP in rats performing the 
behavioural task.
I show in Chapter 5 that Sp-cAMP, at the dose that increased p-CREB in the 
FC (Table 6.5), prevented (R)-CPP-induced attention deficits in rats 
performing the task (Table 6.6), thus supporting a role for decreased cortical p- 
CREB in controlling attention and impulsivity.
Table 6.5.
Time course effects of intra mPFC infusion of Sp-cAMP on p-CREB levels.
p-CREB (10 mill) t 4^
p-CREB (40 mill) t N.E. N.E.
'I reduction; t  increase; N.E. no effect.
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Table 6.6.
Effects of (R)-CPP on behavioural performance in the presence of Sp-cAMP
a c c u r a c y N.E. R
IMPULSIVITY N.E. R
COMPULSIVITY N.E. N.E. N.E.
OMISSIONS t N.E. N.E.
•I reduction; t  increase; N.E. no effect; R reversal.
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6.2 Concluding remarks and clinical implications
This study has analyzed the pattern of (R)-CPP-induced CREB 
phosphorylation in naive, untrained and in rats trained to perform the 5-CSRT 
task, indicating that CREB, which is involved in modulating attentional 
processes, is differentially regulated in a region- and time-dependent manner 
by exposure to NMDAR antagonists. The present results point out that the 
stautus of the animal (trained vs. untrained) determines the effect of (R)-CPP 
on CREB phosphorylation indicating that studying the effects of drugs 
affecting attention in naive animals might not be appropriate to investigate the 
underlying molecular mechanisms. At present, changes in CREB 
phosphorylation on SI33 induced by NMDAR antagonists may be considered 
a sensitive index of NMDAR-induced changes in neuronal activity. Although 
no direct links can be established between changes in CREB phosphorylation 
and attention performance, findings in trained rats suggest that reduced CREB 
phosphorylation in the FC is associated with attention deficits.
There is little doubt that patients with schizophrenia have attentional 
impairment deficits in executive functions and working memory (Egan et al. 
2001) but it is quite difficult to specify the underlying neuronal and 
neurochemical basis of these deficits. In humans, some lines of evidences 
implicate CREB cascade in the pathophysiology of schizophrenia. In 
particular, two novel variants have been found in the promoter region of the 
CREB gene in schizophrenic patients but replication studies are pending 
(Kawanishi et al. 1999). Binding of forskolin to adenylate cyclase was found
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to be significantly elevated in the hippocampal regions in post mortem 
schizophrenic brains as measured by quantitative autoradiography (Kerwin and 
Beats 1990). Moreover, increased cyclic AMP response to forskolin was also 
found in human B-lymphocytes derived from schizophrenics (Natsukari et al. 
1997).
Indeed, the regions which displayed altered CREB activity in response to 
NMDAR blockade are also key regions that are dysfunctional in schizophrenia. 
Thus, CREB may represent a molecular target for the development of novel 
drugs that may result effective on cognitive deficits of schizophrenia.
In summary, the results of this study have identified phospho-S133-CREB as a 
new downstream target modulated by NMDAR antagonists, which may be 
important in attention control.
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